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Hamed Abedtash 
 
AN INTEROPERABLE ELECTRONIC MEDICAL RECORD-BASED PLATFORM 
FOR PERSONALIZED PREDICTIVE ANALYTICS 
 
Precision medicine refers to the delivering of customized treatment to 
patients based on their individual characteristics, and aims to reduce adverse 
events, improve diagnostic methods, and enhance the efficacy of therapies. Among 
efforts to achieve the goals of precision medicine, researchers have used 
observational data for developing predictive modeling to best predict health 
outcomes according to patients’ variables. 
Although numerous predictive models have been reported in the literature, 
not all models present high prediction power, and as the result, not all models may 
reach clinical settings to help healthcare professionals make clinical decisions at the 
point-of-care. The lack of generalizability stems from the fact that no comprehensive 
medical data repository exists that has the information of all patients in the target 
population. Even if the patients’ records were available from other sources, the 
datasets may need further processing prior to data analysis due to differences in the 
structure of databases and the coding systems used to record concepts.  
This project intends to fill the gap by introducing an interoperable solution 
that receives patient electronic health records via Health Level Seven (HL7) 
messaging standard from other data sources, transforms the records to 
observational medical outcomes partnership (OMOP) common data model (CDM) for 
population health research, and applies predictive models on patient data to make 
predictions about health outcomes.  
This project comprises of three studies. The first study introduces CCD-TO-
OMOP parser, and evaluates OMOP CDM to accommodate patient data transferred 
by HL7 consolidated continuity of care documents (CCDs). The second study 
explores how to adopt predictive model markup language (PMML) for standardizing 
dissemination of OMOP-based predictive models. Finally, the third study introduces 
Personalized Health Risk Scoring Tool (PHRST), a pilot, interoperable OMOP-based 
model scoring tool that processes the embedded models and generates risk scores in 
a real-time manner. 
 vii 
The final product addresses objectives of precision medicine, and has the 
potentials to not only be employed at the point-of-care to deliver individualized 
treatment to patients, but also can contribute to health outcome research by easing 
collecting clinical outcomes across diverse medical centers independent of system 
specifications.  
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CHAPTER 1. INTRODUCTION 
1.1. Background 
This project intended to develop an interoperable information technology (IT) 
solution that deploys health outcome predictive models at the point-of-care for 
healthcare providers use. The final product not only will address objectives of 
precision medicine to deliver individualized care to patients, but also has the 
potentials to be employed in clinical decision support systems. 
Personalized medicine also known as “precision medicine” refers to the 
delivering of customized treatment to patients based on their individual 
characteristics (1, p. 125), and aims to reduce adverse events, improve diagnostic 
methods, and enhance the efficacy of therapies. Among efforts to achieve the goals of 
precision medicine, scientists and researchers build predictive modeling using 
population health data to best predict health outcomes according to patients’ 
variables. 
Although numerous electronic medical records (EHR)-based predictive 
models have been reported in the literature, not all models present high prediction 
power, and in rare cases they reach clinical settings to help healthcare professionals 
make clinical decisions at the point-of-care (2, 3). The lack of precision stems from 
the fact that developed predictive models are highly centralized to the data 
warehouse that trained the model. This is because no medical data repository exists 
that stores all health records of a patient from other sources, such as hospitals, 
insurance companies, outpatient pharmacies; thus, predictive models cannot predict 
the outcome as expected when applied outside of the training system. As the result, 
it may fail to be tested and be used in medical practice. Even if the full records were 
available to the researchers, the data may need further processing prior to data 
analysis because they may differ in how the concepts were coded, what coding 
systems were used, and how the databases are structured. 
There are only few reports of deployment of health outcome predictive 
models, and no report exist that applies or evaluates the models across multiple data 
warehouses for clinical effectiveness and cost efficiency. For example, Hu et al., 2015 
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(4) reported an online application for predicting the next 6-month healthcare 
resource utilization by chronic disease patients. The prediction system could make 
real-time risk assessment using a health information exchange (HIE) electronic 
health records warehouse; however, it was not evaluated in other HIE networks. In 
another effort in Canada, Khazaei et al., 2015 (5) proposed a cloud-based Analytics-
as-a-Service framework for real-time patient monitoring in the clinical edition and 
retrospective health analytics in the research edition across multiple EHR systems. 
They deployed an algorithm to identify septic neonates in an intensive care unit; 
however, the report did not provide any information about data exchange standards 
or data transformation processes (e.g., inter-vocabulary mapping of concept code). 
Although no predictive model was deployed, this study sheds light on novel 
approaches of integrating advanced analytics in healthcare system. Toerper et al., 
2015 (6) also developed a web-based application that predicts daily admission bed 
needs based on EHR data to improve patient flow management. Despite providing a 
real-time tool for monitoring and forecasting patient flow in a hospital setting, the 
proposed system is not interoperable to work across other centers to retrieve new 
incoming patients’ data for better prediction performance. 
Another objective of the project is to provide a decision-making tool for 
computerized clinical decision support (CDS) systems. CDS systems have 
demonstrated advantages for improving patient health and safety through helping 
providers in diagnosing diseases (7, 8), reducing medication errors (9, 10), improving 
patient throughput (11), and healthcare cost reduction (12). The CDS systems also 
support evidence-based practice via delivering recommendations based on evidences 
from clinical research regarding the patient’s conditions, treatments, and adverse 
health events (13, 14). The CDS systems generate alerts based on the embedded rule 
engine and available knowledge base to help healthcare providers make better 
clinical decisions; however, the providers often ignore the messages and override 
about 96% of the generated alerts (15-17), mainly because the alerts are nonspecific, 
irrelevant, vague, or shown repeatedly that make the system’s user fatigued (15, 18, 
19). This “alert fatigue” phenomenon may cause prescribers to ignore important 
alerts that ultimately will pose further adverse events and life-threatening risks to 
the patients (20, 21). For that reason, many reports have underscored the urgent 
need for effective solutions to trigger more relevant and accurate alerts (18, 21-23).  
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1.2. Statement of the Problem 
The existing healthcare IT solutions have not leveraged forecasting 
capabilities of predictive models in medical practice to provide clinicians with 
personalized recommendations about patients’ health status. No system also exists 
that can populate and transform patient information for population health research 
from different data repositories with diverse coding systems. This project intends to 
fill the gap via designing, evaluating, implementing an interoperable solution that 
receives patient electronic health records via Health Level Seven (HL7) messaging 
standard, transforms the records to a common data model for population health 
research. Another solution receives predictive model in PMML format, and applies 
the models on patient information to make predictions about health outcomes, and 
delivers the results to healthcare professionals.  
1.3. Conceptual Framework of the Study 
The growing availability of healthcare data in the last decade has provided 
tremendous opportunities for conducting large-scale clinical and population health 
research to support evidence-based medicine. Thanks to the Meaningful Use 
incentive program (24) introduced by American Recovery and Reinvestment Act of 
2009 (25), the electronic health records of millions of Americans are stored in 
repositories throughout the nation that are being used for building new, more 
accurate predictive models. This Big Data from of hospitals, clinics, physician 
offices, and insurance companies comprises patient data from hospitals and 
physician offices, reimbursement claims (e.g., Medicaid and Medicare, private 
insurance companies), genetic and genomic, payments, administrative, and care 
expenditure data that makes it an invaluable, comprehensive resource for 
healthcare organizations and care providers to advance patient safety and quality of 
care (26).  
A wide range of predictive models have been derived from EHRs and 
observational data with the goal to improve patient safety, cut treatment costs 
through early detection of diseases, and assist clinicians to make accurate clinical 
decisions. Typical examples of predictive models include predicting prognostic risk of 
health events (27-29), disease screening (30-32), and managing short- and long-term 
complications (33-36). In one study on senior patients in Veterans Affairs (VA) 
nursing homes, the researchers could estimate personalized change in functional 
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loss and recovery after hospitalization with 84-92% accuracy using random forest 
approach (37). In another study, the use of EHR data could refine prediction of 30-
day hospital readmission risk after percutaneous coronary intervention (38). 
Predictive models have also been used to support individuated decision support 
through estimating complications, short-term readmission, and long-term prognosis 
(39). Lee et al., 2015 (40) also reported a prognostic prediction model that has the 
potential to help clinicians design personalized treatments for ischemic stroke. 
Predictive modeling can also improve patients’ safety by reducing human errors. 
Physicians and healthcare providers are prone to cognitive biases, logical fallacies, 
false assumptions, and other reasoning failures when making clinical decision about 
diagnosis or treatment (41); therefore, predictive analytics tools may help them fill 
the gap by providing prediction estimates about the patients’ conditions.  
The literature has numerous examples of predictive modeling methodologies 
to build individualized models, such as logistic regression to predict prognosis of 
health outcomes (38-40, 42), Cox proportional hazards model for estimating opioid 
dose-related risk of injuries in older adults (43) and survival analysis (44), linear 
regression for exploring outcome predictors (45), and personalizing medicine dosage 
(46) and risk estimations (39), and random forest for individualized medicine doses 
(37, 47). Researchers have also examined several machine learning methods to 
improve the accuracy and generalizability of the developed predictive models, such 
as support vector machine (SVM) for early detection of myocardial infarction (47) 
and mortality risk of radical cystectomy (48), Markov Decision Process for predicting 
mortality and length of hospitalization in septic patients (49), k-nearest neighbor for 
warfarin dosage estimation (50), naïve Bayes network for cardiovascular disease risk 
(51), classification and regression tree (CART) for heart failure patients’ readmission 
risk using EHR data (52). 
Predicative models are also being considered to improve the performance of 
CDS systems. Despite the efforts to optimize the number and quality of alerts, such 
as stratifying alerts by severity (53, 54), adjusting messages based on care setting 
and provider’s specialty (55), introducing context-specific alerts (56), incorporating 
human factor principles (57), filtering overridden alerts (58), prioritizing alerts 
based on experts recommendation (59), no unanimous solution exists in the 
literature for this challenge. In recent years, the CDS systems have moved toward 
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using artificial intelligence and predictive models in clinical practice. This approach 
not only addresses the alert fatigue concern, but also promotes evidence-based 
medicine via providing personalized estimations and recommendations to clinicians 
for better care quality and more effective treatments. For example, Levin et al., 2012 
(60) reported that implementation of a predictive model in an intensive care unit 
CDS system could improve patient flow management by providing real-time, 
personalized length of stay estimations. In addition, machine learning approaches 
could also improve patient outcome through generating personalized risk estimates 
and medicine dosages based on patient’s history of medications and comorbidities 
(61, 62). Artificial intelligence may similarly help clinicians in interpreting medical 
images to make more accurate clinical decisions (63). 
Nevertheless, predictive modeling has limitations. The use of predictive 
models is often limited to the system that has provided the training set for model 
development due to data model and coding constrains. There are CDS systems 
equipped with predictive models to estimate personalized survival and risk of 
adverse events based on individual patient data (64); however, accurate predictions 
are only available if the new set of data is formatted the same as the training 
dataset. In fact, the variables within the predictive model do not match with 
incoming data from other sources. Therefore, predictive models are not designed to 
perform predictions on all patients’ data accessible through health information 
exchange networks. 
Local and commercial EHR systems use diverse data models to store health 
records; consequently, medical concepts and measurements are stored using 
different coding systems that impedes direct exchange of information between 
systems for administration, reimbursement, or medical transactions. Likewise, not 
all predictive models are trained using the same terminologies; thus, similar 
predictor and outcome variables are defined differently across models. For example, 
there are different coding systems for diagnoses (e.g., SNOMED, ICD-9-CM, and 
ICD-10-CM), medicines (e.g., NDC, NDF-RT, and RxNorm), laboratory tests and 
observations (e.g., LOINC, CPT), and procedures (e.g., CPT, ICD-9-CM) that need 
further processes to map the concepts across different coding vocabularies for 
intersystem communications. This diversity of ‘languages’ and the need for 
exchanging data have been the chief motive to develop common data models, such as 
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HL7 Reference Information Model (RIM) (65) and the Observational Medical 
Outcomes Partnership Common Data Model (OMOP CDM) (66). 
Adding new functionalities to EHR systems is often accompanied with 
deployment costs (e.g., hardware and software), modifications in the system’s 
architecture, and extra maintenance expenses (67). Cloud computing is an emerging 
solution that not only reduces the costs, but also offers rapid scaling, improved 
accessibility, and better adaptability to new systems and workflows (68-72). 
According to the National Institute of Standards and Technology (73), cloud 
computing technology refers to “a model for enabling ubiquitous, convenient, on-
demand network access to a shared pool of configurable computing resources (e.g., 
networks, servers, storage, applications, and services) that can be rapidly 
provisioned and released with minimal management effort or service provider 
interaction.” Moving the computing engine to the cloud will ultimately allow the 
EHR venders to expand their systems’ functionality in a shorter time with minor 
changes in the architecture. 
1.4. Purpose of the Study 
The scope of this project is to design and develop a pilot solution that 
standardizes HL7 CCD data into OMOP CDM, receives predictive models in OMOP-
compliant PMML standard format, and deploys the model on patient data (Figure 
1). The OMOP CDM was chosen over other common data model such as Mini-
Sentinel (74, 75) and PCORnet (76) mainly because the OMOP CDM consists a 
vocabulary that provides mapping relationships to standard concepts. For example, 
all condition concepts whether from ICD-9 or ICD-10, they are all mapped to 
SNOMED CT concepts; LOINC is also the reference for standard concepts of 
laboratory measurement codes, and medication codes are mapped to RxNorm 
vocabulary. This is very helpful to achieve the goals of this project, in particular the 
“plug-and-play” approach of deploying predictive models. 
This project consists of three studies that follow three objectives to achieve: 
(a) Developing and testing an interoperable module that transforms 
patient electronic medical records to a common data model for 
population health research 
(b) Developing a standard for disseminating health-related predictive 
models 
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(c) Developing an interoperable prediction system that accepts patients’ 
data with diverse data models to provide real-time, personalized 
estimations about health associated risks or outcomes 
The first study aims to design, develop, and evaluate a module that 
transforms patient electronic medical records transferred through HL7 consolidated-
clinical document architecture (C-CDA) standard to OMOP (Observational Medical 
Outcomes Partnership) common data model (CDM) for population health research. 
This project focuses on one of HL7 C-CDA document types called continuity of care 
(CCD) that encapsulates summary of patient medical records. Using the HL7 C-
CDA-based CCD parser called “CCD-TO-OMOP” will enable precision medicine 
research including predictive modeling studies to get access to a larger pool of 
medical information of patients.  
The second study intends to develop a new standard based on the existing 
predictive model markup language (PMML) for sharing health outcome risk scoring 
models that are generated using OMOP CDM data. This new OMOP-compliant 
PMML (O-PMML) standard was used in developing the final interoperable solution 
of predictive analytics.  
Ultimately, the third study aims to develop a proof-of-concept Personalized 
Health Risk Scoring Tool (PHRST), an interoperable OMOP-based model scoring 
tool that obtains risk score models in a OMOP-compliant standard format, and 
applies the model on patient information to deliver the personalized risk score to the 
end user who can be a healthcare professional.  
  
 8 
 
Figure 1. The scope of the project is to deploy predictive models on patient data exchanged 
via HL7 messaging standard. The project involves standardizing transferred patient 
information into OMOP CDM, introducing a new standard for disseminating OMOP-based 
predictive models, and building a pilot solution for deployment of health risk scoring models. 
 
 
1.5. Research Questions 
This project explores answers to these questions: 
• How well does OMOP CDM accommodate HL7 C-CDA-based CCD 
data? The answer to this question is important to choose a suitable 
data model that standardizes medical records for population health 
research purpose.  
• How PMML can be adopted to share risk scoring models that are 
generated based on OMOP CDM? 
• What are the functional requirements to develop a tool that can apply 
risk scoring models on OMOP CDM data to calculate the risk of health 
outcomes? 
1.6. Definition of Terms 
In this study, the term prediction or predictive refers to the prediction of any 
health-related event to occur in the future, risk estimation of an unobserved event 
that has already occurred, or prediction of an occurred event but not observed. 
Population health or epidemiology is a field of study that aims to improve 
health-related outcomes of the population through investigating the distribution and 
patterns of the outcomes, and the role of interventions and policies on them (77).  
Predictive Model 
Deployment 
Data Standardization 
Patient Information 
Exchange 
Predictive Model 
Dissemination 
Scope 
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Health Level Seven (HL7) consolidated-clinical document architecture (C-
CDA) is a messaging standard for transferring patient medical records between 
systems. Continuity of Care Documents (CCD)  is one of document types of HL7 C-
CDA standard that contains demographic and a summary of clinical information 
facts about a patient's healthcare encounters (78). 
A data model defines data elements, data types, coding standards, semantics, 
and data restrictions within a database (79). For example, Observational Medical 
Outcomes Partnership (OMOP) common data model (CDM) is a data model 
developed for population health research that allows researchers analyze 
observational data of dissimilar databases similarly by standardizing concepts and 
database structure (80). 
Predictive model markup language (PMML) is an extensible markup 
language (XML)-based standard for inter-system sharing of predictive models and 
the associated data mining requirements (81). 
1.7. Significance of the Study 
The first study delivers CCD-TO-OMOP package that links medical data 
repositories to external databases to receive and transform up-to-date data of 
existing or new patients to a standard format, ready for population health research. 
This is a significant achievement as currently no links exist between repositories to 
share patient data that may help increase sample size of population health research, 
ultimately increase power of inferences. This is because of discrepancies in database 
structures and coding systems used to store concepts. Therefore, this module builds 
bridges between observational data warehouses to enhance generalizability of 
population health studies. 
The proposed O-PMML provides an OMOP-compliant standard format for 
sharing health outcome risk scoring models between IT systems that defines the 
specifications of data mining, predictive models, and scoring process. This standard 
enables researchers to disseminate OMOP-based predictive models between disjoint 
OMOP repositories, and deploy the models on observational data of the destined 
database in less time but more accurately. It also provides the opportunity to 
disseminate models through information exchange networks. 
The final interoperable system receives medical information through HL7 
CCDs and predictive models via OMOP-compliant PMMLs, and displays the scoring 
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results to the provider through PHRST. This is a significant feature that enables the 
system to deploy multiple predictive models at once. This system has high potentials 
to act as a decision-making tool in CDS systems to improve patient health outcomes 
through delivering real-time clinical recommendations. The interoperable system 
not only makes it feasible to deploy trained predictive models in CDS systems, but 
also it will be accessible through health information exchange networks for 
distributed computing purposes with no need for further data transformation. 
Hence, personalized recommendations about a patient can be processed independent 
of the technology in CDS and the original data model used in training predictive 
models. 
1.8. Organization of the Study 
This study lays out an IT solution to deliver scoring of predictive and 
population health analyses on patient electronic health records in an interoperable 
manner where both patient information and predictive models are transferred in 
standard formats.  
Chapter 2 asks “Does OMOP CDM accommodate health information 
transferred by HL7 C-CDA CCD messaging standard?” It describes the developed 
CCD-TO-OMOP parser that transforms patient information into OMOP common 
data model. It also examines the robustness of OMOP CDM to take data elements 
and the accuracy of concept standardizing pipeline.  
Chapter 3 asks “How to adopt PMML for disseminating predictive models 
generated based on OMOP CDM requirements?” It explores the architecture of 
PMML, and describes how to adopt the language for standardizing dissemination of 
OMOP-based predictive models. It also introduces the scoring engine that translates 
OMOP-compliant PMMLs to predictive models and applies the model on patient 
data. 
Chapter 4 explores “How to build the interoperable EHR-based predictive 
analytics system”. It describes how CCD-TO-OMOP parser, OMOP-compliant 
PMMLs, and scoring engine are assembled to build an interoperable scoring system 
named Personalized Health Risk Scoring Tool (PHRST) to deliver real-time risk 
scores. 
Chapter 5 concludes with a summary of findings of this project and potential 
future work to improve the performance of the solution and real-world evaluations. 
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CHAPTER 2. OMOP COMMON DATA MODEL ACCOMMODATES HL7 
CONSOLIDATED CDA-BASED CCD DATA FOR POPULATION HEALTH 
RESEARCH 
2.1. Introduction 
Personalized medicine also known as “precision medicine” refers to the 
delivering of customized treatment to patients based on their individual 
characteristics (1), and aims to reduce adverse events, improve diagnostic methods, 
and enhance the efficacy of therapies.  
To achieve the goals of precision medicine, population health scientists and 
researchers extensively rely on observational data that are collected during 
healthcare services to study associations between health determinants and build 
predictive models to tailor individualized therapies for patients. However, no study 
findings exist that can be fully generalized to the whole target population, and not 
all models present high prediction power to reach clinical settings for clinical 
decision making at the point-of-care. The lack of precision stems from the fact that 
analyses are limited to the dataset of medical records that may not well represent 
the population.  
2.1.1. Problem statement 
To mitigate lack of generalizability, it is recommended to sample patients 
from different tiers of the target population; however, no medical data repository has 
the information of all patients and no repository can be found to have all health 
records of patients from other sources, such as hospitals, insurance companies, 
outpatient pharmacies. Even if the full records are available to the researchers from 
other data sources, it may not be straightforward to use the data for research as it is 
probable to see discrepancies in the coding system of concepts and how the 
databases are structured. This study addresses this problem by designing, 
evaluating, implementing an interoperable solution that receives patient electronic 
health records via HL7 messaging standard, and transforms the records to OMOP 
CDM to be used in population health research. 
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2.1.2. HL7 continuity of care document 
The main use of CCDs is to transfer a summary of patient’s demographics 
information, administrative data, and clinical facts such as diagnosed disease, 
symptoms and signs, prescribed and administered medicines, carried out 
procedures, and clinical test and imaging. The document may also contain optional 
sections regarding care encounters, family history, immunizations, functional status, 
payers, and treatment plan. This study evaluated this messaging standard to be 
used as a data stream for epidemiological and drug safety studies. Although the 
architecture of generated CCDs from different institutions follow the HL7 
implementation guidelines, discrepancies may exist in how clinical concepts are 
coded. Therefore, the encapsulated concepts need to be standardized before using the 
patient records in cohort selection and analyses. Table 1 shows a summary of 
document-level templates in HL7 version 3 consolidated clinical document 
architecture (C-CDA) Release 1.1. 
2.1.3. The Observational Medical Outcomes Partnership (OMOP) 
The Observational Medical Outcomes Partnership (OMOP) is a collaboration 
of FDA, pharmaceutical industry, data owners, and academia to identify informatics 
requirements, propose methodologies, and test the solutions for drug safety and 
population health research through enhancing use of observational data (i.e., 
medical records) (82). In population health research, it is preferable to use large, 
multicenter cohort of patients in the studies to minimize potential biases (such as 
sampling and measurement). However, medical data are stored with diverse data 
models and coding systems in healthcare warehouses that makes it cumbersome, 
often unsuccessful to integrate all data elements in one place for research. The 
partnership has introduced a common data model (CDM) to address this problem 
(80).  
The OMOP CDM reorganizes the observational data elements into a format 
that supports population health research to explore and quantify associations 
between exposure and outcomes, survival analysis, and causality relationships. This 
project adopts the CDM to standardize all incoming data into one common format for 
data analyses. In this data model, different codes from various coding systems but 
representing one concept are linked to (i.e., unified under) a common ID called 
OMOP Concept ID. For example, one procedure may be coded in ICD-9-CM, ICD-10-
 13 
CM, CPT-4, or any other vocabularies in different CCDs, but it would be linked to 
one Concept ID in OMOP CDM. In addition, the concepts are placed under the most 
proper domain to conduct epidemiological research. For example, familial histories 
of diseases are usually coded in ICDs and may be considered conditions; however, 
these occurrences are fall under definition of observations. This approach not only 
unifies codes under one concept, but also validates whether the codes are correctly 
assigned to the right concept and domain. 
The latest OMOP CDM version 5.1 (83) comprises six domains and 39 data 
tables (Figure 2). The domains are person-centric that makes the CDM an 
appropriate model for this project to deliver patient-specific predictions. The 
embedded ‘common’ vocabulary covers a complete list of standardized dictionaries 
and vocabularies. Each concept has a unique identifier while preserves the code from 
the original vocabulary for easy matching. There is also a concept relationship table 
that defines direct relationships between concepts to map them across vocabularies 
possible. 
 
 
Figure 2. OMOP Common Data Model Version 5.1 conceptual model (83).  
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2.1.4. Objectives 
This chapter aimed to assess feasibility and accuracy of mapping exchanged 
electronic health records (EHR) via HL7 C-CDA CCDs to OMOP CDM. It also 
validates the suitability of the model to accommodate CCD data. Finally, it delivers 
a validated CCD-TO-OMOP parser that will be used in the proposed interoperable 
predictive analytics framework. 
The accommodation assessment answered the questions whether (a) OMOP 
CDM tables have the right data fields with appropriate data type to store CCD data, 
(b) OMOP CDM vocabulary covers CCD source codes, (c) OMOP CDM has the proper 
concept relationships to map CCD source codes, and (d) HL7 C-CDA-based CCD 
feeds the CDM tables with the minimum required data for epidemiological studies. 
A minimum required data varies one table to another, but generally it consists of the 
code and coding system of the event (e.g., condition report, drug administration), 
date of event, and associated values to the event. For example, the minimum 
expected data in Drug Exposure table were drug code and the respective coding 
system, the date of drug administered or dispensed, quantity of drug dispensed, 
ordered dose, and days of drug supply. 
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Table 1. A summary of document-level template of HL7 C-CDA Consolidated Continuity of Care Document (CCD) Release 1.1 and 
corresponding Object identifiers (OID). 
Section Name Object Identifier (OID) Description 
US Realm Header 2.16.840.1.113883.10.20.22.1.1 Describes patient’s demographics (e.g., gender, race, 
marital status) and common administrative information 
(e.g., patient’s name and address, author, provider). 
Advance Directives Section (entries 
optional) 
2.16.840.1.113883.10.20.22.2.21 Describes patient’s directives of living wills, resuscitation 
status, CPR orders, and healthcare proxies. 
Allergies Section (entries required) 2.16.840.1.113883.10.20.22.2.6.1 Describes allergies to food, medicines, and other 
substances (e.g., latex), and reported adverse reactions. 
Encounters Section (entries optional) 2.16.840.1.113883.10.20.22.2.22 Lists the history of encounters between patient and 
healthcare providers for diagnosis, treatment, or 
evaluating medical condition purposes. 
Family History Section (entries 
optional) 
2.16.840.1.113883.10.20.22.2.15 Describes health risk factors of patient’s biologic parents 
that may affect the patient’s risk of medical condition 
occurrences. 
Functional Status Section (entries 
optional) 
2.16.840.1.113883.10.20.22.2.14 Describes findings and evaluation results of patient’s 
physical function, including basic and instrumental 
activities of daily living (ADLs). 
Immunizations Section (entries 
optional) 
2.16.840.1.113883.10.20.22.2.2.1 Lists history patient’s immunization history. 
Medical Equipment Section (entries 
optional) 
2.16.840.1.113883.10.20.22.2.23 Lists external, implanted, or durable medical devices used 
to treat patient’s medical condition or uphold the health 
status. 
Medications Section (entries required) 2.16.840.1.113883.10.20.22.2.1.1 Lists patient’s history of prescribed and dispensed 
medications. 
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Section Name Object Identifier (OID) Description 
Payers Section (entries optional) 2.16.840.1.113883.10.20.22.2.18 Lists all financial, payment, insurance, and health plan 
coverage records pertinent to the healthcare services 
provided to the patient. 
Plan of Care Section (entries optional) 2.16.840.1.113883.10.20.22.2.10 Lists all patient’s ongoing, incomplete, pending, or 
unfulfilled services, orders, encounters, and procedures to 
be carried out in future. 
Problem Section (entries required) 2.16.840.1.113883.10.20.22.2.5.1 Lists patient’s history of clinical conditions and problems. 
Procedures Section (entries required) 2.16.840.1.113883.10.20.22.2.7.1 Lists patient’s history of surgical, therapeutics, and 
diagnostic procedures. 
Results Section (entries required) 2.16.840.1.113883.10.20.22.2.3.1 Lists all results of laboratory tests, diagnostic procedures, 
and imaging procedures.  
Social History Section (entries optional) 2.16.840.1.113883.10.20.22.2.17 Describes patient’s social observations, e.g., smoking 
status, pregnancy history, tobacco use, cultural and 
religious practices, etc. 
Vital Signs Section (entries optional) 2.16.840.1.113883.10.20.22.2.4 Describes patient’s vital signs, e.g., blood pressure, 
temperature, pulse rate, height, weight, etc. 
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2.2. Methods and Materials 
I developed the CCD-TO-OMOP ETL module that extracts data from HL7 C-
CDA-based CCDs, maps concepts to OMOP vocabulary, transforms the data into 
OMOP data model, and loads them into a PostgreSQL repository. The ETL pipeline 
located data elements in CCDs based on Template IDs and specifications defined by 
HL7 implementation guide document (78). 
This module was developed and tested in two pilot and production phases. In 
the pilot phase, the module was programmed based on the HL7 implementation 
guide and was debugged using on 10 randomly selected CCDs. Final minor tweaks 
were also made in the codes to reach highest possible extraction, transformation, 
and loading performance. In the production phases, the module was tested for 
accuracy and performance on 250 CCDs, inclusive pilot CCDs.  
2.2.1. HL7 Continuity of Care Documents (CCDs) 
I obtained a randomly selected 250 deidentified CCD documents generated 
based on HL7 version 3 (V3) consolidated clinical document architecture (C-CDA) 
Release 1.1 standard from Regenstrief Institute, Indianapolis, IN. The Regenstrief 
data repository contains electronic health records of more than 2.2 million patients 
who have received health care in Indiana State. Each CCD document contained a 
summary of patient health information including demographics, medical history, 
diagnoses, laboratory test results, prescriptions, immunization records, and 
radiology reports. The sample of CCD documents were obtained randomly from all 
age, sex, race, ethnicity, economic and education groups. 
2.2.2. OMOP vocabulary 
The OMOP vocabulary was obtained on April 12, 2017 from Athena website 
(http://athena.ohdsi.org/), the official resource of OMOP CDM standardized 
vocabularies (84). 
2.2.3. Overview of the ETL package 
The “CCD-TO-OMOP” is a Python ETL package that extracts patient medical 
record from CCDs based on HL7 consolidated clinical document architecture (C-
CDA) format, transforms the data into OMOP CDM, and finally loads the 
transformed information into staging tables to be used for further use, e.g., 
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statistical analytics and health outcome predictions. The package consists of four 
modules (Figure 3): CCD Parser, OMOP Mapper, Loader, and Database Connector. 
The CCD Parser module extracts demographics, medicines, conditions, care 
provider encounters, laboratory test results, and observations data from CCDs. The 
extraction pipeline points to the Template IDs specified by HL7 C-CDA (Appendix 
1). It also validates the pulled data whether data elements have the correct values 
for the destination OMOP table.  
Once CCD data are extracted, the OMOP Mapper module transforms the 
data into intermediate OMOP tables–which are instantiated from the OMOP CDM 
module–for further processing. The transformation process translates source codes 
into OMOP standard Concept IDs (e.g., mapping drug codes to a standard RxNorm 
code in OMOP vocabulary), and extracts values where appropriate (e.g., year and 
month from CCD drug dispensing date). Next, the Loader module loads the 
transformed data from the intermediate tables into an OMOP CDM database that 
can be accessible by the end user. Both the OMOP Mapper and Loader modules use 
the Database Connector module to lookup OMOP values and load transformed data 
into the database, respectively. 
 
 
Figure 3. A schematic of CCD-TO-OMOP package 
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2.2.4. Extraction of HL7 CCD data 
The developed ETL mainly targeted clinical data encapsulated in C-CDA-
based CCD documents, including condition occurrences, allergies, drug exposures, 
procedures, encounters, laboratory tests, imaging reports, immunization, vital signs, 
and familial risk factors. The scope of this study was to explore certain tables of 
OMOP CDM that are key to conduct observational studies, including patient 
demographics (Person table), periods of observing patient health events (Observation 
Period table), visit encounters (Visit Occurrence table), diagnoses and health 
conditions (Condition Occurrence table), continuous intervals of diseases and 
conditions (Condition Era table), performed procedures (Procedure Occurrence 
table), administered medications (Drug Exposure table), continuous intervals of 
medication use (Drug Era table), results of medical evaluations (Measurement table), 
and clinical observations (Observation table).  
Based on the described data requirements, the parser located the 
corresponding HL7 C-CDA template within the documents by Template ID to ensure 
targeting the right data elements. Appendix 1 presents all Template IDs that parser 
used to locate entries. The data was captured only if the activity was fulfilled, 
meaning that the activity was an event (i.e., moodCode = “EVN”) and the status was 
completed (i.e., Status Code = “completed”). 
2.2.5. Transformation of HL7 CCD data to OMOP CDM 
The parser transformed the extracted and transformed CCD data table by 
table in the following steps: 
Step 1) Primary mapping source values to OMOP concepts: The parser 
mapped terminology codes and non-coded values to OMOP 
vocabulary concepts using the query in Appendix 2 against OMOP 
standardized vocabularies. The terminology codes represent 
clinical concepts, such as condition, medication, procedure, and 
evaluations from terminologies, including but not limited to 
Current Procedures Terminology (CPT), Systematized 
Nomenclature of Medicine – Clinical Terms (SNOMED CT), 
Logical Observation Identifiers Names & Codes (LOINC), 
International Classification of Diseases (ICD), the Healthcare 
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Common Procedure Coding System (HCPCS), and RxNorm. The 
non-coded values included units of laboratory tests (e.g., mg/L) and 
non-numeric results of measurements (e.g., high, low, normal).  
Step 2) Mapping source values to OMOP standard concepts: The parse 
also mapped terminology codes and non-coded source values to 
OMOP standard concepts using Appendix 3 query against OMOP 
vocabulary. 
Step 3) Applying OMOP transformation rules: Each OMOP CDM table has 
specific business rules to transform source data to be stored in the 
CDM. For example, Condition Era table requires that the 
condition eras shall be built with a “Persistence Window of 30 
days”, meaning that the condition era continues as long as the 
condition has been reported within the following 30 days after the 
report date (Condition Start Date). The parser applies these rules 
on a table by table basis. 
Step 4) Appropriate data allocation: There are some instances that the 
extracted source data does not belong to the target table. 
Therefore, the ETL parser redirected the data into the proper table 
as required by OMOP CDM rules. For example, family history of 
diseases may be reported under Problem Observation section 
within the CCD document; however, these concepts are considered 
observations by OMOP vocabulary. Therefore, the ETL stored the 
concepts in Observation table instead of Condition Occurrence 
table.  
The following sections of this manuscript describe the data transformation 
process more in details. 
2.2.5.1. Mapping source values to OMOP concepts 
There are two types of concepts in OMOP vocabulary: Standard and non-
standard concepts. Designated standard concepts are the only concepts that can be 
used to represent clinical entities in standardized analytics and table fields ending 
with _Concept_Id. The standard concepts originate from standardized vocabularies, 
such as SNOMED CT for conditions and diagnoses, RxNorm for drugs, and LOINC 
 21 
for observations and laboratory tests. Non-standard or source concepts are direct 
representations of source codes in OMOP vocabulary that need to be mapped to 
standard concepts to be used in analytics. OMOP table fields ending with 
_Source_Concept_Id may contain either standard or non-standard concepts 
depending on whether a direct standard or source OMOP concept identifier exist for 
the source code.  
2.2.5.2. Person table 
Person table fields were sourced from recordTarget section of C-CDA 
documents that contains demographics data. The scope of this transformation was to 
process all fields of Person table except Location ID, Provider ID, and Care Site ID. 
Table 2 present more details of data transformation process to build OMOP Person 
table. 
A randomly generated unique identifier was recorded in Person ID for each 
parsed C-CDA document to link further patient information in other tables. Gender 
information are located under administrativeGenderCode element in C-CDA 
document coded in HL7 V3 administrative gender value set, including male, female, 
undifferentiated. Table 3 shows the equivalent OMOP concepts of HL7 
administrative gender codes.  
Date of birth information was extracted from birthTime element with a 
precision from year to days. The first four digits of the value represent patient’s year 
of birth (Year of Birth field), the next two digits are month of birth (Month of Birth 
field), and subsequently the two next digits are days of birth (Day of Birth field).  
Patient’s race and ethnicity information are coded in CDC (Centers for 
Disease Control and Prevention) race and ethnicity value set, and were collected 
from raceCode and ethnicGroupCode elements, respectively. They were mapped to 
OMOP concepts as shown in Table 4.  
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Table 2. Mapping HL7 C-CDA CCD data to Person table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
person_id – Randomly generated unique identification per C-CDA 
document 
gender_concept_id – OMOP standard Concept ID of Gender Source Value 
year_of_birth US Realm Header: birthTime  Extracted year part of the date of birth 
month_of_birth US Realm Header: birthTime  Extracted month part of the date of birth 
day_of_birth US Realm Header: birthTime  Extracted day part of the date of birth 
race_concept_id – OMOP standard Concept ID of Race Source Value 
ethnicity_concept_id – OMOP standard Concept ID of Ethnicity Source 
Value 
gender_source_value US Realm Header: 
administrativeGenderCode  
 
gender_source_concept_id – OMOP Concept ID of Gender Source Value 
If Domain ID = “Gender” and Invalid Reason = Null 
race_source_value US Realm Header: raceCode   
race_source_concept_id – OMOP Concept ID of Race Source Value 
If Domain ID = “Race” and Invalid Reason = Null 
ethnicity_source_value US Realm Header: ethnicGroupCode   
ethnicity_source_concept_id – OMOP concept id of Ethnicity Source Value 
If Domain ID = “Gender” and Invalid Reason = Null 
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Table 3. Matching OMOP concepts of HL7 administrative gender codes  
HL7 V3 Administrative Gender  OMOP Standard Concept 
Code Description  Concept ID Concept Name 
F Female  8532 Female 
M Male  8507 Male 
UN Undifferentiated  8551 Unknown 
 
 
Table 4. Matching OMOP concepts of CDC race and ethnicity value set 
CDC Race and Ethnicity Values  OMOP Standard Concept 
Code Description  Concept ID Concept Name 
1002-5 American Indian or 
Alaska Native 
 8657 American Indian or 
Alaska Native 
2028-9 Asian  8515 Asian 
2054-5 Black or African American  8516 Black or African 
American 
2076-8 Native Hawaiian or Other 
Pacific Islander 
 8557 Native Hawaiian or 
Other Pacific Islander 
2106-3 White  8527 White 
2135-2 Hispanic or Latino  38003563 Hispanic or Latino 
2186-5 Not Hispanic or Latino  38003564 Not Hispanic or Latino 
 
 
2.2.5.3. Observation Period table 
Observation Period table specifies the time frame in which clinical events 
have been continuously captured and the data is available; thus, a patient may have 
multiple observation periods as there are times that patients do not encounter 
clinical events between therapies, such as drug exposure, procedure occurrence, 
condition occurrence, and device exposure. 
Observation periods were populated by consolidating records of visit 
encounters from Visit Occurrence table and reported clinical events from Procedure 
Occurrence, Drug Exposure, Device Exposure, Condition Occurrence, and 
Measurement tables. In case of inpatient visits, the observation period was set to 
begin at the start date of hospitalization and was limited to the clinical events 
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occurred up to 30 days after discharge date to ensure follow-up clinical events were 
included in the same period. In case of outpatient visit occurrences, the observation 
period was calculated by combining continuous clinical encounters if the gaps 
between events were 180 days or less. This wider time windows allows to capture 
related outpatient follow-up events in one period. Finally, the identified periods were 
also consolidated if overlapped or the gap was less than 31 days. Table 5 
summarizes applied rule to transform observation periods. 
 
Table 5. Applied rules to build Observation Period table 
Destination Table Field Applied Rule 
observation_period_id Auto-numbered unique identifier for each 
observation period 
person_id The patient’s identifier from Person table 
observation_period_start_date The start date of consolidated observation period 
observation_period_end_date The end date of consolidated observation period 
period_type_concept_id 44814725 (Period inferred by algorithm) 
 
 
2.2.5.4. Visit Occurrence table 
All patient’s healthcare service visits are stored in Visit Occurrence table at 
healthcare sites, including inpatient, outpatient, emergency room, and long-term 
care services. The parser populates visit occurrence information from Encounter 
Activity entries under Encounters Section in the CCD document that lists patient’s 
visits with healthcare provider that triggered diagnosis, treatment, or evaluation of 
patient health. The CCD Encounter Activity entries provide information about the 
type of encounter, start and end dates of encounter, provider, care service location, 
reported diagnosis due to the encounter, and discharge disposition. Table 6 describes 
the applied rules more in details. 
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Table 6. Mapping HL7 C-CDA data to Visit Occurrence table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
visit_occurrence_id – Auto-numbered unique identifier for each visit 
occurrence 
person_id – The patient’s identifier from Person table 
visit_concept_id – OMOP standard Concept ID of Visit Source Value 
visit_start_date Encounters Section: Encounter Activity 
entry: effectiveTime 
The start date of encounter 
visit_end_date Encounters Section: Encounter Activity 
entry: effectiveTime 
The end date of encounter 
visit_type_concept_id – OMOP standard Concept ID of recorder encounter 
type at C-CDA encounter activity element:  
- 9201 (Inpatient Visit) 
- 9202 (Outpatient Visit) 
- 9203 (Emergency Room Visit) 
visit_source_value Encounters Section: Encounter Activity 
entry: code 
Specifies the care setting where encounter occurred, 
e.g., outpatient, inpatient, etc. 
If source code is a visit concept (i.e., Domain ID = 
“Visit” and Invalid Reason = Null). 
visit_source_concept_id – OMOP Concept ID of Visit Source Value 
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2.2.5.5. Condition Occurrence table 
Observed diseases and symptoms during the observation period which are 
diagnosed by healthcare providers or reported by the patient are captured in 
Condition Occurrence table. The HL7 C-CDA CCD document reports medical 
conditions in Allergies Section and Problem Section. The data of entries were 
captured if the condition or allergy was truly observed (negationInd = “false” under 
Problem Observation). 
The Allergies Section lists the current and past hypersensitivity, adverse 
reactions to any types of allergens, such as food, drug, and latex under Allergy 
Problem Act entries. The cause of the allergy is reported by Allergy-Intolerance 
Observation entry within Allergy Problem Act. Under this entry, allergy observation 
data are recorded in two parts: code element that defines the general type of allergy 
(e.g., allergy to drug substance), and Playing Entity element that specifies the 
allergen (e.g., penicillin). The parser put both data together to determine the 
corresponding OMOP concept. For example, if this was a report of drug allergy to 
penicillin, the parser mapped the finding to a condition concept of “Allergy to 
penicillin” (i.e., Concept ID = 4240903), and stored the record in Condition 
Occurrence table.  
The parser populated reported clinical problems from Problem Observation 
entries under Problem Section that lists current and past medical conditions and 
diagnoses. Since Problem Observation entries may also contain observation, 
procedure, and measurement OMOP concepts other than conditions, the ETL 
pipeline was programmed to only capture the records of OMOP condition concepts 
(i.e., Domain ID = “Condition”), and recorded the data in Condition Occurrence table. 
If the record represented a concept other than condition domain, it was stored in the 
corresponding tables, e.g., familial disease history and history of diagnoses in 
Observation table, medicines in Drug Exposure, and procedures in Procedure 
Occurrence table. Table 7 presents more details on modeling of condition data.  
In case of ongoing allergy and problem concerns (i.e., Status Code = “Active” 
under Problem Concern Act), condition start date was the first reporting date with 
unknown end date (i.e., Null). If it was a resolved problem concern (i.e., Status Code 
= “completed” under Problem Concern Act), both start and end dates were stored in 
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Condition Occurrence table. In case of an allergy which is no longer a concern (i.e., 
Status Code = “completed” under Allergy Problem Act), the record was an 
observation and stored in Observation table. 
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Table 7. Mapping HL7 C-CDA CCD data to Condition Occurrence table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
condition_occurrence_id – Auto-numbered unique identifier for each condition 
occurrence 
person_id – The patient’s identifier from Person table 
condition_concept_id – OMOP standard Concept ID of Condition Source Value 
condition_start_date Allergies 
Allergies Section: Allergy Problem Act: 
Allergy-Intolerance Observation: 
effectiveTime/low 
 
Problems 
Problem Section: Problem Concern Act: 
Problem Observation: effectiveTime/low 
Allergies 
Only if it is an ongoing allergy, i.e., Status Code = “active” 
under Allergy Problem Act 
condition_end_date Problems 
Problem Section: Problem Concern Act: 
Problem Observation: effectiveTime/high 
Allergies 
Null; an active allergy concern does not have end date. 
 
Problems 
If an ongoing concern, i.e., Status Code = “Active” under 
Problem Concern Act, then end date is Null.  
 
If resolved problem concern, i.e., Status Code = 
“completed” under Problem Concern Act, then the 
reported end date.  
condition_type_concept_id – 38000245 (EHR problem list entry) 
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Destination Table Field Matching C-CDA section Applied Rule 
visit_occurrence_id – The identifier of corresponding visit occurrence from Visit 
Occurrence table. Null if Condition Start Date did not 
match with any visit occurrence. 
condition_source_value Allergies 
Allergies Section: Allergy Problem Act: 
Allergy-Intolerance Observation: code 
 
Participating agent in allergies 
Allergies Section: Allergy Problem Act: 
Allergy-Intolerance Observation: Product: 
Product Detail: playingEntity/code 
 
Problems 
Problem Section: Problem Concern Act: 
Problem Observation: code 
If the source code is a condition concept (i.e., Domain ID = 
“Condition” and Invalid Reason = Null). 
 
Allergies 
No space in CDM table to record the participating agent. 
The SNOMED code of the concept that represents the 
allergy or adverse event finding of the allergen is 
recorded (e.g., allergy to penicillin). 
 
Problems 
The source code of reported condition or diagnosis 
condition_source_concept_id – Allergies 
OMOP concept id of Condition Source Value which is the 
same as Condition Concept ID 
 
Problems 
OMOP concept id of Condition Source Value 
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2.2.5.6. Condition Era table 
This table aggregates records of diagnoses and medical conditions in 
consolidated periods of conditions, called condition eras, to prevent double-counting 
of reported conditions, and to enable following chronic conditions through disease 
progression and underlying treatments. 
The parser built Condition Era table using the recorded reports of condition 
in Condition Occurrence table. After excluding the records that no equivalent OMOP 
concept existed for the condition code (i.e. Condition Concept ID = 0), the parser 
consolidated records if the gaps between the start dates of condition occurrences 
were up to 30 days. Table 8 summarizes applied rule to create condition eras. 
. 
Table 8. Applied rules to build Condition Era table 
Destination Table Field Applied Rule 
condition_era_id Auto-numbered unique identifier for each condition 
era 
person_id The patient’s identifier from Person table 
condition_concept_id OMOP standard concept for which condition era is 
built, excluding Condition Concept ID = 0 
condition_era_start_date The start date of consolidated condition era as long as 
medical condition was reported continuously in the 
next 30 days or less. 
condition_era_end_date The end date of consolidated condition era as long as 
medical condition was reported continuously in the 
next 30 days or less. 
condition_type_concept_id 38000247 (Condition era - 30 days persistence 
window) 
condition_occurrence_count The number of condition occurrences involved in the 
consolidated condition era 
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2.2.5.7. Procedure Occurrence table 
This table encompasses the records of diagnostic or therapeutic activities by 
healthcare provider or patient to identify diseases or medical conditions, to 
administer medicine, or to maintain treatment plan (e.g., patient education). The 
parser captured completed procedure activities (Status Code = “completed”) from 
four HL7 C-CDA templates: Procedure Activity Procedure, Procedure Activity 
Observation, and Procedure Activity Act under Procedures Section, and Problem 
Observation under Problem Section. 
The Procedure Activity Procedure template delivers surgical operation data 
for diagnosing or treating diseases that involve physical changes in patient, such as 
biopsy procedure, open heart surgery, drug administration, and laparotomy. The 
Procedure Activity Observation template characterizes diagnostic procedures that 
provide new findings about patient’s disease or medical condition, such as magnetic 
resonance imaging (MRI), echocardiography, and colonoscopy. The Procedure 
Activity Act template covers other clinical activities that do not fall in the previous 
two categories, such as patient education and wound dressing change.  
Other than these three templates, it is probable that some procedures are 
stored in Problem Observation entries. For example, although ICD-9-CM code of 
V76.10 (screening for malignant breast neoplasm, unspecified) is a procedure 
concept; it is listed under problem observations to describe the diagnosis of the 
cancer in claiming medical bills. Thus, the parser was programmed to collect all 
procedure concepts (i.e., Domain ID = “Procedure”) from entries under Problem 
Section. 
As described in Table 9, transformation of data started with mapping 
procedures to OMOP standard concepts belonged to concept domain of “procedure” 
in OMOP vocabulary, and had procedure codes, such as CPT-4, ICDs, SNOMED CT, 
and HCPCS. 
In case of a record of drug administration procedure, the procedure was only 
included in Procedure Occurrence table if the corresponding drug record existed in 
Data Exposure table.  
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Table 9. Mapping HL7 C-CDA CCD data to Procedure Occurrence table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
procedure_occurrence_id – Auto-numbered unique identifier for each procedure 
occurrence 
person_id – The patient’s identifier from Person table 
procedure_concept_id – OMOP standard Concept ID of Procedure Source 
Value 
procedure_date Procedures 
Procedures Section: Procedure Activity 
Procedure: effectiveTime 
Procedures Section: Procedure Activity 
Observation: effectiveTime 
Procedures Section: Procedure Activity Act: 
effectiveTime 
 
Problems 
Problem Section: Problem Concern Act: 
Problem Observation: effectiveTime 
The date when procedure occurred 
If stausCode = “completed” 
procedure_type_concept_id – Procedures 
Procedure Activity Procedure: 38000275 (EHR order 
list entry)  
 
Procedure Activity Observation: 38000275 (EHR 
order list entry) 
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Destination Table Field Matching C-CDA section Applied Rule 
Procedure Activity Act: 38000275 (EHR order list 
entry) 
 
Problems 
Problem Observation: 38000245 (EHR problem list 
entry) 
visit_occurrence_id – The identifier of corresponding visit occurrence from 
Visit Occurrence table. Null if Procedure Date did not 
match with any visit occurrence. 
procedure_source_value Procedures 
Procedures Section: Procedure Activity 
Procedure: code 
Procedures Section: Procedure Activity 
Observation: code 
Procedures Section: Procedure Activity Act: 
code 
 
Problems 
Problem Section: Problem Concern Act: 
Problem Observation: code 
If the source code is a procedure concept (i.e., 
Domain ID = “Procedure” and Invalid Reason = 
Null), AND the service was completed (i.e., 
stausCode = “completed”). 
procedure_source_concept_id – OMOP concept id of Procedure Source Value 
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2.2.5.8. Drug Exposure table 
The Drug Exposure table contains records of vaccines, small-molecule, 
biological, and over-the-counter (OTC) medications. In the C-CDA CCD structure, 
current and past medication activities may be reported in two sections: Medications 
Section represents the history of drug therapy, and Immunization Section lists 
immunization history. The parser collected dispensed or administered medication 
records from Medications Activity template under Medications Section and 
Immunization Activity template under Immunizations Section. Table 11 summarizes 
the processing steps and applied rules to transform medication data. 
Both medication and immunization records were only captured if they were 
supplied to the patients (i.e., dispensed or administered). The record had to meet all 
these criteria to be recognized as an actual medication or immunization activity 
rather than intended action: 
1. Immunization Activity or Medication Activity was completed, i.e., 
substanceAdministration[@moodCode] = “EVN” and 
substanceAdministration/statusCode = “completed”.  
2. Immunization Activity must have substanceAdministration[@negationInd] 
= “false”, indicating that immunization was truly administered. 
3. Medication entries must have Supply Activity indicating that the 
medication was dispensed (supply[@moodCode] = “EVN” and 
supply/statusCode = “completed”) as this template specifies the quantity 
of dispensed drug to the patient. This rule was not applied on 
immunization entries because vaccines are most often recorded as 
administered by a care practitioner. 
2.2.5.8.1. Mapping drug product concepts 
HL7 C-CDA CCD Release 1.1 requires medications to be reported in RxNorm 
concepts, such as semantic clinical drug (SCD), semantic brand drug (SBD), generic 
pack (GPCK), and brand pack (BPCK). The RxNorm codes were mapped to OMOP 
standard Concept IDs using scripts of Appendix 2 and Appendix 3.  
The C-CDA standard also requires immunizations to be coded using Centers 
for Disease Control and Prevention (CDC) Vaccine Code (CVX); however, not only 
the OMOP vocabulary lacks the mappings of CVX codes to standard concepts, but 
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also vaccine codes cannot be mapped explicitly to RxNorm concepts (85). Therefore, 
the equivalent CPT-4 codes of CVX codes were used as the surrogate standard 
concepts. Appendix 4 presents crossmaps of CVX codes to the representing CPT-4 
codes retrieved from CDC website (86). The new mapping relationships were 
appended to Source-To-Concept Map table for automatic transformation of source 
codes to standard concepts. 
The parser also captured the route of drug administration from 
Immunization Activity or Medication Activity templates, and stored the data in 
Route Source Value table field; however, this data was not used to find the standard 
concept of the route. Instead, the drug standard concept was the reference to match 
the correct route of administration. 
2.2.5.8.2. Drug exposure duration 
Start and end dates of drug exposure varies between immunization and 
medication entries. Immunization entries have only start date, while medication 
entries have both start and stop dates of drug treatment under the effectiveTime 
element identified by data type of contiguous time interval (i.e., IVL_TS). For 
example, “20170317” represents March 17, 2017 under Medication Activity template. 
However, in case of medications, the parser only captured the start date from low 
field under the effectiveTime element, and estimated end date (i.e., expiry date) by 
adding days of drug supply to the start date. Since immunizations and procedure 
drugs are administered in a single dose, the end date was recorded the same as 
administration date. 
2.2.5.8.3. Days of drug supply 
There is no field in CCD architecture to report for how long the supply of 
drug should has last (i.e., Days Supply); thus, it was calculated by dividing total 
amount of supplied drug by daily drug usage as shown in the following equation: 
𝐷𝑎𝑦𝑠 𝑜𝑓 𝑠𝑢𝑝𝑝𝑙𝑦 =  
𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦 𝑜𝑓 𝑠𝑢𝑝𝑝𝑙𝑖𝑒𝑑 𝑑𝑟𝑢𝑔
𝐷𝑎𝑖𝑙𝑦 𝑑𝑜𝑠𝑒 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 × 𝑄𝑢𝑎𝑛𝑡𝑖𝑡𝑦 𝑜𝑓 𝑑𝑟𝑢𝑔 𝑝𝑒𝑟 𝑑𝑜𝑠𝑒
 (1) 
where quantity of supplied drug is captured from quantity[@value] element in 
Supply Activity under Medication Activity entries, daily dose interval captured from 
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effectiveTime identified by operator = “A” attribute, and the quantity of drug per dose 
extracted from doseQuantity[@value] of Medication Activity entries under 
Medications Section.  
The unit of supplied drug quantity, such as tablet, milliliter, bottle, box, pack 
was recorded in quantity[@unit]. The quantity of supplied drug information was 
inconsistently represented with or without units. Therefore, supplied quantity of “2” 
for a tablet or capsule product could be reported with no units, or it was presented in 
tablet or bottle units. This was also the case for inhalers, solutions, and injections 
that units varied from no unit to milligram, gram, bottle, inhaler, vial, or syringe 
(Table 10).  
To minimize the error in calculating duration of drug exposure, I developed 
this protocol to calculate days of drug supply:  
(1) Days of drug supply is calculated only if quantity of supplied drug 
(quantity[@value]) is provided. 
(2) If CCD record contains the unit of supplied quantity (quantity[@value]), 
the quantity value is standardized according to the proper physical units, 
and is stored in Quantity field. For example, if it the record constituted 2 
bottles of "Cephalexin 50 MG/ML Oral Suspension", the quantity of 
supplied drug would be 400 ml as each bottle contains 200 ml of the 
suspension. Table 10 presents the source and target units through the 
transformation. 
(3) If CCD record does not contain the unit of supplied quantity 
(quantity[@unit]), the quantity is transformed to the standard quantity 
unit according to Table 10. For example, if a record of "200 ACTUAT 
Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler" has a quantity value 
of “1”, it is presumed that 200 actuations of the drug product were 
supplied. 
(4) If CCD record does not contain any of daily dose interval 
(effectiveTime[@operator = “A”]), dose quantity (doseQuantity[@value]), or 
the unit of dose quantity (doseQuantity[@unit]), the daily drug usage (the 
denominator of equation 1) is estimated using the World Health 
Organization (WHO) defined daily dose (DDD) (87). Thus, days of supply 
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is calculated by dividing total supplied quantity of drug by DDD. For 
example, if a record shows administration of 60 "valsartan 160 MG Oral 
Tablet", the days of supply would be 30 days as DDD of valsartan is 80 
mg. The DDD was only used to test the pipeline. 
(5) If CCD record has the unit of dose quantity (doseQuantity[@unit]), the 
dose quantity value is standardized to the proper physical units according 
to Table 10. For example, a dose quantity of 162 mg "Aspirin 81 MG 
Chewable Tablet" is transformed to 2 tablets. 
(6) If a valid days of drug supply could not be calculated, the value was set to 
1. 
 
Table 10. Corresponding quantity units to CCD quantity values in Drug Exposure table 
Dose form Quantity unit in CCD Quantity unit in Drug 
Exposure table 
Aerosol aero Actuation 
inhalation solution nebu Milliliter 
Inhaler aepb, inhaler, inhalatn Actuation 
Injectable solution amp, soln, vial Milliliter 
Injectable suspension ml, vial Milliliter  
Oral capsule caps, capsule, bottle, cpdr Capsule 
Oral solution bottle, ml, soln Milliliter 
Oral suspension bottle, ml, powder Milliliter 
Oral tablet tabs, tablet, bottle, chew tab, tbdp Tablet 
Patch patch Patch 
Prefilled syringe syringe Milliliter 
Suppository supp Suppository 
Topical cream g, cream, gm, jar, tube Gram 
Topical gel g, gel, jar, tube Gram 
Topical ointment g, oint, jar, tube Gram 
vaginal cream tube Gram 
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Table 11. Mapping HL7 C-CDA CCD data to Drug Exposure table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
drug_exposure_id – Auto-numbered unique identifier for each drug 
exposure occurrence 
person_id – The patient’s identifier from Person table 
drug_concept_id – OMOP standard Concept ID of Drug Source 
Value 
drug_exposure_start_date Immunizations 
Immunizations Section: Immunization Activity: 
effectiveTime[@value] 
 
Medications 
Medications Section: Medication Activity: 
effectiveTime/low 
Medication 
effectiveTime[@xsi:type] = “IVL_TS” 
drug_exposure_end_date – Immunization: Null 
 
Medication 
The expiry date was calculated by adding days of 
drug supply to the start date. 
drug_type_concept_id – 38000177 (Prescription written) 
refills Medications 
Medications Section: Medication Activity: 
repeatNumber 
Immunization: Null 
quantity Medications 
Medications Section: Medication Activity: Supply 
Activity: quantity 
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Destination Table Field Matching C-CDA section Applied Rule 
days_supply – Immunizations: Null 
 
Medications: Using Days of Supply equation (1) 
sig Medications 
Medications Section: Medication Activity: text 
 
route_concept_id – OMOP Concept ID of route of administration 
based on Drug Concept ID looked up in Concept 
Relationship table. 
lot_number Immunizations 
Immunizations Section: Immunization Activity: 
Immunization Medication Information: 
manufacturedMaterial/lotNumberText 
 
Medications 
No lot number 
 
visit_occurrence_id – The identifier of corresponding visit occurrence 
from Visit Occurrence table. Null if Drug 
Exposure Start Date did not match with any visit 
occurrence. 
drug_source_value Immunizations 
Immunizations Section: Immunization Activity: 
Immunization Medication Information: 
manufacturedMaterial/code 
 
Medications 
Immunization 
If Immunization Activity was completed, AND 
Medication Dispense exists, AND the source code 
was a drug concept (i.e., Domain Id = “Drug”, 
AND Invalid Reason = Null). 
 
Medication 
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Destination Table Field Matching C-CDA section Applied Rule 
Medications Section: Medication Activity: Medication 
Information: manufacturedMaterial/code 
If Medication Activity was completed, AND 
Medication Dispense exists, AND the source code 
was a drug concept (i.e., Domain Id = “Drug”, 
AND Invalid Reason = Null). 
drug_source_concept_id – OMOP Concept ID of Drug Source Value 
route_source_value Immunizations 
Immunizations Section: Immunization Activity: 
routeCode[@code] 
 
Medications 
Medications Section: Medication Activity: 
routeCode[@code] 
If the route code does not exist, enter Null.  
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2.2.5.9. Drug Era table 
The Drug Era table is derived from patient’s medication history (Drug 
Exposure table), and identifies the periods of time when patient was continuously 
exposed to medications at ingredient level. Thus, one or more individual drug 
exposure intervals will form a drug era. In case of a compound medication with 
multiple ingredients, individual exposure periods were generated with similar start 
and end date but representing different ingredients. 
The parser derived drug eras from drug exposure records through the 
following steps. After identified OMOP-mapped medication intervals (i.e., Drug 
Concept ID > 0) from Drug Exposure table, the parser joined the drug concepts with 
the corresponding ingredients using the script in Appendix 5. Then, the intervals of 
ingredient exposures were consolidated if the gap between the previous end date and 
the next start date was 30 days or less. Table 12 summarizes applied rule to create 
drug eras. 
 
Table 12. Applied rules to build Drug Era table 
Destination Table Field Applied Rule 
drug_era_id Auto-numbered unique identifier for each condition era 
person_id The patient’s identifier from Person table 
drug_concept_id OMOP standard ingredient concept for which drug era is 
built, excluding Drug Concept ID = 0 
drug_era_start_date The start date of consolidated drug era as long as 
medication was supplied continuously in the next 30 days 
or less. 
drug_era_end_date The end date of consolidated drug era as long as 
medication was supplied continuously in the next 30 days 
or less. 
drug_exposure_count The number of drug exposure intervals that constitute 
the drug era. 
gap_days Deducted number of days covered by drug exposure 
intervals from number of days in the drug era 
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2.2.5.10. Measurement table 
The Measurement table covers records of medical evaluations, including but 
not limited to laboratory tests, vital signs, imaging results, and pathology reports. 
HL7 C-CDA CCD documents extensively provide these data under three sections. 
Results Section reports the physician-generated results of diagnostic procedures, 
imaging, and laboratory test; Vital Signs Section describes the patient vital signs, 
such as blood pressure, temperature, height, weight, etc.; and Problem Observation 
entries under Problem Section record ICD codes, which are in fact measurement 
concepts. For example, V85.32 (Body Mass Index 32.0-32.9, adult) is an ICD-9-CM 
code to claim body weight service showing that patient had a body mass index of 
32.0-32.9. In general, the parser stored records of measurement concepts in 
Measurement table (i.e., Domain ID = “Measurement” and Invalid Reason = Null). 
Table 13 summarizes the applied rules for populating Measurement table. 
Results of medical evaluations such as laboratory tests (e.g., hematology, 
microbiology, toxicology, serology), imaging procedures (e.g., ultrasound, magnetic 
resonance imaging, angiography), and pathology reports (e.g., size of cancerous 
tumor) are stored in Result Organizer template under Results Section. The organizer 
groups related measurement results in the form of Result Observation templates in 
one place; for example, it categorizes all results of basic metabolic panel tests under 
code = “24321-2” LOINC code that contains Result Observation entries of anion gap, 
calcium, chloride, blood urine nitrogen (BUN), etc. The parser captured individual 
measurement records from these Result Observation entries, pointing at 
observation/code for the measurement code, observation/value for the measurement 
result, observation/effectiveTime for the date of service. 
Vital Signs Section contains vital sign records within Vital Sign Observation 
entries under Vital Sign Organizer templates. The parser captured the vital sign 
exam code from observation/code element, date of service from 
observation/effectiveTime, and the vital sign value from observation/value. To 
ensure important vital sign parameters to clinical research are included in the 
mapping process, a custom mapping was added to Source-To-Concept Map table for 
some local codes such as weight, body mass index (BMI), and pulse rate. 
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Problem observations that represent measurement procedure were mapped 
to the corresponding clinical evaluation and value concepts using the script in 
Appendix 6, and the Concept IDs were stored in Measurement Concept ID and Value 
As Concept ID table fields. For example, “Basophilia” (ICD-9-CM = 288.65, OMOP 
Concept ID = 44831073) was mapped to “Basophil count” procedure (OMOP Concept 
ID = 4172647, Domain ID = “Measurement”) and “Above reference range” 
measurement value (Domain ID = “Meas Value”).  
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Table 13. Mapping HL7 C-CDA CCD data to Measurement table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
measurement_id – Auto-numbered unique identifier for each 
measurement 
person_id – The patient’s identifier from Person table 
measurement_concept_id – OMOP standard Concept ID of Measurement Source 
Value 
measurement_date Vital signs 
Vital Signs Section: Vital Signs Organizer: 
Vital Sign Observation: effectiveTime[@value] 
 
Results 
Results Section: Result Organizer: Result 
Observation: effectiveTime[@value] 
 
Problems 
Problem Section: Problem Concern Act: 
effectiveTime/low 
 
measurement_type_concept_id – Vital signs: 44818701 (From physical examination) 
Results: 44818702 (Lab result) 
Problems: 38000245 (EHR problem list entry) 
operator_concept_id – Separate operator (<, >, ≤, or ≥) from Value Source 
Value if represents a value as number. Then, map to 
OMOP standard concept of Domain ID = 'Meas Value 
Operator'. 
value_as_number Vital signs Vital signs 
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Destination Table Field Matching C-CDA section Applied Rule 
Vital Signs Section: Vital Signs Organizer: 
Vital Sign Observation: value[@value] 
 
Results 
Results Section: Result Organizer: Result 
Observation: value[@value] 
If the value is a physical quantity or real number, i.e., 
value[@xsi:type] = “PQ” or “REAL”. 
 
Results 
If the value is a physical quantity, i.e., 
value[@xsi:type] = “PQ”. 
value_as_concept_id – If Value Source Value is a concept code form a coding 
system, e.g., SNOMED CT 
unit_concept_id    – OMOP Concept ID of Unit Source Value 
visit_occurrence_id – The identifier of corresponding visit occurrence from 
Visit Occurrence table. Null if Measurement Date did 
not match with any visit occurrence. 
measurement_source_value Vital signs 
Vital Signs Section: Vital Signs Organizer: 
Vital Sign Observation: code 
 
Results 
Results Section: Result Organizer: Result 
Observation: code 
 
Problems 
Problem Section: Problem Concern Act: code 
Vital signs 
If Vital Sign Observation was completed, AND the 
source code was a measurement concept (i.e., Domain 
ID = “Measurement” AND Invalid Reason = Null). 
 
Results 
If Result Observation was completed, AND the source 
code was a measurement concept (i.e., Domain ID = 
“Measurement” AND Invalid Reason = Null). 
measurement_source_concept_id – OMOP Concept ID of Measurement Source Value 
unit_source_value Vital signs 
Vital Signs Section: Vital Signs Organizer: 
Vital Sign Observation: value[@unit] 
Vital signs 
If the value is a physical quantity, i.e., 
value[@xsi:type] = “PQ”. 
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Destination Table Field Matching C-CDA section Applied Rule 
 
Results 
Results Section: Result Organizer: Result 
Observation: value[@unit] 
 
Results  
If the value is a physical quantity, i.e., 
value[@xsi:type] = “PQ”. 
value_source_value Vital signs 
Vital Signs Section: Vital Signs Organizer: 
Vital Sign Observation: value[@value] 
 
Results 
Results Section: Result Organizer: Result 
Observation: value[@value] 
 
Problems 
Problem Section: Problem Concern Act: code 
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2.2.5.11. Observation table 
The Observation table contains clinical facts of medical procedures and 
examinations that do not belong to other domains, including but not limited to 
personal and family medical history, social life, lifestyle, and smoking behavior. All 
records of observation concepts were stored in Observation table, meaning that 
Domain ID = “Observation” and Invalid Reason = Null.  
Observation entries were extracted from Problem Section (personal and 
family history of diseases), Allergies Section (only history of allergies), Smoking 
Status Observation (smoking behavior) entries under Social History Section. Table 
15 presents the rules applied to populate Observation table. 
Smoking Status Observation reports the current smoking status of patient 
specified by SNOMED CT concepts, and the period of smoking activity is recorded 
under effectiveTime. If patient was a former smoker, observation date (Observation 
Date) would be the end of this period; however, if it was active or unknown smoking 
behavior, the observation date would be the starting time of smoking activity. Table 
14 specifies the matching OMOP standard concepts of HL7 smoking status value 
set. 
Observations may also be reported in Problem Section entries. For example, 
ICD-9-CM code of V12.71 (Personal history of peptic ulcer disease) is an observation 
concept listed under problem observations. Thus, the parser explored Problem 
Observation entries for observation concepts (i.e., Domain ID = “Observation”). 
Resolved allergies observations captured in Allergies Section were also 
directed to Observation table. If the status of an allergy record was not active (i.e., 
Status Code = “active” under Allergy Problem Act), it was mapped to the respective 
observation concept (i.e., history of allergy). 
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Table 14. Matching OMOP concepts of HL7 smoking status value set 
HL7 smoking status value  OMOP Standard Concept 
Code Code Name  Concept ID Concept Name 
8517006 Former smoker  4310250 Ex-smoker 
77176002 Smoker, current 
status unknown  
 4298794 Smoker 
266927001 Unknown if ever 
smoked  
 4141786 Tobacco smoking 
consumption unknown 
449868002 Current every day 
smoker  
 42709996 Smokes tobacco daily 
266919005 Never smoker (Never 
Smoked)  
 4144272 Never smoked tobacco 
428041000124106 Current some day 
smoker  
 4298794 Smoker 
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Table 15. Mapping HL7 C-CDA CCD data to Observation table: Applied rules and corresponding sections. 
Destination Table Field Matching C-CDA section Applied Rule 
observation_id – Auto-numbered unique identifier for each 
observation 
person_id – The patient’s identifier from Person table 
observation_concept_id – OMOP standard Concept ID of Observation 
Source Value 
observation_date Smoking status 
Social History Section: Smoking Status 
Observation: effectiveTime/low or 
effectiveTime/high 
 
Problems 
Problem Section: Problem Concern Act: Problem 
Observation: effectiveTime/low 
 
Allergies 
Allergies Section: Allergy Problem Act: 
effectiveTime/low 
Smoking status 
If this is an active or unknow smoking behavior, 
the only existing time point is stored (i.e., 
effectiveTime/low). 
If this is a past smoking behavior (former 
smoker). Both start and end of smoking behavior 
exist, but the end point shows when smoking 
behavior changed (i.e., effectiveTime/high). 
 
Problems 
Observation table can only store one time point, 
so only the start date is recorded in Observation 
Date field regardless it is a resolved or active 
problem. 
observation_type_concept_id – Smoking: 44814721 (Patient reported) 
 
Problems: 38000276 (Problem list from EHR) 
 
Allergies: 38000280 (Observation recorded from 
EHR) 
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Destination Table Field Matching C-CDA section Applied Rule 
visit_occurrence_id – The identifier of corresponding visit occurrence 
from Visit Occurrence table. Null if Condition 
Start Date did not match with any visit 
occurrence. 
observation_source_value Smoking status: 
Social History Section: Smoking Status 
Observation: value[@code] 
 
Problems 
Problem Section: Problem Concern Act: Problem 
Observation: code 
 
Allergies 
Allergies Section: Allergy Problem Act: Allergy-
Intolerance Observation: code 
 
Participating agent in allergies 
Allergies Section: Allergy Problem Act: Allergy-
Intolerance Observation: Product: Product Detail: 
playingEntity/code 
If the source code is an observation concept (i.e., 
Domain ID = “Observation” and Invalid Reason 
= Null). 
 
Problems 
The observation was truly observed (negationInd 
= “false” under Problem Observation). 
 
Allergies 
OMOP concept id of Condition Source Value 
considering the participating allergen under 
Allergy-Intolerance Observation 
 
observation_source_concept_id – OMOP Concept ID of Observation Source Value 
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2.2.6. Performance assessment of ETL pipeline 
I assessed the accuracy of CCD-TO-OMOP ETL pipeline in two steps:  
(1) Preliminary assessment that involved 10 randomly selected CCDs to 
optimize the pipeline, and 
(2) Final assessment covering all 250 CCDs to finalize the 
transformation pipeline.  
I manually reviewed CCD entries and generated data tables to examine the 
accuracy of data extraction, concept mapping, calculations (e.g., drug day supply), 
derived elements validity (e.g., drug and condition era constructions), and loading 
the data into OMOP CDM repository. 
2.2.6.1. Evaluation of data extraction 
Accuracy of data extraction phase plays a very important role in achieving 
the ultimate valid transformed dataset. The data extraction evaluation involved all 
standardized clinical data tables where the captured data usually reside in field 
ending with _Source_Value, including tables Person, Observation Period, Visit 
Occurrence, Procedure Occurrence, Drug Exposure, Condition Occurrence, 
Measurement, and Observation.  
I manually examined captured data in the tables and checked with actual 
data values in CCD files’ structure to ensure:  
(1) Data elements were correctly targeted in CCD architecture. For example, 
procedure records may be reported by different coding systems (e.g., ICD-
9-CM, CPT-4) under different sections within CCDs, such as Problem 
Section and Procedures Section. 
(2) Rules have been correctly applied when capturing data values from CCDs. 
For example, a drug record must be captured only if the drug was truly 
dispensed or administered to the patient, and the quantity of drug was 
reported. 
If any discrepancy was observed, the pipeline was adjusted to capture the 
right value from the right location within the CCD files.  
2.2.6.2. Evaluation of concept mapping 
Concept mapping is part of the data transformation phase when captured 
concept codes are mapped to OMOP concepts. I manually reviewed all source codes 
and the matching Concept IDs for accuracy by fetching a distinct set of source codes 
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and Concept IDs from all standardized clinical data tables to review a shorter list. 
The transformation involves mapping source values to source Concept IDs (table 
fields ending with _Source_Concept_Id) and OMOP standard concepts (table fields 
ending with _Concept_Id). In case a source code did not correctly matched or equal 
the proper OMOP Concept ID, it was flagged for further investigation to fix the 
glitch. 
2.2.6.3. Evaluation of derived elements 
OMOP CDM has specific tables called standardized derived elements that are 
derived from standardized clinical data tables. Two of these tables were in the scope 
of this study: Condition Era and Drug Era. I reviewed the populated condition eras 
and drug eras for accuracy to make sure the periods do not overlap and correspond 
the right condition occurrence or drug exposure. 
2.2.6.4. Evaluation of calculated data fields 
There are data fields in both standardized clinical data tables and 
standardized derived elements tables that are calculated as part of the data 
transformation process, including start and end dates of eras in Condition Era and 
Drug Era table, days of medication supply and drug exposure end date in Drug 
Exposure table, and observation periods in Observation Period table. I manually 
reviewed the calculated data fields, and adjusted the pipeline if needed. 
2.2.6.5. Evaluation of data loading 
Transformed data elements must be stored in the right place within OMOP 
CDM. Thus, I assessed all populated tables by these criteria to ensure correctness of 
the data loading process: 
(1) Missing values: All table fields with Null values were investigated if 
missing values are valid. Certain fields must be Null because either they 
were not in the scope of this study or no value was available in the CCDs. 
For example, Provider ID was always Null as the Provider table was out 
of scope, and Ethnicity Concept ID was if the CCD did not report ethnicity 
information. 
(2) Concept domain: All Concept IDs in the CDM tables should come from the 
respective domain. For example, condition records in Condition table 
must only have Condition Concept ID from condition domain. To test the 
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validity of the concepts’ domains, I retrieved all recorded Concept IDs in 
the tables were retrieved and joined with their Domain ID in OMOP 
vocabulary, and manually reviewed their validity. 
(3) Foreign key references: CDM tables are linked to each other via foreign 
keys that enables to retrieve associated events in other domains. For 
example, medication records of a patient in Drug Exposure table are 
identified by Person ID foreign key referring to the patient’s unique 
identifier in Person table. Therefore, other records from condition or 
procedure domains can also be collected associated with the drug therapy. 
To ensure data fields are correctly linked, primary and foreign key 
constrains were added to OMOP CDM tables after data loading process. 
The SQL script of the constrains is provided in Appendix 7. 
2.2.7. Statistical methods 
This study mainly involves descriptive analysis of the ETL performance to 
transform data and the completeness of C-CDA CCD data to feed OMOP CDM.  
It also reports accuracy assessment of mapped concepts. The accuracy of 
concept mapping process was assessed by measuring recall and precision of the ETL 
pipeline on 250 CCDs. Recall is the probability that a source code is correctly 
mapped to an OMOP concept, and was calculated by dividing number of truly 
mapped concepts by total number of correctly mapped and incorrectly unmapped 
concepts in each domain. Precision is the probability that a mapped source code is 
truly matched with an OMOP concept, and was calculated by dividing count of truly 
mapped concepts by total number of mapped concepts. A truly mapped code (true 
positive) is a valid source code that maps correctly to the corresponding OMOP 
standard concept, and a truly unmapped code (true negative) is an invalid code for 
which no standard concept is available in OMOP vocabulary. An incorrectly 
unmapped code (false negative) is a valid source code that a standard concept exists 
in the vocabulary but they do not match due to missing mapping relationships or a 
flaw in the pipeline. 
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2.3. Results 
2.3.1. Performance of data extraction pipeline 
The developed CCD-TO-OMOP data processing pipeline could successfully 
extract all required data elements from CCDs as it was planned. All rules were also 
applied properly as defined by HL7 implementation guide, such as the appropriate 
data element were targeted by Template IDs, it was ensured that drugs were truly 
administered to the patient, only occurred conditions were captured, and 
distinguished active versus history of allergies. 
2.3.2. Performance of data transformation pipeline 
The data transformation part of the ETL involved mapping source codes to 
standard concepts, building standardized derived elements, and calculating data 
fields. Performance of concept mapping is discussed in a separate section (see 2.3.3). 
2.3.2.1. Standardized derived elements 
The ETL created Condition Era (Table 16) and Drug Era (Table 17) tables, 
showing the continuous report of conditions and drug administrations, respectively. 
A total of 3,157 drug eras were derived from 7,859 drug exposure records, and 5,088 
condition eras were formed from 12,648 condition occurrences.  
 
Table 16. An excerpt of records in Condition Era table.  
Condition 
Concept ID 
Condition Name 
Condition Era 
Start Date 
Condition 
Era End Date 
4008576 Diabetes mellitus without complication 5/12/2012 5/12/2012 
4008576 Diabetes mellitus without complication 12/28/2012 12/29/2012 
4009042 Acute abscess of nasal sinus 11/10/2012 11/11/2012 
4010024 Localized abdominal pain 10/7/2012 10/8/2012 
4023183 Gastric reflux 10/8/2012 10/8/2012 
4023183 Gastric reflux 6/8/2015 6/8/2015 
4028741 Benign hypertension 4/16/2012 4/16/2012 
4028741 Benign hypertension 6/8/2015 6/8/2015 
4029305 Hypercholesterolemia 10/8/2012 10/8/2012 
4029305 Hypercholesterolemia 6/8/2015 6/8/2015 
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Table 17. An excerpt of records in Drug Era table. 
Drug 
Concept ID 
Drug Name 
Drug Era 
Start Date 
Drug Era 
End Date 
Drug Exposure 
Counts 
Gap Days 
1307046 Metoprolol 9/21/2013 3/13/2015 4 -2 
1307046 Metoprolol 4/14/2015 7/13/2015 3 0 
1307046 Metoprolol 9/9/2015 3/4/2016 6 -3 
1308216 Lisinopril 9/10/2013 2/9/2016 8 -288 
1332418 Amlodipine 9/10/2013 4/13/2015 5 10 
1332418 Amlodipine 11/9/2015 2/7/2016 3 0 
1539403 Simvastatin 9/12/2013 10/12/2013 1 0 
1539403 Simvastatin 11/12/2013 2/10/2014 2 30 
1539403 Simvastatin 3/19/2014 4/18/2014 1 0 
1539403 Simvastatin 5/28/2014 3/5/2015 4 41 
1539403 Simvastatin 4/6/2015 6/3/2015 2 -2 
 
 
2.3.3. Mapping performance of CCD data to OMOP CDM 
2.3.3.1. Conditions and diagnoses 
The ETL pipeline yielded very good to excellent performance in mapping 
source codes to OMOP standard concepts (Figure 4). A total of 12,648 records and 
1,459 concepts of diagnoses and reported conditions were retrieved from the CCDs 
(Table 18). All extracted condition concepts were coded in SNOMED CT, of which 
1,456 (99.8%) could map to OMOP standard concepts representing 12,644 (99.7%) 
records. These mapped source codes accurately matched the corresponding standard 
concepts in OMOP vocabulary.  
The three unmapped source codes could not map to standard concepts 
because either the concept was deprecated or the relationship to standard concept 
was obsolete. 
2.3.3.2. Drugs 
A total of 7,859 drug administration and immunization records were 
extracted from the CCD documents, of which 596 records had empty drug code field; 
thus, 7,263 records were analyzed for evaluating mapping performance (Table 18). 
Out of extracted 770 drug concepts, 758 (98.4%) all-RxNorm codes correctly mapped 
to OMOP standard concepts representing 7,230 (99.5%) records.  
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The remaining 12 (1.6%) concepts that consisted 33 (0.5%) of the records were 
coded in local code (n = 4), RxNorm (n = 7), and CVX (n = 1). They could not map to 
standard concepts because the relationships to standard concepts were deprecated or 
the corresponding OMOP concepts did not exist in the vocabulary. 
2.3.3.3. Procedures 
Out of 1,128 retrieved procedure records, 941 (83.4%) records correctly 
mapped to standard concepts (Table 18). This represents 367 (92.7%) of total 
extracted 396 concepts. Most of procedures codes were from ICD-9-CM Procedure 
(72.5%) and CPT-4 (25.5%) coding systems, and the remaining were local (1%) or 
SNOMED CT (1%) codes. Among these, almost all ICD-9-CM codes (99.3%) could 
map to standard concepts while 79.2% of CPT-4 codes matched the corresponding 
standard concepts in OMOP vocabulary. None of local codes and 2 (50%) out of four 
SNOMED CT procedure codes could also map to standard concepts. 
Among 29 (7.3%) unmapped procedure codes, 21 CPT-4 and two ICD-9-CM, 
and two SNOMED CT codes could not map to standard concepts due to deprecated 
relationships. Regarding the remaining 4 local codes, there were no matching record 
available in OMOP vocabulary to standardize the concepts. 
2.3.3.4. Measurements and clinical evaluations 
A total of 36,184 records of 683 measurement concepts were extracted from 
CCDs (Table 18). The transformation process yielded 94.0% (n = 642) correct 
mapping of concepts to OMOP standard concepts representing 35,724 (98.7%) 
records. The measurement concepts were mostly coded in LOINC (n = 605), and the 
remaining were either local (n = 3) or SNOMED CT (n = 40) codes. Of these, 599 
(99%) of LOINC codes could map to standard concepts, 40 (85.1%) SNOMED CT, 
and 3 (9.7%) local codes. 
There were 41 (6%) unmapped source codes were representing 460 (1.3%) of 
total records. Among them, 6 LOINC and 7 SNOMED CT codes could not map to 
standard concepts because either the concept record or the mapping relationships 
were obsolete, while there was no record available in OMOP vocabulary to match 28 
local codes. 
2.3.3.5. Observations  
All 71 observation concepts were coded in SNOMED CT, representing 280 
records (Table 18). All concepts correctly mapped to OMOP standard concepts. 
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2.3.3.6. CDC race and ethnicity value set 
Four race codes were captured from 74 records that all mapped to OMOP 
standard concepts (Table 18). 
 
 
 
Figure 4. Overall mapping performance of concepts and records to OMOP CDM vocabulary 
by domain. 
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Table 18. Mapping performance of source codes to standard concepts of OMOP CDM 
vocabulary. 
Domain and 
Code System 
 Concepts  Records 
 Mapped,  
n (%) 
Unmapped, 
n (%) 
Total 
 Mapped,  
n (%) 
Unmapped, 
n (%) 
Total 
         
Condition    1,459    12,648 
SNOMED CT  1,456 (99.8) 3 (0.2) 1,459  12,644 (99.97) 4 (0.03) 12,648 
         
Drug  758 (98.4) 12 (1.6) 770  7,230 (99.5) 33 (0.5) 7,263 
CVX   1 (100) 1   5 (100) 5 
Local code   4 (100) 4   7 (100) 7 
RxNorm  758 (99.1) 7 (0.9) 765  7,230 (99.7) 21 (0.3) 7,251 
         
Procedure  367 (92.7) 29 (7.3) 396  941 (83.4) 187 (16.6) 1,128 
CPT-4  80 (79.2) 21 (20.8) 101  195 (75.6) 63 (24.4) 258 
ICD-9-CM  285 (99.3) 2 (0.7) 287  744 (99.1) 7 (0.9) 751 
Local code   4 (100) 4   8 (100) 8 
SNOMED CT  2 (50) 2 (50) 4  2 (0.8) 109 (98.2) 111 
         
Measurement  642 (94.0) 41 (6.0) 683  35,724 (98.7) 460 (1.3) 36,184 
Local code  3 (9.7) 28 (90.3) 31  663 (64.6) 363 (35.4) 1,026 
LOINC  599 (99.0) 6 (1.0) 605  34,788 (99.9) 33 (0.1) 34,821 
SNOMED CT  40 (85.1) 7 (14.9) 47  273 (81.0) 64 (19.0) 337 
         
Observation    71    280 
SNOMED CT  71 (100)  71  280 (100)  280 
         
Race    4    74 
CDC Race 
and Ethnicity  
 4 (4)  4  74 (100)   
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2.3.4. Accuracy of concept mapping  
The concept mapping pipeline yielded an overall recall of 98.5% and precision 
of 100% (Table 19). The recall of condition codes was 99.8% as three condition codes 
did not map to standard concepts due to missing mapping relationships. Of 12 
unmapped drug codes, four codes truly and eight incorrectly did not map to standard 
concepts, resulting a recall of 99.0%. The lowest recall (93.6%) was achieved with 
procedure codes where 25 codes could not map to standard concept in OMOP 
vocabulary, mainly because the vocabular failed to have code-to-standard 
relationships in place of deprecated ones for CPT-4 codes. All but 13 measurement 
codes did not map to standard concepts, yielding a recall of 98.0%. Although the 
vocabulary contained the concepts, proper mapping relationships did not exist to be 
used by the pipeline. The recall of pipeline to map observation codes was 100% as all 
could map to standard concepts. 
 
 
Table 19. Accuracy assessment of ETL pipeline to map source codes to standard concepts 
Concept’s 
Domain 
 Mapped Code  Unmapped Code  
Recall 
(%) 
Precision 
(%)  
Correct 
(TP) 
Incorrect 
(FP) 
 
Correct 
(TN) 
Incorrect 
(FN) 
 
Condition  1,456 0  0 3  99.8 100 
Drug  758 0  4 8  99.0 100 
Procedure  367 0  0 25  93.6 100 
Measurement  642 0  0 13  98.0 100 
Observation  71 0  0 0  100 100 
Total  3,294 0  4 49  98.5 100 
 
TP = True positive, FP = False positive, TN = True negative, FN = False negative 
 
  
 60 
2.3.5. Completeness of CCD data elements required by OMOP CDM 
In general, CCD documents provided minimum required data elements of 
patient information to feed OMOP CDM (Table 20). Out of 250 patients’ CCDs, all 
provided gender information and 94.8% had birth dates. However, the documents 
significantly lacked race and ethnicity information as only 29.6% held race and none 
had ethnicity information. On visit occurrence information, all captured records 
from CCDs reported start and end dates of encounters, while 95.6% of the records 
specified the type of setting (e.g., inpatient, outpatient). The 212 records not 
reporting visit codes were obtained from 48 CCDs. All records of conditions, 
procedures, and observations fully reported code and date of occurrences.  
Drug exposure and measurement records provided data elements diversely. 
Although all drug exposure records reported drug supply date and 99.8% had 
quantity and days of supply information, only 92.4% of them accompanied drug 
codes, meaning that 596 drug exposure records could not be included in the CDM as 
the drug could not be recognized. Likewise, all measurement records had the code 
and date of service, but 3% of the records captured from 43 documents did not 
present measurement values. 
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Table 20. The number of patients and records for which CCDs carried data. 
OMOP Table and Data Elements 
 
Records 
Providing Value 
 
Records  
Not Providing Value 
 Count, n (%)  Count, n (%) 
Involved 
CCDs, n (%) 
Person (N = 250)      
Birth date  237 (94.8)  13 (5.2) 13 (5.2) 
Gender code  250 (100)  0 (0)  
Race code  74 (29.6)  176 (70.4) 176 (70.4) 
Ethnicity code  0 (0)  250 (100) 250 (100) 
Visit Occurrence (N = 4,795)      
Visit Start Date  4,795 (100)  0 (0)  
Visit End Date  4,795 (100)  0 (0)  
Visit code  4,583 (95.6)  212 (4.4) 48 (19.2) 
Condition Occurrence (N = 12,648)      
Condition date  12,648 (100)  0 (0)  
Condition code  12,648 (100)  0 (0)  
Procedure Occurrence (N = 1,128)      
Procedure date  1,128 (100)  0 (0)  
Procedure code  1,128 (100)  0 (0)  
Drug Exposure (N = 7,859)      
Drug supply date  7,859 (100)  0 (0)  
Quantity supplied  7,847 (99.8)  12 (0.02) 7 (2.8) 
Days of supply  7,847 (99.8)  12 (0.02) 7 (2.8) 
Drug code  7,263 (92.4)  596 (7.6) 69 (27.6) 
Measurement (N = 36,184)      
Measurement date  36,184 (100)  0 (0)  
Measurement value  35,059 (97.0)  1,095 (3.0) 43 (17.2) 
Measurement code  36,184 (100)  0 (0)  
Observation (N = 280)      
Observation date  280 (100)  0 (0)  
Observation code  280 (100)  0 (0)  
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2.4. Discussion 
The OMOP CDM demonstrated the ability to accommodate patient electronic 
health records transferred by HL7 C-CDA-based CCD. Demographics, healthcare 
provider encounters, medication information, procedures, measurements, and 
diagnoses could be successfully extracted, transformed, and loaded to the CDM with 
high accuracy. The final dataset can be used for population health observational 
studies, such as drug safety surveillance and comparative effectiveness research. 
2.4.1. Accommodation of CCD data in OMOP CDM 
All CDM tables assessed in this study could successfully accommodated CCD 
data; however, some tweaks were needed in Drug Exposure and Condition 
Occurrence tables to optimize data transformation.  
The Person table had proper fields to store source codes and standard 
concepts of patient demographics data elements captured from US Realm Header of 
CCD documents. The minimum required data elements included date of birth, 
gender, race, and ethnicity. The vocabulary possessed corresponding standard 
concepts of the source codes; however, it did not provide mapping relationships to 
transform CDC race and ethnicity value sets to standard concepts. Thus, new 
relationships were added to Source-To-Concept Map table to enable mapping of race 
information.  
The Visit Occurrence, Measurements, and Observation tables successfully 
fitted source codes and standard concepts. The vocabulary had also the proper 
relationships to map source codes to standard concepts.  
The Condition Occurrence table had also proper data fields to store both 
source code and standard concept of reported medical conditions, but failed to collect 
few elements of active allergy information. In order to map events to standard 
concepts in the OMOP vocabulary, the source code of the event is sufficient to lookup 
the matching concept. While C-CDA CCDs only use one code (e.g., ICDs, SNOMED 
CT) to report conditions, the allergies are presented by two codes, one for the allergy 
event and one for the playing entity that caused the allergy. On the other side, 
Condition Occurrence table has only space for the source code (one Condition Source 
Value and one Condition Source Concept ID fields); thus; can only take the generic 
allergy concept (e.g., Concept ID = 439224 if drug allergy).  
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The Procedure Occurrence table could properly accommodate the required 
data elements from CCDs, including procedure codes and date of service; however, 
the OMOP vocabulary presented moderate-to-good performance to map procedure 
codes to standard concepts as only supported mapping of 92.7% procedure codes to 
standard concepts, representing 83.4% of procedure records. Despite all unmapped 
codes (excluding local codes) had representing non-standard Concept IDs in the 
vocabulary, the code-to-standard relationships were flagged as depreciated and no 
updated mappings were provided. This issue was resolved by incorporating the 
updated mapping relationships in the CDM. 
The Drug Exposure table could properly contain drug supply date, supplied 
drug quantity, and drug code extracted from CCDs; however, drug’s days of supply 
had to be estimated using the developed protocol because HL7 C-CDA does not 
provide this information explicitly. An alternative approach to compute days of 
supply is to use daily dose interval and quantity of drug per dose; however, this 
information was provided sparsely in the CCDs. Thus, I applied the WHO’s defined 
daily dose (DDD) as the reference for daily drug usage to benchmark the pipeline. It 
should be emphasized that the DDD was not for making inferences about drug 
exposures. The daily defined dose defines the average dose of a drug used for 
maintenance therapy of the main indication in adults, and it has been used for drug 
utilization, pharmacoepidemiologic, and pharmacoeconomic research (87). Although 
the DDD is a composite, standard measure of drug exposure in various countries, 
and has been used in many studies (88-93), using DDD as the substitute for 
prescribed daily dose may cause incorrect estimations about drug’s days of supply 
(94-96). Therefore, it is crucial to include enough data elements in the CCDs to 
correctly estimate drug’s days of supply if the documents are meant to be used for 
observational analyses. 
2.4.2. Strengths 
I found several strengths in standardizing CCD data to OMOP CDM. First, 
the CDM allows to gather patient electronic health records from other sources 
independent of the structure of database. Second, the OMOP vocabulary supports 
most of the coding systems that are being used in CCD architecture, and it is also 
scalable to cover local codes and emerging dictionaries in future. Third, the CDM 
provides new measures, such as drug’s days of supply to data analysts that are not 
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explicitly reported by CCDs. Fourth, the derived tables, such as Drug Era and 
Condition Era that provide timeline of therapies and condition reports for health 
outcome research. Fifth, the CDM standardizes diverse quantity unit of supplied 
drug to make drug exposure records comparable. In general, transforming CCD data 
with such highly complex architecture and varied elements into a common data 
model will allow using the data to analyze data across other observational 
databases. 
2.4.3. Challenges 
Missing data in the CCDs exceedingly challenged the pipeline, in particular 
to calculate drug’s days of supply. The CCDs also reported limited information on 
race and ethnicity, and 3% of the measurement records had no values. When using 
CCDs’ data for observational analyses, the researcher may need to ensure first that 
the missing values are legit after consulting with the data provider; then, 
alternative solutions should be followed to limit bias, such as case deletion, mean 
substitution, and imputation (97-100). 
Although HL7 C-CDA Release 1.1 requires medications to be recorded in 
RxNorm codes, there were few records of medications coded using local codes or only 
the medication name was provided. The parser in this study captured drug 
information only if it was coded in a standardized vocabulary like RxNorm. 
Therefore, two types of records could not be extracted: The records with drug 
concepts coded in non-standardized vocabularies (e.g., local dictionaries), and the 
records that only provided the drug name not the standard concept. 
Vaccines were recorded in CVX codes in CCDs, but the OMOP vocabulary did 
not have the proper mappings to standard concepts. To enhance the performance of 
concept mapping pipeline, new code-to-standard mapping relationships were added 
to Source-To-Concept Map table that mapped CVX codes to the corresponding 
standard CPT-4 drug Concept IDs as the surrogate concepts. Ideally, one vaccination 
code should map to one RxNorm concept, but it does not happen with vaccine codes 
because neither CVX nor CPT-4 codes specify the type or variant of vaccines, which 
is crucial to find the explicit RxNorm concept (85). 
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2.4.4. Limitations of the study 
It is possible that the accommodation and accuracy assessment would yield 
different results when processing CCDs from other institutions as they may differ in 
providing non-required (i.e., recommended or optional) data elements. The OMOP 
CDM was evaluated on 250 randomly selected CCD files from Regenstrief Institute, 
and needs to be evaluated on a larger, diverse pool of CCD documents.  
The assessment results are also limited to CCDs that are structured based on 
HL7 C-CDA Release 1.1 standard. Other versions of CCD documents may have 
different constrains on the data elements, and may vary in providing data fields. 
Therefore, it is recommended to test other versions of CCDs on OMOP CDM. 
In general, observation entries can be found in different sections within the 
architecture of HL7 C-CDA CCD, including Family History Section, Functional 
Status Section, Problem Section, Allergies Section, and Social History Section. 
However, only Problem Section (personal and family history of diseases), Allergies 
Section (only history of allergies), Smoking Status Observation (smoking behavior) 
entries under Social History Section were analyzed in this study since other sections 
were optional sections and did not exist in the CCDs. Therefore, if the missing 
sections were provided, the CDM could yield a more comprehensive list of patient’s 
conditions and observations. 
CCD documents generated by different systems may differ in providing data 
elements as that the CCD architecture delineates constrains of elements whether 
they are optional or recommended to be included in the documents, such as 
Encounters Section, Immunizations Section, Social History Section, Vital Signs 
Section, race and ethnicity in US Realm Header, the unit of supplied quantity and 
daily dose quantity in Medications Section, and procedure service date in Procedures 
Section.  Therefore, it is important to ensure these data are included in the CCDs 
that exchange patient information for observational studies.  
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CHAPTER 3. A STANDARD FOR DISSEMINATING HEALTH RISK 
PREDICTION MODELS TO SUPPORT CLINICAL DECISION-MAKING 
3.1. Background 
A wide range of predictive models have been derived from EHRs and 
observational data with the goal to improve patient safety, cut treatment costs 
through early detection of diseases, and assist clinicians to make accurate clinical 
decisions. Typical examples of predictive models include predicting prognostic risk of 
health events (27-29), disease screening (30-32), and managing short- and long-term 
complications (33-36). In one study on senior patients in Veterans Affairs (VA) 
nursing homes, the researchers could estimate personalized change in functional 
loss and recovery after hospitalization with 84-92% accuracy using random forest 
approach (37). In another study, the use of EHR data could refine prediction of 30-
day hospital readmission risk after percutaneous coronary intervention (38). 
Predictive models have also been used to support individuated decision 
support through estimating complications, short-term readmission, and long-term 
prognosis (39). Lee et al., 2015 (40) also reported a prognostic prediction model that 
has the potential to help clinicians design personalized treatments for ischemic 
stroke. Predictive modeling can also improve patients’ safety by reducing human 
errors. Physicians and healthcare providers are prone to cognitive biases, logical 
fallacies, false assumptions, and other reasoning failures when making clinical 
decision about diagnosis or treatment (41); therefore, predictive analytics tools may 
help them fill the gap by providing prediction estimates about the patients’ 
conditions. 
3.2. Problem statement 
Deploying predictive models for testing in medical practice or delivering 
health-related predictions at the point-of-care is a costly and time-consuming 
process that requires teams of professionals from IT managers, computer 
programmers, and analysts to database administrators to deploy the models and 
analyze the results for accuracy. The process needs to be repeated every time a new 
model is deployed as predictive models differ in specifications and data 
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requirements. The deployment is even more challenging when implementing the 
predictive models across desperate databases with different structures. 
3.3. Overview of PMML 
Introduced in 1997 (101), Predictive Model Markup Language (PMML) is an 
open source that allows exchanging predictive and data mining models between data 
systems (81, 101). The PMML can share the specifications of predictive models, data 
mining process, data transformation procedure, definitions of variables, the output 
of the model, model scoring steps, model explanation, model validation, and target 
properties of outputs (81). A PMML document may contain the definition of one or 
more analytic models. Due to the extensible markup language (XML) based 
architecture, the PMML is platform-independent, human readable, and easy to 
implement and maintain in the existing operating systems. It also supports varieties 
of algorithms as the latest PMML version 4.3 covers 17 classes of models from 
logistic regression, linear regression, Bayesian network to Cox proportional hazards 
model and decision tree (102).  
3.4. The Structure of PMML 
The general structure of PMML version 4.3 document is composed of five 
sections (103): Header, Mining Build Task, Data Dictionary, Transformation 
Dictionary, and Model (Figure 5).  
The required Header section starts the document, and provides information 
about copyright, a description of the model, model’s version, and the model generator 
software, and the timestamp when model was created.  
The optional Mining Build Task section describes the specifications of data 
mining process, and how the model was trained. This section has no predefined 
structure, and can contain any mining standards, such as structured query language 
(SQL).  
The required Data Dictionary section is shared among all models in the 
document, and defines the name, type (e.g., integer, double, string, date), and value 
of participating data fields in the model. Each Data Field element defines one 
continuous, categorical, ordinal, or text variable of the model.  
The optional Data Transformation section specifies the procedures (e.g., 
normalization, discretization, value mapping, built-in functions, aggregation) to 
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transform input variables from Data Dictionary to Derived Fields that will be used 
by the model. This section also allows to define new functions to apply on variables. 
The required Model section defines the specifications of predictive model. The 
elements of Model section may differ depending on the model type; however, these 
elements are shared between all types: Model name, mining function name (e.g., 
regression, clustering, classification), Mining Schema, Output, Model Statistics, 
Targets, Local Transformations, Model Verification, and Model Explanation. All 
models in a PMML document can access the elements under Data Dictionary and 
Transformation Dictionary sections. Every model mining process begins with the 
Mining Schema section that lists the participating variables in the under-process 
model as Mining Field elements from the pool of Data Field and Derived Field 
elements. The optional Output section lists Output Field elements that specify the 
model’s returning result values including the name, value type (i.e., continuous, 
categorical, ordinal, or text), data type (e.g., integer, double, date, text), and the 
procedure to compute final output values. The optional Model Statistics section 
contains univariate and multivariate statistics on Data Fields, providing further 
information about the nature of training dataset, and the model’s quality. The 
optional Targets section provides more information about the predicted Data Field, 
such as prior probabilities, scaling factor, minimum and maximum values of the 
Data Field in training set. The Local Transformations section specifies 
transformation procedures as Derived Field elements for Mining Field elements. The 
transformation types are similar to Transformation Dictionary but are only applied 
locally to the parent Model. The Model Verification section offers a sample set of 
inputs and validated results from the training dataset to the destination system. 
This helps assess the performance of model and compare accuracy of the model’s 
validity across datasets. While Model Statistics provides descriptive properties of 
input variables of the model, the Model Explanation section contains information 
about the quality of model, such as receiver operating characteristic (ROC), adjusted 
r-squared, the sum of squares regression statistics to enable assessing quality of 
model across datasets.  
Each type of predictive model may also have specific sections. As an example, 
regression model has also Regression Table section that specifies the values of 
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participating predictor variables (Figure 5). If the model predicts one numeric 
variable (i.e., linear regression), only one Regression Table should exist, and the 
model will have two or more of this section if the predicted variable is categorical 
(i.e., logistic or polynomial regression). 
 
 
Figure 5. The general structure of a PMML document (left), and the schema of sections 
under Regression Model (right). 
 
 
3.5. Objectives  
This study intended to develop a new standard based on the existing 
predictive model markup language (PMML) for disseminating health outcome risk 
scoring models that are generated based on OMOP CDM data. This new OMOP-
compliant PMML (O-PMML) standard defines the specifications of models, involved 
variables, data mining process, scoring steps, and data transformation procedure in 
accordance to the CDM specifications. The O-PMML enables IT solutions to deploy 
predictive models on OMOP CDM repositories in a “plug-and-play” manner that not 
only can save implementation cost and time, but also ensures consistency of 
computations across systems. This paper evaluates the feasibility and performance 
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of using the new standard to estimate risk score Framingham 10-year risk of 
cardiovascular diseases.  
3.6. Methods 
3.6.1. The structure of OMOP-compliant PMML 
This paper presents adoption of PMML version 4.3 (104) for sharing 
regression models to estimate disease risk scores using OMOP CDM data. The O-
PMML standard was designed to fulfill specific requirements of mining OMOP 
CDM. These requirements included: 
Req. 1) The standard should enable sharing information about the model 
provider, the generator software, descriptions of the model, and 
compatible version of OMOP CDM. 
Req. 2) The standard must enable sharing participating dependent and 
independent variables and the corresponding coefficients. 
Req. 3) The standard must enable sharing data transformation 
procedures. For example, what are the cutoff points to transform 
a continuous measure to categorical values. 
Req. 4) The standard must enable sharing the mining process of CDM 
tables for defining variables. For example, how to determine 
whether the patient is diabetic or current smoker. 
Req. 5) The standard must specify the output values, and enable sharing 
the process to compute the output values. For example, how to 
calculate the risk score yielded from the model. 
 
The OMOP-compliant PMML is based on PMML architecture (Figure 5) with 
proper modifications to satisfy the aforementioned requirements of OMOP CDM. 
The modifications mostly involve changes in constrains and Extension elements. It 
should be noted that all added extensions have an attribute of extender throughout 
the O-PMML that shows the change is due to OMOP requirements. The general 
architecture of O-PMML consists of Header, Mining Build Task, Data Dictionary, 
and Transformation Dictionary sections (Figure 6). All sections are required to be 
included in the PMML document except Transformation Dictionary which is added if 
data fields need transformation before entering the predictive model. The type of 
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predictive model is selected from Model Element group, which only covers regression 
models in our case. The full XML schema of O-PMML is provided in Appendix 8. 
The Header section satisfies the requirement of sharing general information 
about the model, author, and CDM version (Req. 1). The Data Dictionary and 
Regression Model sections of the PMML fulfill Req. 2 with no further modifications 
needed. The Data Dictionary section specifies non-transformed data fields that will 
participate in the models within PMML document. The Transformation Dictionary 
and Local Transformations sections also satisfy Req. 3 to share data transformation 
processes. The Mining Build Task section addresses Req. 4 as enables sharing 
database mining pipelines. Finally, the Output elements under Regression Model 
section fulfills Req. 5 as provide the space to specify yield values and processes to 
calculate the final outputs (e.g., risk score). 
 
 
<xs:element name="PMML"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Header"/> 
      <xs:element ref="DataDictionary"/> 
      <xs:element ref="TransformationDictionary" minOccurs="0"/> 
      <xs:element ref="MiningBuildTask"/> 
      <xs:sequence minOccurs="1"> 
        <xs:group ref="MODEL-ELEMENT"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="version" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:group name="MODEL-ELEMENT"> 
  <xs:choice> 
    <xs:element ref="RegressionModel"/> 
  </xs:choice> 
</xs:group> 
 
Figure 6. The XML schema of the general architecture of O-PMML  
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The Header section has already the placeholder for storing the information of 
software generating the predictive model under Application element, and 
descriptions of the model in description attribute under Header element, but an 
extension was added to cover information on OMOP version and model provider 
(Figure 7). The new extension has two required children elements of OmopCdm 
representing the version of OMOP and author showing the model’s author.  
The Data Dictionary section lists data variables in Data Field elements that 
will participate in the model (Figure 8). The data fields are categorical, ordinal, or 
continuous values retrieved directly from OMOP CDM that may or may not undergo 
transformations before being used in the model. If the data is categorical or ordinal, 
the value element specifies possible values under Data Field elements. In case of 
interval data fields, the interval element defines the lower and upper bound 
closures. The data fields also allow to distinguish missing, valid, and invalid input 
values. For example, we can specify if ‘99’ represents missing values or a certain 
value like ‘I’ denotes invalid values in a field to be excluded from analyses. 
The Transformation Dictionary and Local Transformations sections define 
transformation procedures of data fields before participating in the models (Figure 
9). Under these sections, data fields can be transformed to yield Derived Field 
elements through normalization, discretization, value mapping, text indexing, 
aggregation (e.g., count, average, sum), lag, and applying built-in (e.g., addition, 
subtraction, divide, multiplication, log10, ln, conditions) or user-defined functions. In 
contrast to Transformation Dictionary that applies globally to all models within the 
PMML document, Local Transformations can only be used by the local Regression 
Model where located (Figure 11).  
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<xs:element name="Header"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="1" ref="Extension"/> 
      <xs:element ref="Application"/> 
      <xs:element ref="Annotation"/> 
      <xs:element ref="Timestamp"/> 
    </xs:sequence> 
    <xs:attribute name="copyright" type="xs:string"/> 
    <xs:attribute name="description" type="xs:string"/> 
    <xs:attribute name="modelVersion" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Application"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
    <xs:attribute name="version" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Annotation" type="xs:string"/> 
  
<xs:element name="Timestamp" type="xs:dateTime"/> 
 
<xs:element name="Extension"> 
  <xs:complexType> 
    <xs:choice> 
      <xs:element minOccurs="0" ref="OmopCdm"/> 
      <xs:element minOccurs="0" ref="author"/> 
 
    etc. 
 
    </xs:choice> 
    <xs:attribute name="extender" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="OmopCdm"> 
  <xs:complexType> 
    <xs:attribute name="version" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="author"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
 
Figure 7. The XML schema of Header section in O-PMML 
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<xs:element name="DataDictionary"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DataField" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="numberOfFields" type="xs:nonNegativeInteger"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="DataField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:sequence> 
        <xs:element ref="Interval" minOccurs="0" maxOccurs="unbounded"/> 
        <xs:element ref="Value" minOccurs="0" maxOccurs="unbounded"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Value"> 
  <xs:complexType> 
    <xs:attribute name="value" type="xs:string" use="required"/> 
    <xs:attribute name="displayValue" type="xs:string"/> 
    <xs:attribute name="property" default="valid"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="valid"/> 
          <xs:enumeration value="invalid"/> 
          <xs:enumeration value="missing"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Interval"> 
  <xs:complexType> 
    <xs:attribute name="closure" use="required"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="openClosed"/> 
          <xs:enumeration value="openOpen"/> 
          <xs:enumeration value="closedOpen"/> 
          <xs:enumeration value="closedClosed"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="leftMargin" type="NUMBER"/> 
    <xs:attribute name="rightMargin" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
 
Figure 8. The XML schema of Data Dictionary section and Data Field elements in O-PMML  
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<xs:element name="TransformationDictionary"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DefineFunction" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:element ref="DerivedField" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="LocalTransformations"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DerivedField" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="DerivedField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:group ref="EXPRESSION"/> 
      <xs:element ref="Value" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:group name="EXPRESSION"> 
  <xs:choice> 
    <xs:element ref="Constant"/> 
    <xs:element ref="FieldRef"/> 
    <xs:element ref="NormContinuous"/> 
    <xs:element ref="NormDiscrete"/> 
    <xs:element ref="Discretize"/> 
    <xs:element ref="MapValues"/> 
    <xs:element ref="TextIndex"/>         
    <xs:element ref="Apply"/> 
    <xs:element ref="Aggregate"/> 
    <xs:element ref="Lag"/> 
  </xs:choice> 
</xs:group> 
 
Figure 9. The XML schema of Transformation Dictionary section, Local Transformations 
section, Derived Field elements, and acceptable data transformation expressions in O-PMML 
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The Mining Build Task section acts as the blueprint to mine Data Field 
values from OMOP CDM. It describes what criteria were applied to define the 
variable, and which CDM tables are involved to extract data fields. This section of 
PMLL has no specific structure, and it can contain any mining standards. Therefore, 
a new XML schema was designed for this section that not only satisfies Req. 4, but 
also needs minimum implementation in the existing working PMML parser 
modules. The new schema uses Extension elements to define the data mining 
pipelines, specified by attribute extender of “OMOP” (Figure 10). For each Data Field 
element, there is one Extension element with the same attribute name. The 
Extension element must have only one Statement element and may have Input 
Parameters section. The Statement element contains the SQL, R, or Java script to 
query the CDM tables to retrieve values of data fields. If the script requires input 
values, for example index date or Person ID, the placeholder value is denoted by at 
symbol (e.g., @PERSON_ID). The Input Parameters section specifies the input 
values of the Statement element’s script before querying the database. Each 
placeholder value is defined by an Input Parameter element that specifies the name 
and type of the input value.  
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<xs:element name="MiningBuildTask"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="1" maxOccurs="unbounded" ref="Extension"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Extension"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="0"  ref="InputParameters"/> 
      <xs:element minOccurs="0" ref="Statement"/> 
 
         etc. 
 
    </xs:sequence> 
    <xs:attribute name="extender" type="xs:string" use="optional" 
fixed="omop"/> 
 <xs:attribute name="name" type="xs:string" use="optional"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="InputParameters"> 
  <xs:complexType> 
    <xs:sequence> 
   <xs:element minOccurs="1" ref="InputParameter"/> 
 </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="InputParameter"> 
  <xs:complexType> 
 <xs:attribute name="name" type="xs:string" use="required"/> 
 <xs:attribute name="displayName" type="xs:string" use="optional"/> 
 <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="Statement"> 
  <xs:complexType> 
 <xs:attribute name="dialect" type="STATEMENT-DIALECT" use="required"/> 
  </xs:complexType> 
</xs:element> 
 
<xs:simpleType name="STATEMENT-DIALECT"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="postgresql"/> 
    <xs:enumeration value="mssql"/> 
    <xs:enumeration value="mysql"/> 
    <xs:enumeration value="netezza"/> 
    <xs:enumeration value="r"/> 
    <xs:enumeration value="java"/> 
    <xs:enumeration value="sql"/> 
  </xs:restriction> 
</xs:simpleType> 
 
Figure 10. The new XML schema of Mining Build Task section and the required elements 
and attributes in O-PMML  
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The Regression Model section (Figure 11) follows PMML standard with no 
change. It specifies the participating variables in Mining Schema section, the 
coefficient of variables in Regression Table section, optional data transformations in 
Local Transformations section applicable to the model, the yields of the model and 
the required processes to compute output values in optional Output section, 
statistics of training set in optional Model Stats section, optional information about 
the quality of model in Model Explanation section, properties of target values in 
optional Targets section, and a dataset for verifying the results of the model in 
optional Model Verification section.  
 
 
<xs:element name="RegressionModel"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="MiningSchema"/> 
      <xs:element ref="RegressionTable" maxOccurs="unbounded"/> 
      <xs:element ref="LocalTransformations" minOccurs="0"/> 
      <xs:element ref="Output" minOccurs="0"/> 
      <xs:element ref="ModelStats" minOccurs="0"/> 
      <xs:element ref="ModelExplanation" minOccurs="0"/> 
      <xs:element ref="Targets" minOccurs="0"/> 
      <xs:element ref="ModelVerification" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="modelName" type="xs:string"/> 
    <xs:attribute name="functionName" type="MINING-FUNCTION" use="required"/> 
    <xs:attribute name="algorithmName" type="xs:string"/> 
    <xs:attribute name="modelType" use="optional"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="linearRegression"/> 
          <xs:enumeration value="stepwisePolynomialRegression"/> 
          <xs:enumeration value="logisticRegression"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="targetFieldName" type="FIELD-NAME" use="optional"/> 
    <xs:attribute name="normalizationMethod" 
type="REGRESSIONNORMALIZATIONMETHOD" default="none"/> 
    <xs:attribute name="isScorable" type="xs:boolean" default="true"/> 
  </xs:complexType> 
</xs:element> 
 
Figure 11. The XML schema of Regression Model section in O-PMML 
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The Mining Schema (Figure 12) describes the participating variables by 
Mining Field elements where the usage type attribute specifies whether the variable 
is dependent (i.e., predicted) or independent (i.e., active). The Mining Field elements 
may refer to Data Field elements in Data Dictionary section, or Derived Field 
elements in Transformation Dictionary or Local Transformations sections. 
 
 
<xs:element name="MiningSchema"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element maxOccurs="unbounded" ref="MiningField"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="MiningField"> 
  <xs:complexType> 
    <xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="usageType" type="FIELD-USAGE-TYPE" default="active"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    ... 
  </xs:complexType> 
</xs:element> 
 
Figure 12. The XML schema of Mining Schema section and Mining Field elements under 
Regression Model in O-PMML 
 
 
The Regression Table (Figure 13) denotes the intercept and the coefficients of 
participating variables in the predictive model by elements Numeric Predictor (i.e., 
numeric independent variables), Categorical Predictor (i.e., categorical independent 
variables), and Predictor Term (i.e., interactions). 
 
 
<xs:element name="RegressionTable"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="NumericPredictor" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:element ref="CategoricalPredictor" minOccurs="0" 
maxOccurs="unbounded"/> 
      <xs:element ref="PredictorTerm" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="intercept" type="REAL-NUMBER" use="required"/> 
    <xs:attribute name="targetCategory" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
 
Figure 13. The XML schema of Regression Table section under Regression Model   
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The Output section (Figure 14) describes the output values of the model 
(e.g., estimated risk score, occurrence of event, probability) and the transformation 
processes required to calculate the final values in Output Field elements. The 
transformation expressions are similar to that of Transformation Dictionary. 
 
 
<xs:element name="Output"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="OutputField" minOccurs="1" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
 
<xs:element name="OutputField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:sequence minOccurs="0" maxOccurs="1"> 
        <xs:element ref="Decisions" minOccurs="0" maxOccurs="1"/> 
        <xs:group ref="EXPRESSION" minOccurs="1" maxOccurs="1"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
    <xs:attribute name="targetField" type="FIELD-NAME"/> 
    <xs:attribute name="feature" type="RESULT-FEATURE" 
default="predictedValue"/> 
    <xs:attribute name="value" type="xs:string"/> 
    <xs:attribute name="isFinalResult" type="xs:boolean" default="true"/> 
  </xs:complexType> 
</xs:element> 
 
Figure 14. The XML schema of Output section and Output Filed elements in O-PMML 
 
 
 
3.6.2. The OMOP-compliant PMML scoring engine 
In order to evaluate the performance of the OMOP-compliant PMML 
standard to estimate risk score of diseases, a scoring engine was designed and 
developed that extracts the definitions of the embedded risk scoring model, queries 
the OMOP CDM to retrieve data values, and generates the output values of the 
model. 
The O-PMML scoring engine is a Python module that comprises of three 
components: O-PMML Parser, SQL Executer, and Scorer (Figure 15). The O-PMML 
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Parser analyzes the OMOP-compliant PMMLs to extract the specifications of 
regression model, including participating variables from Data Dictionary and 
Mining Schema sections, the corresponding coefficients from Regression Table 
section, data mining scripts from Mining Build Task section, and transformation 
procedures from Data Transformation, Local Transformations, and Output sections. 
Then, the SQL Executer uses the SQL scripts of Mining Build Task, asks for input 
parameters in accordance to the specified Input Parameters, replaces SQL 
placeholders with the parameter values, and retrieves data fields from the CDM. 
Finally, the Scorer component applies the predictive model on the retrieved data 
values from database to generate the output values according to the procedures 
specified by the O-PMML. When multiple values of a measurement exist for one 
index date, the Scorer includes the average of all values on that date in calculating 
the outputs of the algorithm. 
 
 
Figure 15. A schematic of O-PMML scoring engine 
 
 
 
3.6.3. Case study: CVD risk scoring model 
In order to evaluate the feasibility and performance of the O-PMML 
standard, I conducted a case study to use the standard for disseminating and scoring 
Framingham 10-year risk of CVD model.  
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3.6.3.1. Data source 
The data pipelines and O-PMML were tested on the medical records of 250 
patients obtained from Regenstrief Institute in HL7 consolidated CCDs. The content 
of CCDs was transformed to OMOP CDM using the CCD-TO-OMOP as described in 
Chapter 2.  
3.6.3.2. The Framingham 10-year risk of CVD scoring model 
D'Agostino et al., 2008 (105) generated this prediction algorithm from the 
original and offspring cohorts of Framingham Heart Study to estimate the 10-year 
risk of cardiovascular disease in men (Figure 16) and women (Figure 17) aged 
between 30 and 74 years old. The predictive model estimates the risk based on the 
patient’s age, serum total cholesterol level (mg/dL), serum high-density lipoprotein 
(HDL) cholesterol level (mg/dL), systolic blood pressure (mmHg), use of hypertension 
controlling medications, cigarette smoking status, and diabetes status. 
 
 
∑ 𝛽𝑋 = 3.06117×ln 𝐴𝑔𝑒 + 1.12370× ln 𝑇𝑜𝑡𝑎𝑙 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 − 0.93263× ln 𝐻𝐷𝐿 + 1.93303× ln 𝑆𝐵𝑃𝑛𝑜𝑡 𝑡𝑟𝑒𝑎𝑡𝑒𝑑
+ 1.99881× ln 𝑆𝐵𝑃𝑡𝑟𝑒𝑎𝑡𝑒𝑑 + 0.65451×𝑆𝑚𝑜𝑘𝑒𝑟 + 0.57367×𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 
 
𝑅𝑖𝑠𝑘 𝑜𝑓 𝐶𝑉𝐷 𝑖𝑛 10 𝑦𝑒𝑎𝑟𝑠 𝑓𝑜𝑟 𝑚𝑒𝑛 = 1 − 0.88936exp (∑ 𝛽𝑋−23.9802) 
 
Figure 16. Framingham 10-year risk of CVD for men (105) 
 
 
∑ 𝛽𝑋 = 2.32888×ln 𝐴𝑔𝑒 + 1.20904× ln 𝑇𝑜𝑡𝑎𝑙 𝐶ℎ𝑜𝑙𝑒𝑠𝑡𝑒𝑟𝑜𝑙 − 0.70833× ln 𝐻𝐷𝐿 + 2.76157× ln 𝑆𝐵𝑃𝑛𝑜𝑡 𝑡𝑟𝑒𝑎𝑡𝑒𝑑
+ 2.82263× ln 𝑆𝐵𝑃𝑡𝑟𝑒𝑎𝑡𝑒𝑑 + 0.52873×𝑆𝑚𝑜𝑘𝑒𝑟 + 0.69154×𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐 
 
𝑅𝑖𝑠𝑘 𝑜𝑓 𝐶𝑉𝐷 𝑖𝑛 10 𝑦𝑒𝑎𝑟𝑠 𝑓𝑜𝑟 𝑤𝑜𝑚𝑒𝑛 = 1 − 0.95012exp (∑ 𝛽𝑋−26.1931) 
 
Figure 17. Framingham 10-year risk of CVD for women (105)  
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3.6.3.3. The specifications of O-PMML containing Framingham algorithms 
This study compiled one model per O-PMML document for simple 
presentation of the schema; thus, separate documents were generated for men and 
women algorithms of the Framingham risk scoring model as presented in Appendix 
9 and Appendix 10. The two algorithms only differ in values of intercept and 
coefficients of variables.  
The Framingham O-PMML was structured in a way that allowed to build a 
timeline of estimated risk scores. This was achieved by embedding an input 
parameter in the script to take the index date of interest, and gather values of 
participating variables in the algorithm according to the specified index date. The 
input parameter of Person ID also enabled calculating the score for one patient at a 
time.  
The Mining Build Task section lists mining scripts to retrieve input data 
values from the CDM. The Input Parameters specifies the required entries to fill 
placeholders within the Statement script. For example, the age script needs Index 
Date, Person ID, and the database’s schema name where CDM is located before 
querying database to calculate patient’s age (Figure 18). Table 21 lists the criteria 
applied to collect the values of Framingham risk score variables. 
 
 
<MiningBuildTask> 
  <Extension name="age" extender="omop"> 
    <InputParameters> 
      <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
      <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
      <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
    </InputParameters> 
    <Statement dialect="postgresql"> 
      select distinct extract(year from date '@INDEX_DATE')-year_of_birth as 
AGE from @SCHEMA.person where person_id=@PERSON_ID; 
    </Statement> 
  </Extension> 
 
  etc. 
 
<MiningBuildTask> 
 
Figure 18. An excerpt of the Mining Build Task section of Framingham O-PMML 
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Table 21. The criteria applied to collect values of participating variables in Framingham 10-
year risk of cardiovascular disease 
Data Field 
Name 
Data Field Display 
Name 
Description 
age Age The age of patient at index date 
TCL Total cholesterol level Serum total cholesterol level (OMOP Concept 
ID = 3027114) within 30 days of index date 
HDL HDL cholesterol level Serum HDL cholesterol level (OMOP Concept 
ID = 3007070) within 30 days of index date 
HTNTRT Antihypertensive 
medication use 
Use of antihypertensive medication within 30 
days of index date, including angiotensin-
converting-enzyme inhibitors, angiotensin 
receptor blockers, beta blockers, calcium 
channel blockers, diuretics, antiadrenergic 
agents, thiazides, hydrazinophthalazines, oral 
minoxidil, nitroprusside, pinacidil, tyrosine 
hydroxylase inhibitors, pargyline, and 
endothelin receptor antagonists 
SBP Systolic blood pressure Systolic blood pressure within 30 days of 
index date 
smoker Cigarette smoking 
status 
Report of smoking within 90 days of index 
date 
diabetic Diabetes status Report of diabetic conditions prior to index 
date 
OR 
Report of fasting blood sugar ≥126 mg/dL 
within 60 days of index date 
OR 
Use of insulin or oral antidiabetic medications 
within 30 days of index date 
 
 
 
The Data Dictionary section of the O-PMML specifies eight unprocessed data 
variables that will participate in the model after undergoing transformation 
processes described in Transformation Dictionary section. As shown in Figure 19, 
the inclusion of patients is limited to the age interval between 30 and 74 years old, 
and possible values of antihypertensive medication use (HTNTRT), smoking status 
(smoker), and diabetes status (diabetic) data fields are specified.  
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<DataDictionary numberOfFields="8"> 
    <DataField name="hazard" displayName="Cumulative Hazard" 
optype="continuous" dataType="double"/> 
    <DataField name="age" displayName="Age" optype="continuous" 
dataType="double"> 
      <Interval closure="closedClosed" leftMargin="30" rightMargin="74"/> 
    </DataField> 
    <DataField name="TCL" displayName="Total Cholesterol" optype="continuous" 
dataType="double"/> 
    <DataField name="HDL" displayName="HDL" optype="continuous" 
dataType="double"/> 
    <DataField name="HTNTRT" displayName="Antihypertensive medication use 
(y/n)" optype="categorical" dataType="boolean"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="SBP" displayName="Systolic Blood Pressure" 
optype="continuous" dataType="double"/> 
    <DataField name="smoker" displayName="Smoker(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="diabetic" displayName="Diabetic(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
</DataDictionary> 
 
Figure 19. The Data Dictionary section of Framingham O-PMML 
 
 
 
The Transformation Dictionary section specifies the transformation processes 
on data fields from Data Dictionary. As shown in Figure 20, age, total cholesterol 
level, HDL level, and systolic blood pressure (SBP) need to undergo natural 
logarithm transformation. It also uses conditional function to specify criteria to 
determine whether SBP was measured when the patient was taking 
antihypertensive medication. The equivalent SQL statements of the conditional 
processes are: 
 
case when HTNTRT=0 then logSBP else 0 end as logSBP_NOTTRT 
case when HTNTRT=1 then logSBP else 0 end as logSBP_TRT 
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<TransformationDictionary> 
    <DerivedField name="logAge" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="age"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logTCL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="TCL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logHDL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="HDL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="SBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_NOTTRT" dataType="double" optype="continuous"> 
      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <Constant dataType="integer">0</Constant> 
        <FieldRef field="logSBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_TRT" dataType="double" optype="continuous"> 
      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <FieldRef field="logSBP"/> 
        <Constant dataType="integer">0</Constant> 
      </Apply> 
    </DerivedField> 
  </TransformationDictionary> 
 
Figure 20. The Transformation Dictionary section of Framingham O-PMML 
 
 
 
The Framingham risk score equation was built based on Cox proportional-
hazards regression. The equation (Figure 16 and Figure 17) consists of two parts: 
The linear regression of predictors that calculates relative hazard, and risk 
calculation. The two parts were respectively translated in Regression Table and 
Output sections of the Regression Model (Figure 21). The Mining Filed elements list 
the participating variables in the regression model from Data Dictionary (smoker, 
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diabetic) and Transformation Dictionary (logAge, logTCL, logHDL, logSBP_TRT, 
logSBP_NOTTRT) fields. The Output Field elements specify the computation 
processes to calculate ultimate output values (i.e., risk score). The Scorer component 
only delivers the outputs that are specified as final results (i.e., isFinalResult = 
“true”). 
 
 
<RegressionModel modelName="framingham10ycvdmen" functionName="regression" 
algorithmName="Cox proportional-hazards regression" isScorable="true"> 
  <MiningSchema> 
    <MiningField name="hazard"  usageType="predicted"/> 
    <MiningField name="logAge"  usageType="active"/> 
    <MiningField name="logTCL"  usageType="active"/> 
    <MiningField name="logHDL"  usageType="active"/> 
    <MiningField name="logSBP_TRT"  usageType="active"/> 
    <MiningField name="logSBP_NOTTRT"  usageType="active"/> 
    <MiningField name="smoker"  usageType="active"/> 
    <MiningField name="diabetic"  usageType="active"/> 
  </MiningSchema> 
   
  <Output> 
   <OutputField name="hazard" optype="continuous" dataType="double" 
feature="predictedValue" isFinalResult="false"/> 
    <OutputField name="hazard_ratio" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="false"> 
      <Apply function="exp"> 
        <FieldRef field="hazard"/> 
      </Apply> 
    </OutputField> 
    <OutputField name="risk" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="true"> 
      <Apply fucntion="-"> 
        <Constant>1.0</Constant> 
        <Apply fucntion="pow"> 
          <Constant>0.95012</Constant> 
          <FieldRef field="hazard_ratio"/> 
        </Apply> 
      </Apply> 
    </OutputField> 
  </Output> 
   
  <RegressionTable  intercept="-26.1931"> 
    <NumericPredictor name="logAge" coefficient="2.32888"/> 
    <NumericPredictor name="logTCL" coefficient="1.20904"/> 
    <NumericPredictor name="logHDL" coefficient="-0.70833"/> 
    <NumericPredictor name="logSBP_TRT" coefficient="2.82263"/> 
    <NumericPredictor name="logSBP_NOTTRT" coefficient="2.76157"/> 
    <CategoricalPredictor name="smoker" value="1" coefficient="0.52873"/> 
    <CategoricalPredictor name="diabetic" value="1" coefficient="0.69154"/> 
  </RegressionTable> 
</RegressionModel> 
 
Figure 21. The Regression Model section of Framingham O-PMML 
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3.6.3.4. Performance assessment of Framingham O-PMML 
The scoring engine was programmed to generate 10-year risk score of 
cardiovascular disease using the develop Framingham O-PMMLs at every visit 
occurrences (i.e., index date). The risk scores were calculated only if all variables 
were available at the index date. The estimated scores were manually assessed later 
for accuracy.  
3.7. Results 
3.7.1. Patient characteristics 
Out of 250 studied patients, 226 (82 men and 144 women) were included in 
the final analysis as 24 patients did not have any information about date of birth, or 
visit occurrence. The analysis of visit occurrence records of 226 patients yielded 
4,472 index dates. The initial pool of patient records aged from 0 to 87 years old, but 
the risk score was generated for the records between 30 and 67 years old. Table 22 
shows detail information about the characteristics of included patient records. 
 
Table 22. The characteristics of patient records for which Framingham 10-year risk score of 
cardiovascular disease was generated 
Characteristics Analyzed Patient Records 
(N = 4,472) 
Records with Risk Scores 
(N = 56) 
Gender, n (%)   
Men 1,154 (25.8) 11(19.6) 
Women 3,318 (74.2) 45 (80.4) 
Age, range 0 – 87 years 30 – 67 years 
Total cholesterol level, 
range 
87 – 298 mg/dL 87 – 219 mg/dL 
HDL cholesterol level, 
range 
25 – 65 mg/dL 25 – 47.5 mg/dL 
Systolic blood pressure, 
range 
106 – 162 mmHg 106 – 162 mmHg 
Antihypertensive 
medications user, n (%) 
537 (12.0) 31 (55.4) 
Current smoker, n (%) 0 (0) 0 (0) 
Diabetic, n (%) 709 (15.9) 4 (7.1) 
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3.7.2. Risk scores 
A total of 56 risk scores were calculated for 8 unique patients. These patients 
had the full set of required data values to generate the risk score. Most of the 
analyzed records lacked one or more data values; thus, they were excluded from the 
scoring step. The risk scores ranged from 1.11% to 36.37%. The lowest calculated 
risk score belonged to a 30-year old, non-smoker, and non-diabetic woman with total 
cholesterol level of 184 mg/dL, HDL of 31 mg/dL, no antihypertensive medication 
use, and SBP of 106 mmHg. The patient with the highest risk score was diabetic, 
non-smoker, 64-year old man with total cholesterol level of 87 mg/dL, HDL of 25 
mg/dL, taking antihypertensive medications, and SBP of 149.5 mmHg. All generated 
risk scores were valid after inspected manually. The full list of estimated risk scores 
is available in Appendix 11.  
The architecture of O-PMML also allowed to capture the timeline of risk 
scores. Figure 22 depicts the timeline of risk score for the 8 patients who had the 
required values of algorithm’s variables at the index dates. 
 
 
 
Figure 22. The timeline of estimated 10-year risk score of cardiovascular disease of patients 
that had full set of required values to generate scores.  
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3.8. Discussion 
3.8.1. An overview of O-PMML 
This study demonstrated that the adopted O-PMML can be used for 
delivering estimations and predictions about health-related events of patients to 
care providers to support clinical-decision making and precision medicine. The 
adoption process intended to keep the original structure of PMML intact, and only 
involved a new structure for the Mining Build Task section; thus, the O-PMML will 
work with the already-developed PMML parsers. However, minor modifications in 
the parsers are needed to process the Mining Build Task section that contains 
scripts to properly mine OMOP CDM. The study also found the O-PMML as a 
feasible tool to deploy models on OMOP CDM, and score the algorithms through the 
developed scoring engine.  
The O-PMML was designed to satisfy the five requirements of sharing 
OMOP-compatible predictive models, metadata, model’s specifications, database 
mining pipelines, data transformation procedures, and model’s output. However, the 
PMML allows sharing further capabilities to evaluate the quality of models, share a 
sample of training dataset for cross-validation, and specify the properties of output 
values using optional sections Model Stats, Model Explanation, Targets, and Model 
Verification. This paper did not discuss these sections in detail, but their compliance 
with OMOP CDM can be subjects of new research in future. 
3.8.2. Advantages of O-PMML 
The O-PMML standard in conjunction with the developed scoring engine offer 
the capability to “plug-and-play” predictive models on OMOP-formatted medical 
data repositories. There are numerous reports of individualized predictive models 
using the EHR in the literature that are supported by PMML structure, such as 
logistic regression to predict prognosis of health outcomes (38-40, 42), Cox 
proportional hazards model for estimating opioid dose-related risk of injuries in 
older adults (43) and survival analysis (44), linear regression for exploring outcome 
predictors (45), and personalizing medicine dosage (46) and risk estimations (39), 
and random forest for individualized medicine doses (37, 47). Researchers have also 
examined several machine learning methods to improve the accuracy and 
generalizability of the developed predictive models, such as support vector machine 
(SVM) for early detection of myocardial infarction (47) and mortality risk of radical 
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cystectomy (48), Markov Decision Process for predicting mortality and length of 
hospitalization in septic patients (49), k-nearest neighbor for warfarin dosage 
estimation (50), naïve Bayes network for cardiovascular disease risk (51), 
classification and regression tree (CART) for heart failure patients’ readmission risk 
using EHR data (52). Ultimately, this standard will help develop interoperable 
personalized scoring systems offering real-time, personalized predictions to 
clinicians about patients at the point-of-care. It can also help test the performance of 
predictive models across databases through prediction-as-a-service (106) with 
minimum implementation efforts needed.  
In addition, the new structure of Mining Build Task section within O-PMML 
grants more flexibility to the O-PMML to score predictive models at certain index 
dates. Therefore, the O-PMMLs can not only share the specifications of predictive 
model, but also allow running the scoring algorithms multiple times on patient data 
to deliver the trend of measures throughout time. One example use case is to 
monitor drug adherence among patients through episodes of care, and explore the 
effectiveness of interventions on improving medication use. In this case, applying an 
O-PMML containing an algorithm to estimate drug adherence on patient medical 
records will deliver series of scores at intervention time points. 
3.8.3. Limitations 
This study only focused on sharing a regression model using the O-PMML to 
deliver predictions about health-related events. The standard needs to be tested for 
other types of predictive models such as logistic regression, decision tree, and 
random forest that are widely used in clinical research. The performance assessment 
of O-PMML was also limited to small sample of patients. The standard needs to be 
tested on larger, multi-center sample of patients to ensure the accuracy of processing 
pipelines, and the feasibility of implementing O-PMML across systems. 
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CHAPTER 4. THE INTEROPERABLE SYSTEM FOR DELIVERING 
PERSONALIZED HEALTH OUTCOME PREDICTIONS 
4.1. Background 
The literature has many examples of predictive modeling developed to 
support clinical decision-making through offering estimations about the health 
status of patients. Typical examples of predictive models include predicting 
prognostic risk of health events (27-29), disease screening (30-32), and managing 
short- and long-term complications (33-36). 
Although numerous EHR-based predictive models have been reported in the 
literature, there are only few reports of deployment of health outcome predictive 
models, and no report exist that applies or evaluates the models across multiple data 
warehouses for clinical effectiveness and cost efficiency. For example, Hu et al., 2015 
(4) reported an online application for predicting the next 6-month healthcare 
resource utilization by chronic disease patients. The prediction system could make 
real-time risk assessment using a health information exchange (HIE) electronic 
health records (EHR) warehouse; however, it was not evaluated in other HIE 
networks.  
In another effort in Canada, Khazaei et al., 2015 (5) proposed a cloud-based 
Analytics-as-a-Service framework for real-time patient monitoring in the clinical 
edition and retrospective health analytics in the research edition across multiple 
EHR systems. They deployed an algorithm to identify septic neonates in an 
intensive care unit; however, the report did not provide any information about data 
exchange standards or data transformation processes (e.g., inter-vocabulary 
mapping of concept code). Although no predictive model was deployed, this study 
sheds light on novel approaches of integrating advanced analytics in healthcare 
system. Toerper et al., 2015 (6) also developed a web-based application that predicts 
daily admission bed needs based on EHR data to improve patient flow management. 
Despite providing a real-time tool for monitoring and forecasting patient flow in a 
hospital setting, the proposed system is not interoperable to work across other 
centers to retrieve new incoming patients’ data for better prediction performance. 
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The existing healthcare IT solutions have not fully leveraged forecasting 
capabilities of predictive models in medical practice to provide clinicians with 
personalized recommendations about patients’ health status. Testing the quality of 
predictions is also challenging as deployment of predictive models required extensive 
efforts and teams of analysts, statisticians, IT professionals, and computer 
programmer. This project intends to fill the gap via designing, evaluating, 
implementing an interoperable solution that receives patient electronic health 
records via Health Level Seven (HL7) messaging standard, transforms the records to 
a common data model for population health research, and applies risk prediction 
models received in PMML format on patient data to make predictions about health 
outcomes, and delivers the results to healthcare professionals. 
4.2. Objectives 
This paper describes an interoperable framework for delivering real-time, 
personalized predictions about patient health status by applying predictive models 
on exchanged patient information. To proof the concept, Personalized Health Risk 
Scoring Tool (PHRST), a web-based, interoperable OMOP-based model scoring tool 
was developed that receives patient medical records from OMOP CDM repository, 
applies risk score models obtained in a standard PMML-based format on patient 
information, and delivers personalized risk scores to the end user who can be a 
healthcare professional. 
4.3. Methods 
4.3.1. The personalized health outcome prediction framework 
Figure 23 shows the proposed interoperable framework that delivers 
personalized health outcome predictions through applying predictive models on 
patient medical records. The framework is designed to be interoperable in two 
directions, patient’s data input and predictive model input. It receives the medical 
records in HL7 C-CDA-based CCDs, and accepts trained predictive models in 
OMOP-compliant PMML. The system is capable of performing predictions through a 
wide range of OMOP-compliant machine learning models, such as regression 
(general linear, multinomial logistic, ordinal multinomial, generalized linear, Cox 
regression), decision tree, support vector machine, and random forest.  
Figure 24 presents the data flow in the personalized health outcome 
prediction framework. Once the system receives patient health information enclosed 
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in HL7 CCD, a parser developed in the previous study called CCD-TO-OMOP parser 
(Chapter 2) extracts data from the document, transform the data to OMOP CDM, 
and stores in a PostgreSQL database. The module is equipped with an Extract-Load-
Transform (ETL) processor that maps diagnoses, laboratory tests, drugs, 
demographics, observations, allergies, and other data element requirements into 
OMOP CDM version 5.1 (Figure 2). The resulting transformed data are passed to an 
PMML scoring engine developed in a previous study (Chapter 3) to estimate outcome 
predictions. Both PMMLs and the scoring engine are compliant with OMOP CDM. 
The engine receives O-PMML containing predictive models from an internal or 
externa repository, and applies the model on retrieved patient information from the 
CDM. The framework allows to run multiple predictive models received in O-PMML 
documents from an O-PMML Repository on many patients’ medical records at once. 
As a final step, the prediction output can be send back to the client in a message or 
displayed on a user interface. 
 
 
 
Figure 23. A schematic of the interoperable framework for delivering personalized health 
outcome predictions  
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4.3.2. Architecture and dataflow of PHRST 
To show case the concept of interoperable personalized health outcome 
prediction framework, a web-based application was developed based on the 
described framework to assess compatibility of components to deliver outputs of 
predictive models. The Personalized Health Risk Scoring Tool (PHRST) solution 
(pronounced First) composes of four components (Figure 24): A data warehouse that 
contains OMOP-transformed patient medical records (Chapter 2); the O-PMML 
scoring engine (Chapter 3) that generates predictions by applying predictive models 
from OMOP-compliant PMMLs on patient information from the database; a user 
interface that displays the prediction outputs to the user; and a representational 
state transfer (REST) application programming interface (API) that connects the 
user interface to the database and scoring engine. All responses from the server are 
JavaScript Object Notation (JSON) documents. 
On load, the PHRST shows a list of patients stored in the OMOP CDM to the 
user. It also pulls the list of available predictive models on the server. Once a patient 
is selected, the system proposes the list of models to user for selection. The user may 
choose to run one or multiple predictive models on the selected patients. Upon 
clicking on the start button, a request is sent to the scoring engine on server through 
the API to parse the corresponding O-PMML document and compute outputs of the 
selected models. Then, prediction outputs are transferred through the API in JSON 
documents back to user interface to display in tables. The solution can deliver both 
cross-sectional and longitudinal estimations of the health outcome, depending on the 
design of O-PMMLs.  
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Figure 24. A diagram of the architecture and data flow of personalized health outcome 
prediction framework 
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4.3.3. Case study: Framingham risk functions in action 
This case study intended to deploy Framingham risk functions in plug-and-
play manner on patient medical records using PHRST solution, and deliver 
contemporaneous risk predictions based on their medical history.  
4.3.3.1. Data source 
The proof-of-concept study involved medical records of 250 patients obtained 
from Regenstrief Institute in HL7 consolidated CCDs. The content of CCDs was 
transformed to OMOP CDM using the CCD-TO-OMOP as described in Chapter 2. 
4.3.3.2. Predictive models 
Framingham Heart Study has generated series of robust risk predictive 
models estimating various health outcomes to help clinicians better assess the risk 
of diseases and assist them in evidence-based clinical decision-making process. The 
algorithms include risk estimation of atrial fibrillation (107, 108), cardiovascular 
disease(105, 109), congestive heart failure (110), coronary heart disease (111-113), 
diabetes (114), hypertension (115), intermittent claudication (116), and stroke (117, 
118). This case study tested deployment of 10-year risk of cardiovascular disease 
model on PHRST using the designed O-PMML in Chapter 3 (Appendix 9 and 
Appendix 10). 
4.4. Results 
4.4.1. PHRST development 
The single-page user interface of PHRST web application was developed in 
HTML5 and CSS3, and APIs were Java web services. The solution offers risk 
predictions of diseases personalized to each patient, allowing users to select one 
patient at a time and order one or multiple risk predictions. The application alerts 
the user when the risk estimates are available, an error has occurred, or not 
sufficient data exist to compute risk scores (Figure 25). The user can also see more 
details of granular data values when selects a generated risk score (Figure 26).  
  
 98 
 
Figure 25. The view of PHRST application that allows users to select patients and order risk 
score estimates. The names of patients are fictitious. 
 
 
 
 
Figure 26. The view of PHRST application that displays more details of the selected 
patient’s risk factor data and the estimated risk score. The names of patients are fictitious.  
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4.4.2. Deployment of Framingham risk functions on PHRST 
The solution successfully called O-PMMLs on the server and generated risk 
estimates. Depending on the size of available patients’ medical records in the 
database, the processing time took from seconds to under one minute. The 
specifications of O-PMMLs were cached upon first call, then used in the subsequent 
requests; thus, the processing reduced after the first model was processed. 
The solution is designed and programmed in a way that plugs new 
algorithms into play once O-PMMLs reach the server. Upon arrival in the server via 
a message or simply copied to the disc, PHRST lists the models on the panel for user 
selection. Each model is assigned a unique ID which is called upon a request to 
compute the model’s output. 
4.5. Discussion 
4.5.1. An overview 
The PHRST solution was developed based on the described conceptual 
framework of personalized health outcome predictions to allow delivering risk 
estimates of patient health outcome to clinicians, and ease deployment of new 
predictive models in clinical setting. New predictive algorithms can easily plug into 
the solution when exchanged in O-PMML format to the server, and will be ready-to-
use on OMOP CDM medical records with no further implementation efforts. The 
user interface of PHRST not only displays the estimated risk score at a certain point 
of time, but also present a timeline of estimations in the past. This can be very 
useful when monitoring patients for treatment efficacy and medication adherence.  
4.5.2. Advantages of the framework 
Interoperability is the main benefit of the framework. The system not only 
can work with other electronic medical record systems to receive patient 
information, but also can “plug-and-play” predictive models from third parties 
immediately. The solution can be implemented as a cloud-based system external to 
the EHR and the recipient of prediction outputs. This feature promotes the 
framework as a suitable solution for prediction-as-a-service (106). 
Another advantage of this framework is that the system is database-
structure agnostic, meaning that accepts patient medical records from other EHR 
systems independent of the architecture and coding systems. The CCD-TO-OMOP 
parser transforms medical records to OMOP CDM that unifies most of commonly 
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used coding systems to standard concepts. This feature is crucial when the solution 
is hosted on a cloud server and receives heterogenous medical records from diverse, 
disparate databases to deliver health outcome predictions. 
4.5.3. Similar studies 
There are very few reports of similar frameworks in the literature, and no 
study was found on dual-interoperable solution that supports OMOP CDM to deliver 
personalized health outcome estimations. There is a sequel of reports from a team on 
an interoperable system designed to exchange predictive models in PMML, and 
transfer patient data in HL7 standard in clinical decision support systems (119-121). 
Although the reported frameworks were similarly designed to deliver output of 
model scoring operations on EHR data, they still needed custom-coding to adopt 
diversity of data structure across data repositories (120). This is a critical challenge 
for a cloud-based solution intended to process heterogenous EHR data that our study 
addressed successfully.  
4.5.4. Limitations  
The framework was tested on a small set of patient data and limited number 
of regression models. To ensure high performance and accurate prediction delivery, 
the framework needs to be assessed on larger multi-center patient datasets with 
diverse formats, and other commonly used machine learning algorithms in 
healthcare research and practice. 
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CHAPTER 5. CONCLUSION 
5.1. OMOP CDM Accommodates HL7 Consolidated CCD Data 
The OMOP CDM demonstrated the capability to accommodate concepts and 
data elements of HL7 CCD documents with high accuracy. The CDM allows 
researchers to analyze patients’ medical information similarly across discrete EHR 
systems when transferred via HL7 CCD messaging standard. The performance of 
the developed data transformation pipeline needs to be validated on a larger pool of 
CCD files from diverse providers. 
5.2. A New Standard Enables Sharing Health Risk Prediction Models 
The O-PMML, a customized version of PMML could disseminate predictive 
models to operate on OMOP CDM and generate predictions about health outcome. 
This is very important to not only clinical research, but also evidence-based clinical 
practice. Using this standard, we can share and deploy newly developed predictive 
models across databases to evaluate the performance of algorithms in order to 
improve the quality of predictions. It also allows to deliver the predictions about 
patent health outcomes at the-point-care to support clinical decision-making. 
5.3. An Interoperable System Delivers Personalized Health Outcome 
Predictions 
The PHRST solution proved the conceptual interoperable framework to 
deliver personalized health outcome predictions by applying predictive models on 
patient data on-the-fly. The proposed solution can handle heterogenous EHR data 
coded in diverse terminologies since patient information is transferred to OMOP 
CDM before undergoing computation process. This is one of the central benefits of 
using this framework in a multi-center setting. 
5.4. Future Work 
The O-PMML standard was designed to facilitate delivering estimations 
about health-related events, such as risk score and drug adherence indexes to 
support clinical decision-making, improving quality of healthcare service, and 
ultimately and patient’s quality of life. In future work, we need to evaluate the 
impact of O-PMML standard on these topics. 
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The user interface of PHRST is now in the proof-of-concept stage, and there 
are high potentials for further developments. It is imperative to test other types of 
machine learning algorithms and risk prediction models across multiple center 
databases to ensure integrity of the system and quality of predictions. 
Finally, privacy and security of the developed solutions was out of scope of 
this project; however, we need to address confidentiality, privacy, technical, 
implementation cost challenges (122, 123) in order to achieve a real-time predictive 
analytics system that delivers patient-specific predictions. the HIPAA privacy and 
security rules require covered entities including providers, hospitals, insurers, and 
their business associates to protect the privacy and confidentiality of individually 
identifiable health information (124). The entities are always reluctant to send out 
patient data to other parties unless they ensure that privacy and security 
safeguards are prepared; thus, these topics deserve high attention in future 
investigations to make sure existing security and privacy protocol for exchanging 
and maintaining IT solutions properly apply to the solutions. 
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APPENDICES 
Appendix 1. Template IDs of C-CDA Continuity of Care Document (CCD) Release 1.1 
templates used by CCD parser to locate entries 
Template Name Template 
Type 
Template ID 
US Realm Header 2.16.840.1.113883.10.20.22.1.1 
   
Allergies Section (entries required) Section 2.16.840.1.113883.10.20.22.2.6.1 
Allergy Problem Act Entry 2.16.840.1.113883.10.20.22.4.30 
Allergy-Intolerance 
Observation 
Entry 2.16.840.1.113883.10.20.22.4.7 
   
Encounters Section (entries 
optional) 
Section 2.16.840.1.113883.10.20.22.2.22 
Encounter Activity Entry 2.16.840.1.113883.10.20.1.21 
   
Immunizations Section (entries 
optional) 
Section 2.16.840.1.113883.10.20.22.2.2 
Immunization Activity Entry 2.16.840.1.113883.10.20.22.4.52 
Immunization Medication 
Information 
Entry 2.16.840.1.113883.10.20.22.4.54 
   
Medications Section (entries 
required) 
Section 2.16.840.1.113883.10.20.22.2.1.1 
Medication Activity Entry 2.16.840.1.113883.10.20.22.4.16 
Medication Information Entry 2.16.840.1.113883.10.20.22.4.23 
Supply Activity Entry 2.16.840.1.113883.10.20.1.34 
   
Problem Section (entries required) Section 2.16.840.1.113883.10.20.22.2.5.1 
Problem Concern Act Entry 2.16.840.1.113883.10.20.22.4.3 
Problem Observation Entry 2.16.840.1.113883.10.20.22.4.4 
   
Procedures Section (entries 
required) 
Section 2.16.840.1.113883.10.20.22.2.7.1 
Procedure Activity Act  2.16.840.1.113883.10.20.22.4.12 
Procedure Activity Observation  2.16.840.1.113883.10.20.22.4.13 
Procedure Activity Procedure  2.16.840.1.113883.10.20.22.4.14 
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Template Name Template 
Type 
Template ID 
   
Results Section (entries required) Section 2.16.840.1.113883.10.20.22.2.3.1 
Result Organizer Entry 2.16.840.1.113883.10.20.22.4.1 
Result Observation Entry 2.16.840.1.113883.10.20.22.4.2 
   
Social History Section (entries 
optional) 
Section 2.16.840.1.113883.10.20.22.2.17 
Smoking Status Observation Entry 2.16.840.1.113883.10.20.22.4.78 
   
Vital Signs Section (entries 
optional) 
Section 2.16.840.1.113883.10.20.22.2.4 
Vital Signs Organizer Entry 2.16.840.1.113883.10.20.22.4.26 
Vital Sign Observation Entry 2.16.840.1.113883.10.20.1.31 
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Appendix 2. SQL query to map source codes to OMOP source concepts 
SELECT C.CONCEPT_CODE AS SOURCE_CODE, C.CONCEPT_ID AS SOURCE_CONCEPT_ID, 
C.VOCABULARY_ID AS SOURCE_VOCABULARY_ID, C.DOMAIN_ID AS SOURCE_DOMAIN_ID, 
C.CONCEPT_CLASS_ID AS SOURCE_CONCEPT_CLASS_ID, C.INVALID_REASON AS 
SOURCE_INVALID_REASON, C.CONCEPT_ID AS TARGET_CONCEPT_ID, C.VOCABULARY_ID AS 
TARGET_VOCABULARY_ID, C.DOMAIN_ID AS TARGET_DOMAIN_ID, C.CONCEPT_CLASS_ID AS 
TARGET_CONCEPT_CLASS_ID, C.INVALID_REASON AS TARGET_INVALID_REASON, 
C.STANDARD_CONCEPT AS TARGET_STANDARD_CONCEPT 
FROM CONCEPT C 
UNION 
SELECT SOURCE_CODE, SOURCE_CONCEPT_ID, SOURCE_VOCABULARY_ID, C1.DOMAIN_ID AS 
SOURCE_DOMAIN_ID, C2.CONCEPT_CLASS_ID AS SOURCE_CONCEPT_CLASS_ID, 
STCM.INVALID_REASON AS SOURCE_INVALID_REASON,TARGET_CONCEPT_ID, 
TARGET_VOCABULARY_ID, C2.DOMAIN_ID AS TARGET_DOMAIN_ID, C2.CONCEPT_CLASS_ID 
AS TARGET_CONCEPT_CLASS_ID, C2.INVALID_REASON AS TARGET_INVALID_REASON, 
C2.STANDARD_CONCEPT AS TARGET_STANDARD_CONCEPT 
FROM SOURCE_TO_CONCEPT_MAP STCM 
LEFT OUTER JOIN CONCEPT C1 
ON C1.CONCEPT_ID = STCM.SOURCE_CONCEPT_ID 
LEFT OUTER JOIN CONCEPT C2 
ON C2.CONCEPT_ID = STCM.TARGET_CONCEPT_ID 
WHERE STCM.INVALID_REASON IS NULL 
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Appendix 3. SQL query to map source codes to OMOP standard concepts 
SELECT C.CONCEPT_CODE AS SOURCE_CODE, C.CONCEPT_ID AS SOURCE_CONCEPT_ID, 
C.VOCABULARY_ID AS SOURCE_VOCABULARY_ID, C.DOMAIN_ID AS SOURCE_DOMAIN_ID, 
C.CONCEPT_CLASS_ID AS SOURCE_CONCEPT_CLASS_ID, C.INVALID_REASON AS 
SOURCE_INVALID_REASON, C1.CONCEPT_ID AS TARGET_CONCEPT_ID, C1.VOCABULARY_ID 
AS TARGET_VOCABUALRY_ID, C1.DOMAIN_ID AS TARGET_DOMAIN_ID, 
C1.CONCEPT_CLASS_ID AS TARGET_CONCEPT_CLASS_ID, C1.INVALID_REASON AS 
TARGET_INVALID_REASON, C1.STANDARD_CONCEPT AS TARGET_STANDARD_CONCEPT 
FROM CONCEPT C 
JOIN CONCEPT_RELATIONSHIP CR 
ON C.CONCEPT_ID = CR.CONCEPT_ID_1 
AND CR.INVALID_REASON IS NULL 
AND CR.RELATIONSHIP_ID = 'Maps to' 
JOIN CONCEPT C1 
ON CR.CONCEPT_ID_2 = C1.CONCEPT_ID 
AND C1.INVALID_REASON IS NULL 
UNION 
SELECT SOURCE_CODE, SOURCE_CONCEPT_ID, SOURCE_VOCABULARY_ID, C1.DOMAIN_ID AS 
SOURCE_DOMAIN_ID, C2.CONCEPT_CLASS_ID AS SOURCE_CONCEPT_CLASS_ID, 
STCM.INVALID_REASON AS SOURCE_INVALID_REASON, TARGET_CONCEPT_ID, 
TARGET_VOCABULARY_ID, C2.DOMAIN_ID AS TARGET_DOMAIN_ID, C2.CONCEPT_CLASS_ID 
AS TARGET_CONCEPT_CLASS_ID, C2.INVALID_REASON AS TARGET_INVALID_REASON, 
C2.STANDARD_CONCEPT AS TARGET_STANDARD_CONCEPT 
FROM SOURCE_TO_CONCEPT_MAP STCM 
LEFT OUTER JOIN CONCEPT C1 
ON C1.CONCEPT_ID = STCM.SOURCE_CONCEPT_ID 
LEFT OUTER JOIN CONCEPT C2 
ON C2.CONCEPT_ID = STCM.TARGET_CONCEPT_ID 
WHERE STCM.INVALID_REASON IS NULL 
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Appendix 4. Mapped CVX codes to OMOP standard Concept IDs 
CVX 
Code 
CPT 
Code 
OMOP Concept 
ID 
CVX Short Description 
01 90701 No Concept ID DTP 
02 90712 2213470 OPV 
03 90707 2213466 MMR 
04 90708 2213467 M/R 
05 90705 2213464 measles 
06 90706 2213465 rubella 
07 90704 2213463 mumps 
08 90744 2213491 Hep B, adolescent or pediatric 
09 90714 2213472 Td (adult), adsorbed 
09 90718 No Concept ID Td (adult), adsorbed 
10 90713 2213471 IPV 
12 90296 2213401 diphtheria antitoxin 
13 90389 2213410 TIG 
14 90741 No Concept ID IG, unspecified formulation 
15 No Code No Concept ID influenza, split (incl. purified surface 
antigen) 
16 90659 No Concept ID influenza, whole 
17 90737 No Concept ID Hib, unspecified formulation 
18 90675 2213449 rabies, intramuscular injection 
19 90585 2213425 BCG 
19 90728 No Concept ID BCG 
20 90700 2213459 DTaP 
21 90716 2213474 varicella 
22 90720 2213478 DTP-Hib 
23 90727 2213482 plague 
24 90581 2213424 anthrax 
25 90690 2213453 typhoid, oral 
26 90725 2213481 cholera, unspecified formulation 
27 90287 2213398 botulinum antitoxin 
28 90702 2213461 DT (pediatric) 
29 90291 2213400 CMVIG 
30 90371 2213402 HBIG 
31 No Code No Concept ID HepA Pediatric (Unspecified, historical) 
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CVX 
Code 
CPT 
Code 
OMOP Concept 
ID 
CVX Short Description 
32 90733 2213484 meningococcal MPSV4 
33 90732 2213483 pneumococcal polysaccharide PPV23 
34 90375 2213403 RIG 
34 90376 2213404 RIG 
35 90703 2213462 tetanus toxoid, adsorbed 
36 90396 2213412 VZIG 
37 90717 2213475 yellow fever 
39 90735 2213486 Japanese encephalitis SC 
40 90676 2213450 rabies, intradermal injection 
41 90692 2213455 typhoid, parenteral 
42 90745 No Concept ID Hep B, adolescent/high risk infant 
43 90739 43527982 Hep B, adult 
43 90743 2213490 Hep B, adult 
43 90746 2213492 Hep B, adult 
44 90740 2213489 Hep B, dialysis 
44 90747 2213493 Hep B, dialysis 
45 90731 No Concept ID Hep B, unspecified formulation 
46 90646 2213432 Hib (PRP-D) 
47 90645 2213431 Hib (HbOC) 
48 90648 2213434 Hib (PRP-T) 
49 90647 2213433 Hib (PRP-OMP) 
50 90721 2213479 DTaP-Hib 
51 90748 2213494 Hib-Hep B 
52 90632 2213427 Hep A, adult 
53 90693 2213456 typhoid, parenteral, AKD (U.S. military) 
54 90476 2213422 adenovirus, type 4 
55 90477 2213423 adenovirus, type 7 
62 90649 2213435 HPV, quadrivalent 
66 90665 No Concept ID Lyme disease 
71 90379 No Concept ID RSV-IGIV 
79 90393 2213411 vaccinia immune globulin 
83 90633 2213428 Hep A, ped/adol, 2 dose 
84 90634 2213429 Hep A, ped/adol, 3 dose 
85 90730 No Concept ID Hep A, unspecified formulation 
 109 
CVX 
Code 
CPT 
Code 
OMOP Concept 
ID 
CVX Short Description 
86 90281 2213395 IG 
87 90283 2213396 IGIV 
88 90724 No Concept ID influenza, unspecified formulation 
90 90726 No Concept ID rabies, unspecified formulation 
91 90714 2213472 typhoid, unspecified formulation 
93 90378 2213405 RSV-MAb 
94 90710 2213469 MMRV 
100 90669 2213447 pneumococcal conjugate PCV 7 
101 90691 2213454 typhoid, ViCPs 
104 90636 2213430 Hep A-Hep B 
106 90700 2213459 DTaP, 5 pertussis antigens 
110 90723 2213480 DTaP-Hep B-IPV 
111 90660 2213442 influenza, live, intranasal 
113 90714 2213472 Td (adult) preservative free 
114 90734 2213485 meningococcal MCV4P 
115 90715 2213473 Tdap 
116 90680 2213451 rotavirus, pentavalent 
118 90650 2213436 HPV, bivalent 
119 90681 2213452 rotavirus, monovalent 
120 90698 2213458 DTaP-Hib-IPV 
121 90736 2213487 zoster 
125 90664 40756887 Novel Influenza-H1N1-09, nasal 
126 90666 40756874 Novel influenza-H1N1-09, preservative-free 
127 90668 40757097 Novel influenza-H1N1-09 
128 90470 No Concept ID Novel Influenza-H1N1-09, all formulations 
128 90663 No Concept ID Novel Influenza-H1N1-09, all formulations 
130 90696 2213457 DTaP-IPV 
133 90670 2213448 Pneumococcal conjugate PCV 13 
134 90738 2213488 Japanese Encephalitis IM 
135 90662 2213444 Influenza, high dose seasonal 
136 90734 2213485 Meningococcal MCV4O 
140 90655 2213437 Influenza, seasonal, injectable, preservative 
free 
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CVX 
Code 
CPT 
Code 
OMOP Concept 
ID 
CVX Short Description 
140 90656 2213438 Influenza, seasonal, injectable, preservative 
free 
141 90657 2213439 Influenza, seasonal, injectable 
141 90658 2213440 Influenza, seasonal, injectable 
144 90654 42742499 influenza, seasonal, intradermal, 
preservative free 
146 90697 No Concept ID DTaP,IPV,Hib,HepB 
148 90644 40757102 Meningococcal C/Y-HIB PRP 
149 90672 43527981 influenza, live, intranasal, quadrivalent 
150 90686 44816520 influenza, injectable, quadrivalent, 
preservative free 
153 90661 2213443 Influenza, injectable, MDCK, preservative 
free 
155 90673 44816443 influenza, recombinant, injectable, 
preservative free 
158 90687 44816519 influenza, injectable, quadrivalent 
158 90688 44816518 influenza, injectable, quadrivalent 
161 90685 44816521 Influenza, injectable, quadrivalent, 
preservative free, pediatric 
162 90621 No Concept ID meningococcal B, recombinant 
163 90620 No Concept ID meningococcal B, OMV 
165 90651 46257428 HPV9 
166 90630 46257714 influenza, intradermal, quadrivalent, 
preservative free 
168 90653 43527980 influenza, trivalent, adjuvanted 
171 90674 No Concept ID Influenza, injectable, MDCK, preservative 
free, quadrivalent 
174 90625 No Concept ID cholera, live attenuated 
175 90675 2213449 Rabies - IM Diploid cell culture 
176 90675 2213449 Rabies - IM fibroblast culture 
 
 
  
 111 
Appendix 5. SQL query to find ingredients of OMOP standard drug concepts 
SELECT DISTINCT A.CONCEPT_ID AS DRUG_EXPOSURE_CONCEPT_ID, 
  C.CONCEPT_ID AS INGREDIENT_CONCEPT_ID 
  FROM CONCEPT C 
  JOIN CONCEPT_ANCESTOR CA 
   ON CA.ANCESTOR_CONCEPT_ID = C.CONCEPT_ID 
   AND C.VOCABULARY_ID = 'RxNorm' 
   AND C.CONCEPT_CLASS_ID = 'Ingredient' 
   AND INVALID_REASON IS NULL 
  JOIN CONCEPT A 
   ON CA.DESCENDANT_CONCEPT_ID = A.CONCEPT_ID 
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Appendix 6. SQL query to map measurement observations to the corresponding clinical 
evaluation and measurement value concepts 
WITH SNOMED_TO_MEAS AS ( 
 SELECT DISTINCT C1.CONCEPT_ID AS STANDARD_CONCEPT_ID, C1.CONCEPT_NAME AS 
STANDARD_CONCEPT_NAME, R.RELATIONSHIP_ID,  
  C2.CONCEPT_ID AS MEASUREMENT_CONCEPT_ID, C2.CONCEPT_NAME AS 
MEASUREMENT_NAME, C2.DOMAIN_ID AS MEASUREMENT_DOMAIN_ID, C2.CONCEPT_CLASS_ID AS 
MEASUREMENT_CLASS_ID 
 FROM OMOP.CONCEPT C1, OMOP.CONCEPT_RELATIONSHIP R, OMOP.CONCEPT C2 
 WHERE C1.CONCEPT_ID = R.CONCEPT_ID_1 AND C2.CONCEPT_ID = R.CONCEPT_ID_2 
  AND R.RELATIONSHIP_ID IN ('HAS INTERPRETATION', 'HAS INTERPRETS') 
  AND R.INVALID_REASON IS NULL AND C1.INVALID_REASON IS NULL AND 
C2.INVALID_REASON IS NULL 
  AND C1.DOMAIN_ID = 'MEASUREMENT' 
  AND C1.VOCABULARY_ID IN ('SNOMED') AND C2.DOMAIN_ID IN 
('MEASUREMENT', 'PROCEDURE', 'MEAS VALUE') 
 ORDER BY C1.CONCEPT_ID), 
 MEASUREMENT AS ( 
  SELECT DISTINCT STM.STANDARD_CONCEPT_ID, 
STM.STANDARD_CONCEPT_NAME, STM.MEASUREMENT_CONCEPT_ID, STM.MEASUREMENT_NAME 
  FROM SNOMED_TO_MEAS STM 
  WHERE STM.RELATIONSHIP_ID = 'HAS INTERPRETS' 
  ), 
 MEASVALUE AS ( 
  SELECT DISTINCT STM.STANDARD_CONCEPT_ID, 
STM.STANDARD_CONCEPT_NAME, STM.MEASUREMENT_CONCEPT_ID AS MEASVALUE_CONCEPT_ID, 
   STM.MEASUREMENT_NAME AS MEASVALUE_NAME 
  FROM SNOMED_TO_MEAS STM 
  WHERE STM.RELATIONSHIP_ID = 'HAS INTERPRETATION') 
 
SELECT M.*, MV.MEASVALUE_CONCEPT_ID, MV.MEASVALUE_NAME  
FROM MEASUREMENT M 
LEFT JOIN MEASVALUE MV  
ON M.STANDARD_CONCEPT_ID = MV.STANDARD_CONCEPT_ID; 
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Appendix 7. SQL script to add table constrains to OMOP CDM 
Primary key constraints 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT XPK_PERSON PRIMARY KEY ( PERSON_ID ) ; 
ALTER TABLE OMOP.OBSERVATION_PERIOD ADD CONSTRAINT XPK_OBSERVATION_PERIOD 
PRIMARY KEY ( OBSERVATION_PERIOD_ID ) ; 
ALTER TABLE OMOP.VISIT_OCCURRENCE ADD CONSTRAINT XPK_VISIT_OCCURRENCE PRIMARY 
KEY ( VISIT_OCCURRENCE_ID ) ; 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT XPK_PROCEDURE_OCCURRENCE 
PRIMARY KEY ( PROCEDURE_OCCURRENCE_ID ) ; 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT XPK_DRUG_EXPOSURE PRIMARY KEY ( 
DRUG_EXPOSURE_ID ) ; 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT XPK_CONDITION_OCCURRENCE 
PRIMARY KEY ( CONDITION_OCCURRENCE_ID ) ; 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT XPK_MEASUREMENT PRIMARY KEY ( 
MEASUREMENT_ID ) ; 
ALTER TABLE OMOP.OBSERVATION  ADD CONSTRAINT XPK_OBSERVATION PRIMARY KEY ( 
OBSERVATION_ID ) ; 
ALTER TABLE OMOP.DRUG_ERA ADD CONSTRAINT XPK_DRUG_ERA PRIMARY KEY ( DRUG_ERA_ID 
) ; 
ALTER TABLE OMOP.CONDITION_ERA ADD CONSTRAINT XPK_CONDITION_ERA PRIMARY KEY ( 
CONDITION_ERA_ID ); 
 
Foreign key constraints 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_GENDER_CONCEPT FOREIGN KEY 
(GENDER_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_RACE_CONCEPT FOREIGN KEY 
(RACE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_ETHNICITY_CONCEPT FOREIGN KEY 
(ETHNICITY_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_GENDER_CONCEPT_S FOREIGN KEY 
(GENDER_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_RACE_CONCEPT_S FOREIGN KEY 
(RACE_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PERSON ADD CONSTRAINT FPK_PERSON_ETHNICITY_CONCEPT_S FOREIGN 
KEY (ETHNICITY_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.OBSERVATION_PERIOD ADD CONSTRAINT 
FPK_OBSERVATION_PERIOD_PERSON FOREIGN KEY (PERSON_ID)  REFERENCES OMOP.PERSON 
(PERSON_ID); 
ALTER TABLE OMOP.OBSERVATION_PERIOD ADD CONSTRAINT 
FPK_OBSERVATION_PERIOD_CONCEPT FOREIGN KEY (PERIOD_TYPE_CONCEPT_ID)  REFERENCES 
OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.VISIT_OCCURRENCE ADD CONSTRAINT FPK_VISIT_PERSON FOREIGN KEY 
(PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.VISIT_OCCURRENCE ADD CONSTRAINT FPK_VISIT_CONCEPT FOREIGN KEY 
(VISIT_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.VISIT_OCCURRENCE ADD CONSTRAINT FPK_VISIT_TYPE_CONCEPT FOREIGN 
KEY (VISIT_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.VISIT_OCCURRENCE ADD CONSTRAINT FPK_VISIT_CONCEPT_S FOREIGN 
KEY (VISIT_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
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ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_PERSON 
FOREIGN KEY (PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_CONCEPT 
FOREIGN KEY (PROCEDURE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_TYPE_CONCEPT 
FOREIGN KEY (PROCEDURE_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_MODIFIER 
FOREIGN KEY (MODIFIER_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_VISIT 
FOREIGN KEY (VISIT_OCCURRENCE_ID)  REFERENCES OMOP.VISIT_OCCURRENCE 
(VISIT_OCCURRENCE_ID); 
ALTER TABLE OMOP.PROCEDURE_OCCURRENCE ADD CONSTRAINT FPK_PROCEDURE_CONCEPT_S 
FOREIGN KEY (PROCEDURE_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT 
(CONCEPT_ID); 
 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_PERSON FOREIGN KEY 
(PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_CONCEPT FOREIGN KEY 
(DRUG_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_TYPE_CONCEPT FOREIGN KEY 
(DRUG_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_ROUTE_CONCEPT FOREIGN 
KEY (ROUTE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_DOSE_UNIT_CONCEPT 
FOREIGN KEY (DOSE_UNIT_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_VISIT FOREIGN KEY 
(VISIT_OCCURRENCE_ID)  REFERENCES OMOP.VISIT_OCCURRENCE (VISIT_OCCURRENCE_ID); 
ALTER TABLE OMOP.DRUG_EXPOSURE ADD CONSTRAINT FPK_DRUG_CONCEPT_S FOREIGN KEY 
(DRUG_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT FPK_CONDITION_PERSON 
FOREIGN KEY (PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT FPK_CONDITION_CONCEPT 
FOREIGN KEY (CONDITION_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT FPK_CONDITION_TYPE_CONCEPT 
FOREIGN KEY (CONDITION_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT FPK_CONDITION_VISIT 
FOREIGN KEY (VISIT_OCCURRENCE_ID)  REFERENCES OMOP.VISIT_OCCURRENCE 
(VISIT_OCCURRENCE_ID); 
ALTER TABLE OMOP.CONDITION_OCCURRENCE ADD CONSTRAINT FPK_CONDITION_CONCEPT_S 
FOREIGN KEY (CONDITION_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT 
(CONCEPT_ID); 
 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_PERSON FOREIGN KEY 
(PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_CONCEPT FOREIGN KEY 
(MEASUREMENT_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_TYPE_CONCEPT 
FOREIGN KEY (MEASUREMENT_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT 
(CONCEPT_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_OPERATOR FOREIGN 
KEY (OPERATOR_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_VALUE FOREIGN KEY 
(VALUE_AS_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
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ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_UNIT FOREIGN KEY 
(UNIT_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_VISIT FOREIGN KEY 
(VISIT_OCCURRENCE_ID)  REFERENCES OMOP.VISIT_OCCURRENCE (VISIT_OCCURRENCE_ID); 
ALTER TABLE OMOP.MEASUREMENT ADD CONSTRAINT FPK_MEASUREMENT_CONCEPT_S FOREIGN 
KEY (MEASUREMENT_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_PERSON FOREIGN KEY 
(PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_CONCEPT FOREIGN KEY 
(OBSERVATION_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_TYPE_CONCEPT 
FOREIGN KEY (OBSERVATION_TYPE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT 
(CONCEPT_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_VALUE FOREIGN KEY 
(VALUE_AS_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_QUALIFIER FOREIGN 
KEY (QUALIFIER_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_UNIT FOREIGN KEY 
(UNIT_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_VISIT FOREIGN KEY 
(VISIT_OCCURRENCE_ID)  REFERENCES OMOP.VISIT_OCCURRENCE (VISIT_OCCURRENCE_ID); 
ALTER TABLE OMOP.OBSERVATION ADD CONSTRAINT FPK_OBSERVATION_CONCEPT_S FOREIGN 
KEY (OBSERVATION_SOURCE_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.DRUG_ERA ADD CONSTRAINT FPK_DRUG_ERA_PERSON FOREIGN KEY 
(PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.DRUG_ERA ADD CONSTRAINT FPK_DRUG_ERA_CONCEPT FOREIGN KEY 
(DRUG_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
 
ALTER TABLE OMOP.CONDITION_ERA ADD CONSTRAINT FPK_CONDITION_ERA_PERSON FOREIGN 
KEY (PERSON_ID)  REFERENCES OMOP.PERSON (PERSON_ID); 
ALTER TABLE OMOP.CONDITION_ERA ADD CONSTRAINT FPK_CONDITION_ERA_CONCEPT FOREIGN 
KEY (CONDITION_CONCEPT_ID)  REFERENCES OMOP.CONCEPT (CONCEPT_ID); 
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Appendix 8. The XML schema of O-PMML standard 
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" 
xmlns="http://www.dmg.org/PMML-4_3" elementFormDefault="unqualified" 
targetNamespace="http://www.dmg.org/PMML-4_3"> 
<!-- PMML --> 
<xs:element name="PMML"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Header"/> 
      <xs:element ref="DataDictionary"/> 
      <xs:element ref="TransformationDictionary" minOccurs="0"/> 
      <xs:element ref="MiningBuildTask"/> 
      <xs:sequence minOccurs="1"> 
        <xs:group ref="MODEL-ELEMENT"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="version" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:group name="MODEL-ELEMENT"> 
  <xs:choice> 
    <xs:element ref="RegressionModel"/> 
  </xs:choice> 
</xs:group> 
<!-- Header --> 
<xs:element name="Header"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="1" ref="Extension"/> 
      <xs:element ref="Application"/> 
      <xs:element ref="Annotation"/> 
      <xs:element ref="Timestamp"/> 
    </xs:sequence> 
    <xs:attribute name="copyright" type="xs:string"/> 
    <xs:attribute name="description" type="xs:string"/> 
    <xs:attribute name="modelVersion" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Application"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
    <xs:attribute name="version" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Annotation" type="xs:string"/> 
<xs:element name="Timestamp" type="xs:dateTime"/> 
<xs:element name="OmopCdm"> 
  <xs:complexType> 
    <xs:attribute name="version" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="author"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
<!-- Extensions --> 
<xs:element name="Extension"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="0" ref="OmopCdm"/> 
      <xs:element minOccurs="0" ref="author"/> 
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   <xs:element minOccurs="0" ref="InputParameters"/> 
   <xs:element minOccurs="0" ref="Statement"/> 
    </xs:sequence> 
    <xs:attribute name="extender" type="xs:string" use="optional" 
fixed="omop"/> 
 <xs:attribute name="name" type="xs:string" use="optional"/> 
  </xs:complexType> 
</xs:element> 
<!-- Data Dictionary --> 
<xs:element name="DataDictionary"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DataField" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="numberOfFields" type="xs:nonNegativeInteger"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="DataField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:sequence> 
        <xs:element ref="Interval" minOccurs="0" maxOccurs="unbounded"/> 
        <xs:element ref="Value" minOccurs="0" maxOccurs="unbounded"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="OPTYPE">       
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="categorical"/> 
    <xs:enumeration value="ordinal"/> 
    <xs:enumeration value="continuous"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="DATATYPE">       
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="string"/> 
    <xs:enumeration value="integer"/> 
    <xs:enumeration value="float"/> 
    <xs:enumeration value="double"/> 
    <xs:enumeration value="boolean"/> 
    <xs:enumeration value="date"/> 
    <xs:enumeration value="time"/> 
    <xs:enumeration value="dateTime"/> 
    <xs:enumeration value="dateDaysSince[0]"/> 
    <xs:enumeration value="dateDaysSince[1960]"/> 
    <xs:enumeration value="dateDaysSince[1970]"/> 
    <xs:enumeration value="dateDaysSince[1980]"/> 
    <xs:enumeration value="timeSeconds"/> 
    <xs:enumeration value="dateTimeSecondsSince[0]"/> 
    <xs:enumeration value="dateTimeSecondsSince[1960]"/> 
    <xs:enumeration value="dateTimeSecondsSince[1970]"/> 
    <xs:enumeration value="dateTimeSecondsSince[1980]"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:element name="Value"> 
  <xs:complexType> 
    <xs:attribute name="value" type="xs:string" use="required"/> 
    <xs:attribute name="displayValue" type="xs:string"/> 
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    <xs:attribute name="property" default="valid"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="valid"/> 
          <xs:enumeration value="invalid"/> 
          <xs:enumeration value="missing"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Interval"> 
  <xs:complexType> 
    <xs:attribute name="closure" use="required"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="openClosed"/> 
          <xs:enumeration value="openOpen"/> 
          <xs:enumeration value="closedOpen"/> 
          <xs:enumeration value="closedClosed"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="leftMargin" type="NUMBER"/> 
    <xs:attribute name="rightMargin" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<!-- Transformation Dictionary --> 
<xs:element name="TransformationDictionary"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DefineFunction" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:element ref="DerivedField" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<!-- Local Transforamtions --> 
<xs:element name="LocalTransformations"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DerivedField" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="DerivedField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:group ref="EXPRESSION"/> 
      <xs:element ref="Value" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
<!-- Transformation Expressions --> 
<xs:group name="EXPRESSION"> 
  <xs:choice> 
    <xs:element ref="Constant"/> 
    <xs:element ref="FieldRef"/> 
    <xs:element ref="NormContinuous"/> 
    <xs:element ref="NormDiscrete"/> 
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    <xs:element ref="Discretize"/> 
    <xs:element ref="MapValues"/> 
    <xs:element ref="TextIndex"/>         
    <xs:element ref="Apply"/> 
    <xs:element ref="Aggregate"/> 
    <xs:element ref="Lag"/> 
  </xs:choice> 
</xs:group> 
<xs:element name="Constant"> 
  <xs:complexType> 
    <xs:simpleContent> 
      <xs:extension base="xs:string"> 
        <xs:attribute name="dataType" type="DATATYPE"/> 
      </xs:extension> 
    </xs:simpleContent> 
  </xs:complexType> 
</xs:element> 
<xs:element name="FieldRef"> 
  <xs:complexType> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="mapMissingTo" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="NormContinuous"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="LinearNorm" minOccurs="2" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="mapMissingTo" type="NUMBER"/> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="outliers" type="OUTLIER-TREATMENT-METHOD" 
default="asIs"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="LinearNorm"> 
  <xs:complexType> 
    <xs:attribute name="orig" type="NUMBER" use="required"/> 
    <xs:attribute name="norm" type="NUMBER" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="NormDiscrete"> 
  <xs:complexType> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/>     
    <xs:attribute name="value" type="xs:string" use="required"/> 
    <xs:attribute name="mapMissingTo" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Discretize"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="DiscretizeBin" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="mapMissingTo" type="xs:string"/> 
    <xs:attribute name="defaultValue" type="xs:string"/> 
    <xs:attribute name="dataType" type="DATATYPE"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="DiscretizeBin"> 
  <xs:complexType> 
    <xs:sequence> 
       
      <xs:element ref="Interval"/> 
 120 
    </xs:sequence> 
    <xs:attribute name="binValue" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="MapValues"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="0" maxOccurs="unbounded" ref="FieldColumnPair"/> 
      <xs:choice minOccurs="0"> 
        <xs:element ref="TableLocator"/> 
        <xs:element ref="InlineTable"/> 
      </xs:choice> 
    </xs:sequence> 
    <xs:attribute name="mapMissingTo" type="xs:string"/> 
    <xs:attribute name="defaultValue" type="xs:string"/> 
    <xs:attribute name="outputColumn" type="xs:string" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="FieldColumnPair"> 
  <xs:complexType> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="column" type="xs:string" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="TextIndex"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="TextIndexNormalization" minOccurs="0" 
maxOccurs="unbounded"/> 
      <xs:group ref="EXPRESSION"/> 
    </xs:sequence> 
    <xs:attribute name="textField" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="localTermWeights" default="termFrequency"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="termFrequency"/> 
          <xs:enumeration value="binary"/> 
          <xs:enumeration value="logarithmic"/> 
          <xs:enumeration value="augmentedNormalizedTermFrequency"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="isCaseSensitive" type="xs:boolean" default="false"/> 
    <xs:attribute name="maxLevenshteinDistance" type="xs:integer" default="0"/> 
    <xs:attribute name="countHits" default="allHits"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="allHits"/> 
          <xs:enumeration value="bestHits"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="wordSeparatorCharacterRE" type="xs:string" 
default="\s"/> 
    <xs:attribute name="tokenize" type="xs:boolean" default="true"/>     
  </xs:complexType> 
</xs:element> 
<xs:element name="TextIndexNormalization"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:choice minOccurs="0"> 
        <xs:element ref="TableLocator"/> 
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        <xs:element ref="InlineTable"/> 
      </xs:choice> 
    </xs:sequence> 
    <xs:attribute name="inField" type="xs:string" default="string"/> 
    <xs:attribute name="outField" type="xs:string" default="stem"/> 
    <xs:attribute name="regexField" type="xs:string" default="regex"/> 
    <xs:attribute name="recursive" type="xs:boolean" default="false"/> 
    <xs:attribute name="isCaseSensitive" type="xs:boolean"/> 
    <xs:attribute name="maxLevenshteinDistance" type="xs:integer"/> 
    <xs:attribute name="wordSeparatorCharacterRE" type="xs:string"/> 
    <xs:attribute name="tokenize" type="xs:boolean"/>     
  </xs:complexType> 
</xs:element> 
<xs:element name="Aggregate"> 
  <xs:complexType> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="function" use="required"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="count"/> 
          <xs:enumeration value="sum"/> 
          <xs:enumeration value="average"/> 
          <xs:enumeration value="min"/> 
          <xs:enumeration value="max"/> 
          <xs:enumeration value="multiset"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="groupField" type="FIELD-NAME"/> 
    <xs:attribute name="sqlWhere" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Lag"> 
    <xs:complexType> 
      <xs:sequence> 
 <xs:element ref="BlockIndicator" minOccurs="0" maxOccurs="unbounded"/> 
      </xs:sequence> 
      <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
      <xs:attribute name="n" type="xs:positiveInteger" default="1"/> 
  </xs:complexType> 
  </xs:element> 
  <xs:element name="BlockIndicator"> 
    <xs:complexType> 
      <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    </xs:complexType> 
  </xs:element> 
<xs:element name="DefineFunction"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="ParameterField" minOccurs="1" maxOccurs="unbounded"/> 
      <xs:group ref="EXPRESSION"/> 
    </xs:sequence> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
    <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="ParameterField"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="dataType" type="DATATYPE"/> 
  </xs:complexType> 
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</xs:element> 
<xs:element name="Apply"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:group ref="EXPRESSION" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="function" type="xs:string" use="required"/> 
    <xs:attribute name="mapMissingTo" type="xs:string"/> 
    <xs:attribute name="defaultValue" type="xs:string"/> 
    <xs:attribute name="invalidValueTreatment" type="INVALID-VALUE-TREATMENT-
METHOD" default="returnInvalid"/> 
  </xs:complexType> 
</xs:element> 
<!-- Mining Build Task --> 
<xs:element name="MiningBuildTask"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element minOccurs="1" maxOccurs="unbounded" ref="Extension"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="InputParameters"> 
  <xs:complexType> 
    <xs:sequence> 
   <xs:element minOccurs="1" ref="InputParameter"/> 
 </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="InputParameter"> 
  <xs:complexType> 
 <xs:attribute name="name" type="xs:string" use="required"/> 
 <xs:attribute name="displayName" type="xs:string" use="optional"/> 
 <xs:attribute name="optype" type="OPTYPE" use="required"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Statement"> 
  <xs:complexType> 
 <xs:attribute name="dialect" type="STATEMENT-DIALECT" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="STATEMENT-DIALECT"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="postgresql"/> 
    <xs:enumeration value="mssql"/> 
    <xs:enumeration value="mysql"/> 
    <xs:enumeration value="netezza"/> 
    <xs:enumeration value="r"/> 
    <xs:enumeration value="java"/> 
    <xs:enumeration value="sql"/> 
  </xs:restriction> 
</xs:simpleType> 
<!-- Regression Model --> 
<xs:element name="RegressionModel"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="MiningSchema"/> 
      <xs:element ref="RegressionTable" maxOccurs="unbounded"/><xs:element 
ref="Output" minOccurs="0"/> 
      <xs:element ref="ModelStats" minOccurs="0"/> 
      <xs:element ref="ModelExplanation" minOccurs="0"/> 
      <xs:element ref="Targets" minOccurs="0"/> 
      <xs:element ref="LocalTransformations" minOccurs="0"/> 
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      <xs:element ref="ModelVerification" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="modelName" type="xs:string"/> 
    <xs:attribute name="functionName" type="MINING-FUNCTION" use="required"/> 
    <xs:attribute name="algorithmName" type="xs:string"/> 
    <xs:attribute name="modelType" use="optional"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="linearRegression"/> 
          <xs:enumeration value="stepwisePolynomialRegression"/> 
          <xs:enumeration value="logisticRegression"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="targetFieldName" type="FIELD-NAME" use="optional"/> 
    <xs:attribute name="normalizationMethod" 
type="REGRESSIONNORMALIZATIONMETHOD" default="none"/> 
    <xs:attribute name="isScorable" type="xs:boolean" default="true"/> 
  </xs:complexType> 
</xs:element> 
<!-- Mining Schema --> 
<xs:element name="MiningSchema"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element maxOccurs="unbounded" ref="MiningField"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="MiningField"> 
  <xs:complexType> 
    <xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="usageType" type="FIELD-USAGE-TYPE" default="active"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="importance" type="PROB-NUMBER"/> 
    <xs:attribute name="outliers" type="OUTLIER-TREATMENT-METHOD" 
default="asIs"/> 
    <xs:attribute name="lowValue" type="NUMBER"/> 
    <xs:attribute name="highValue" type="NUMBER"/> 
    <xs:attribute name="missingValueReplacement" type="xs:string"/> 
    <xs:attribute name="missingValueTreatment" type="MISSING-VALUE-TREATMENT-
METHOD"/> 
    <xs:attribute name="invalidValueTreatment" type="INVALID-VALUE-TREATMENT-
METHOD" default="returnInvalid"/> 
  </xs:complexType> 
</xs:element> 
<!-- Regression Table --> 
<xs:element name="RegressionTable"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="NumericPredictor" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:element ref="CategoricalPredictor" minOccurs="0" 
maxOccurs="unbounded"/> 
      <xs:element ref="PredictorTerm" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="intercept" type="REAL-NUMBER" use="required"/> 
    <xs:attribute name="targetCategory" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="REGRESSIONNORMALIZATIONMETHOD"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="none"/> 
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    <xs:enumeration value="simplemax"/> 
    <xs:enumeration value="softmax"/> 
    <xs:enumeration value="logit"/> 
    <xs:enumeration value="probit"/> 
    <xs:enumeration value="cloglog"/> 
    <xs:enumeration value="exp"/> 
    <xs:enumeration value="loglog"/> 
    <xs:enumeration value="cauchit"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:element name="NumericPredictor"> 
  <xs:complexType> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="exponent" type="INT-NUMBER" default="1"/> 
    <xs:attribute name="coefficient" type="REAL-NUMBER" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="CategoricalPredictor"> 
  <xs:complexType> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="value" type="xs:string" use="required"/> 
    <xs:attribute name="coefficient" type="REAL-NUMBER" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="PredictorTerm"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="FieldRef" minOccurs="1" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME"/> 
    <xs:attribute name="coefficient" type="REAL-NUMBER" use="required"/> 
  </xs:complexType> 
</xs:element> 
<!-- Output --> 
<xs:element name="Output"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="OutputField" minOccurs="1" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="OutputField"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:sequence minOccurs="0" maxOccurs="1"> 
        <xs:element ref="Decisions" minOccurs="0" maxOccurs="1"/> 
        <xs:group ref="EXPRESSION" minOccurs="1" maxOccurs="1"/> 
      </xs:sequence> 
    </xs:sequence> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="dataType" type="DATATYPE" use="required"/> 
    <xs:attribute name="targetField" type="FIELD-NAME"/> 
    <xs:attribute name="feature" type="RESULT-FEATURE" 
default="predictedValue"/> 
    <xs:attribute name="value" type="xs:string"/> 
    <xs:attribute name="isFinalResult" type="xs:boolean" default="true"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="MINING-FUNCTION"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="associationRules"/> 
 125 
    <xs:enumeration value="sequences"/> 
    <xs:enumeration value="classification"/> 
    <xs:enumeration value="regression"/> 
    <xs:enumeration value="clustering"/> 
    <xs:enumeration value="timeSeries"/> 
    <xs:enumeration value="mixed"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="FIELD-USAGE-TYPE"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="active"/> 
    <xs:enumeration value="predicted"/> 
    <xs:enumeration value="target"/> 
    <xs:enumeration value="supplementary"/> 
    <xs:enumeration value="group"/> 
    <xs:enumeration value="order"/> 
    <xs:enumeration value="frequencyWeight"/> 
    <xs:enumeration value="analysisWeight"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="OUTLIER-TREATMENT-METHOD"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="asIs"/> 
    <xs:enumeration value="asMissingValues"/> 
    <xs:enumeration value="asExtremeValues"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="MISSING-VALUE-TREATMENT-METHOD"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="asIs"/> 
    <xs:enumeration value="asMean"/> 
    <xs:enumeration value="asMode"/> 
    <xs:enumeration value="asMedian"/> 
    <xs:enumeration value="asValue"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="INVALID-VALUE-TREATMENT-METHOD"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="returnInvalid"/> 
    <xs:enumeration value="asIs"/> 
    <xs:enumeration value="asMissing"/> 
  </xs:restriction> 
</xs:simpleType> 
<!-- Model Explanation --> 
<xs:element name="ModelExplanation"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:choice> 
        <xs:element ref="PredictiveModelQuality" minOccurs="0" 
maxOccurs="unbounded"/> 
      </xs:choice> 
      <xs:element ref="Correlations" minOccurs="0"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="PredictiveModelQuality"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="ROC" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="targetField" type="xs:string" use="required"/> 
    <xs:attribute name="dataName" type="xs:string" use="optional"/> 
    <xs:attribute name="dataUsage" default="training"> 
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      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="training"/> 
          <xs:enumeration value="test"/> 
          <xs:enumeration value="validation"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="meanError" type="NUMBER" use="optional"/> 
    <xs:attribute name="meanAbsoluteError" type="NUMBER" use="optional"/> 
    <xs:attribute name="meanSquaredError" type="NUMBER" use="optional"/> 
    <xs:attribute name="rootMeanSquaredError" type="NUMBER" use="optional"/> 
    <xs:attribute name="r-squared" type="NUMBER" use="optional"/> 
    <xs:attribute name="adj-r-squared" type="NUMBER" use="optional"/> 
    <xs:attribute name="sumSquaredError" type="NUMBER" use="optional"/> 
    <xs:attribute name="sumSquaredRegression" type="NUMBER" use="optional"/> 
    <xs:attribute name="numOfRecords" type="NUMBER" use="optional"/> 
    <xs:attribute name="numOfRecordsWeighted" type="NUMBER" use="optional"/> 
    <xs:attribute name="numOfPredictors" type="NUMBER" use="optional"/> 
    <xs:attribute name="degreesOfFreedom" type="NUMBER" use="optional"/> 
    <xs:attribute name="fStatistic" type="NUMBER" use="optional"/> 
    <xs:attribute name="AIC" type="NUMBER" use="optional"/> 
    <xs:attribute name="BIC" type="NUMBER" use="optional"/> 
    <xs:attribute name="AICc" type="NUMBER" use="optional"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="ROC"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="ROCGraph"/> 
    </xs:sequence> 
    <xs:attribute name="positiveTargetFieldValue" type="xs:string" 
use="required"/> 
    <xs:attribute name="positiveTargetFieldDisplayValue" type="xs:string"/> 
    <xs:attribute name="negativeTargetFieldValue" type="xs:string"/> 
    <xs:attribute name="negativeTargetFieldDisplayValue" type="xs:string"/> 
  </xs:complexType> 
</xs:element>     
<xs:element name="ROCGraph"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="XCoordinates"/> 
      <xs:element ref="YCoordinates"/> 
      <xs:element ref="BoundaryValues" minOccurs="0"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Correlations"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="CorrelationFields"/> 
      <xs:element ref="CorrelationValues"/> 
      <xs:element ref="CorrelationMethods" minOccurs="0"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="CorrelationFields"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:group ref="STRING-ARRAY"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
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<xs:element name="CorrelationValues"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Matrix"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="CorrelationMethods"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Matrix"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element>     
<!-- Model Verification --> 
<xs:element name="ModelVerification"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="VerificationFields"/> 
      <xs:element ref="InlineTable"/> 
    </xs:sequence> 
    <xs:attribute name="recordCount" type="INT-NUMBER" use="optional"/> 
    <xs:attribute name="fieldCount" type="INT-NUMBER" use="optional"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="VerificationFields"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element maxOccurs="unbounded" ref="VerificationField"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="VerificationField"> 
  <xs:complexType> 
    <xs:attribute name="field" type="xs:string" use="required"/> 
    <xs:attribute name="column" type="xs:string" use="optional"/> 
    <xs:attribute name="precision" type="xs:double" default="1E-6"/> 
    <xs:attribute name="zeroThreshold" type="xs:double" default="1E-16"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="ResultField"> 
  <xs:complexType> 
    <xs:attribute name="name" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="displayName" type="xs:string"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="dataType" type="DATATYPE"/> 
    <xs:attribute name="feature" type="RESULT-FEATURE"/> 
    <xs:attribute name="value" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="RESULT-FEATURE"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="predictedValue"/>   
    <xs:enumeration value="predictedDisplayValue"/> 
    <xs:enumeration value="transformedValue"/>  
    <xs:enumeration value="decision"/> 
    <xs:enumeration value="probability"/> 
    <xs:enumeration value="affinity"/> 
    <xs:enumeration value="residual"/> 
    <xs:enumeration value="standardError"/> 
    <xs:enumeration value="clusterId"/> 
    <xs:enumeration value="clusterAffinity"/> 
    <xs:enumeration value="entityId"/> 
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    <xs:enumeration value="entityAffinity"/> 
    <xs:enumeration value="warning"/> 
    <xs:enumeration value="ruleValue"/> 
    <xs:enumeration value="reasonCode"/> 
    <xs:enumeration value="antecedent"/> 
    <xs:enumeration value="consequent"/> 
    <xs:enumeration value="rule"/> 
    <xs:enumeration value="ruleId"/> 
    <xs:enumeration value="confidence"/> 
    <xs:enumeration value="support"/> 
    <xs:enumeration value="lift"/> 
    <xs:enumeration value="leverage"/> 
  </xs:restriction> 
</xs:simpleType> 
<xs:element name="Decisions"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Decision" minOccurs="1" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="businessProblem" type="xs:string"/> 
    <xs:attribute name="description" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Decision"> 
  <xs:complexType> 
    <xs:attribute name="value" type="xs:string" use="required"/> 
    <xs:attribute name="displayValue" type="xs:string"/> 
    <xs:attribute name="description" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="RULE-FEATURE"> 
  <xs:restriction base="xs:string"> 
    <xs:enumeration value="antecedent"/> 
    <xs:enumeration value="consequent"/> 
    <xs:enumeration value="rule"/> 
    <xs:enumeration value="ruleId"/> 
    <xs:enumeration value="confidence"/> 
    <xs:enumeration value="support"/> 
    <xs:enumeration value="lift"/> 
    <xs:enumeration value="leverage"/> 
    <xs:enumeration value="affinity"/> 
  </xs:restriction> 
</xs:simpleType> 
<!-- Model Statistics --> 
<xs:element name="ModelStats"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="UnivariateStats" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:element ref="MultivariateStats" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="UnivariateStats"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Counts" minOccurs="0"/> 
      <xs:element ref="NumericInfo" minOccurs="0"/> 
      <xs:element ref="DiscrStats" minOccurs="0"/> 
      <xs:element ref="ContStats" minOccurs="0"/> 
      <xs:element ref="Anova" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="field" type="FIELD-NAME"/> 
    <xs:attribute name="weighted" default="0"> 
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      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="0"/> 
          <xs:enumeration value="1"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute>  
  </xs:complexType> 
</xs:element> 
<xs:element name="Counts"> 
  <xs:complexType> 
    <xs:attribute name="totalFreq" type="NUMBER" use="required"/> 
    <xs:attribute name="missingFreq" type="NUMBER"/> 
    <xs:attribute name="invalidFreq" type="NUMBER"/> 
    <xs:attribute name="cardinality" type="xs:nonNegativeInteger"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="NumericInfo"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Quantile" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="minimum" type="NUMBER"/> 
    <xs:attribute name="maximum" type="NUMBER"/> 
    <xs:attribute name="mean" type="NUMBER"/> 
    <xs:attribute name="standardDeviation" type="NUMBER"/> 
    <xs:attribute name="median" type="NUMBER"/> 
    <xs:attribute name="interQuartileRange" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Quantile"> 
  <xs:complexType> 
    <xs:attribute name="quantileLimit" type="PERCENTAGE-NUMBER" 
use="required"/> 
    <xs:attribute name="quantileValue" type="NUMBER" use="required"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="DiscrStats"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Array" minOccurs="0" maxOccurs="2"/> 
    </xs:sequence> 
    <xs:attribute name="modalValue" type="xs:string"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="ContStats"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Interval" minOccurs="0" maxOccurs="unbounded"/> 
      <xs:group ref="FrequenciesType" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="totalValuesSum" type="NUMBER"/> 
    <xs:attribute name="totalSquaresSum" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:group name="FrequenciesType"> 
  <xs:sequence> 
    <xs:group ref="NUM-ARRAY" minOccurs="1" maxOccurs="3"/> 
  </xs:sequence> 
</xs:group> 
<xs:element name="MultivariateStats"> 
  <xs:complexType> 
    <xs:sequence> 
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      <xs:element ref="MultivariateStat" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="targetCategory" type="xs:string" use="optional"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="MultivariateStat"> 
  <xs:complexType> 
    <xs:attribute name="name" type="xs:string"/> 
    <xs:attribute name="category" type="xs:string"/> 
    <xs:attribute name="exponent" type="INT-NUMBER" default="1"/> 
    <xs:attribute name="isIntercept" type="xs:boolean" default="false"/> 
    <xs:attribute name="importance" type="PROB-NUMBER"/> 
    <xs:attribute name="stdError" type="NUMBER"/> 
    <xs:attribute name="tValue" type="NUMBER"/> 
    <xs:attribute name="chiSquareValue" type="NUMBER"/> 
    <xs:attribute name="fStatistic" type="NUMBER"/> 
    <xs:attribute name="dF" type="NUMBER"/> 
    <xs:attribute name="pValueAlpha" type="PROB-NUMBER"/> 
    <xs:attribute name="pValueInitial" type="PROB-NUMBER"/> 
    <xs:attribute name="pValueFinal" type="PROB-NUMBER"/> 
    <xs:attribute name="confidenceLevel" type="PROB-NUMBER" default="0.95"/> 
    <xs:attribute name="confidenceLowerBound" type="NUMBER"/> 
    <xs:attribute name="confidenceUpperBound" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Anova"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="AnovaRow" minOccurs="3" maxOccurs="3"/> 
    </xs:sequence> 
    <xs:attribute name="target" type="FIELD-NAME"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="AnovaRow"> 
  <xs:complexType> 
    <xs:attribute name="type" use="required"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="Model"/> 
          <xs:enumeration value="Error"/> 
          <xs:enumeration value="Total"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="sumOfSquares" type="NUMBER" use="required"/> 
    <xs:attribute name="degreesOfFreedom" type="NUMBER" use="required"/> 
    <xs:attribute name="meanOfSquares" type="NUMBER"/> 
    <xs:attribute name="fValue" type="NUMBER"/> 
    <xs:attribute name="pValue" type="PROB-NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Partition"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="PartitionFieldStats" minOccurs="0" 
maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="name" type="xs:string" use="required"/> 
    <xs:attribute name="size" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
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<xs:element name="PartitionFieldStats"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Counts" minOccurs="0"/> 
      <xs:element ref="NumericInfo" minOccurs="0"/> 
      <xs:group ref="FrequenciesType" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="field" type="FIELD-NAME" use="required"/> 
    <xs:attribute name="weighted" default="0"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="0"/> 
          <xs:enumeration value="1"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
  </xs:complexType> 
</xs:element> 
<!-- Targets --> 
<xs:element name="Targets"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Target" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="Target"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="TargetValue" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
    <xs:attribute name="field" type="FIELD-NAME"/> 
    <xs:attribute name="optype" type="OPTYPE"/> 
    <xs:attribute name="castInteger"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="round"/> 
          <xs:enumeration value="ceiling"/> 
          <xs:enumeration value="floor"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="min" type="xs:double"/> 
    <xs:attribute name="max" type="xs:double"/> 
    <xs:attribute name="rescaleConstant" type="xs:double" default="0"/> 
    <xs:attribute name="rescaleFactor" type="xs:double" default="1"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="TargetValue"> 
  <xs:complexType> 
    <xs:sequence> 
      <xs:element ref="Partition" minOccurs="0"/> 
    </xs:sequence> 
    <xs:attribute name="value" type="xs:string"/> 
    <xs:attribute name="displayValue" type="xs:string"/> 
    <xs:attribute name="priorProbability" type="PROB-NUMBER"/> 
    <xs:attribute name="defaultValue" type="NUMBER"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="InlineTable"> 
  <xs:complexType> 
    <xs:sequence> 
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      <xs:element ref="row" minOccurs="0" maxOccurs="unbounded"/> 
    </xs:sequence> 
  </xs:complexType> 
</xs:element> 
<xs:element name="row"> 
  <xs:complexType> 
    <xs:complexContent mixed="true"> 
      <xs:restriction base="xs:anyType"> 
        <xs:sequence> 
          <xs:any processContents="skip" minOccurs="2" maxOccurs="unbounded"/> 
        </xs:sequence>  
      </xs:restriction> 
    </xs:complexContent> 
  </xs:complexType> 
</xs:element> 
<xs:simpleType name="NUMBER"> 
  <xs:restriction base="xs:double"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="INT-NUMBER"> 
  <xs:restriction base="xs:integer"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="REAL-NUMBER"> 
  <xs:restriction base="xs:double"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="PROB-NUMBER"> 
  <xs:restriction base="xs:double"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="PERCENTAGE-NUMBER"> 
  <xs:restriction base="xs:double"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:simpleType name="FIELD-NAME"> 
  <xs:restriction base="xs:string"> 
  </xs:restriction> 
</xs:simpleType> 
<xs:element name="Matrix"> 
  <xs:complexType> 
    <xs:choice minOccurs="0"> 
      <xs:group ref="NUM-ARRAY" maxOccurs="unbounded"/> 
      <xs:element ref="MatCell" maxOccurs="unbounded"/> 
    </xs:choice> 
    <xs:attribute name="kind" use="optional" default="any"> 
      <xs:simpleType> 
        <xs:restriction base="xs:string"> 
          <xs:enumeration value="diagonal"/> 
          <xs:enumeration value="symmetric"/> 
          <xs:enumeration value="any"/> 
        </xs:restriction> 
      </xs:simpleType> 
    </xs:attribute> 
    <xs:attribute name="nbRows" type="INT-NUMBER" use="optional"/> 
    <xs:attribute name="nbCols" type="INT-NUMBER" use="optional"/> 
    <xs:attribute name="diagDefault" type="REAL-NUMBER" use="optional"/> 
    <xs:attribute name="offDiagDefault" type="REAL-NUMBER" use="optional"/> 
  </xs:complexType> 
</xs:element> 
<xs:element name="MatCell"> 
  <xs:complexType> 
    <xs:simpleContent> 
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      <xs:extension base="xs:string"> 
        <xs:attribute name="row" type="INT-NUMBER" use="required"/> 
        <xs:attribute name="col" type="INT-NUMBER" use="required"/> 
      </xs:extension> 
    </xs:simpleContent> 
  </xs:complexType> 
</xs:element> 
</xs:schema> 
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Appendix 9. The O-PMML containing predictive model for estimating Framingham 10-year 
risk of cardiovascular disease for men. 
<?xml version="1.0"?> 
<PMML version="4.3" xmlns="http://www.dmg.org/PMML-4_3" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.dmg.org/PMML-4_3 http://www.dmg.org/v4-3/pmml-
4-3.xsd"> 
  <Header copyright="Copyright (c) 2017 Hamed Abedtash 
{hamed.abedtash@gmail.com}" description="Framingham 10-year risk of 
cardiovascular disease for men"> 
    <Extension extender="omop"> 
      <OmopCdm version="5.1"/> 
      <author name="Hamed Abedtash"/> 
    </Extension> 
    <Application name="OMOP-PMML Writer" version="0.1"/> 
    <Timestamp>2017-04-30 16:52:26</Timestamp> 
  </Header> 
  <MiningBuildTask> 
    <Extension name="age" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        select distinct extract(year from date '@INDEX_DATE')-year_of_birth as 
AGE from @SCHEMA.person where person_id=@PERSON_ID; 
      </Statement> 
    </Extension> 
    <Extension name="TCL" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with tcl as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
            FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
              where measurement_concept_id in (3027114) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                 and person_id=@PERSON_ID) meas 
            join (select distinct person_id, measurement_concept_id,  
              max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
              from @SCHEMA.measurement 
              where measurement_concept_id in (3027114) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                 and person_id=@PERSON_ID) measmax 
            on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from tcl 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
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    </Extension> 
    <Extension name="HDL" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with hdl as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
            FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
              where measurement_concept_id in (3007070) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                and person_id=@PERSON_ID) meas 
            join (select distinct person_id, measurement_concept_id,  
              max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
              from @SCHEMA.measurement 
              where measurement_concept_id in (3007070) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                and person_id=@PERSON_ID) measmax 
            on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from hdl 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
    </Extension> 
    <Extension name="HTNTRT" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with htnmed as (select distinct c2.concept_id 
                from omop.concept c1,omop.concept_ancestor a,omop.concept c2 
                where c1.concept_code in ('C02A', 'C02B', 'C02C', 'C02D', 
'C02K','C09AA','C09CA','C07AA','C07AB','C07AG','C08CA','C08D','C03AA','
C03BA','C03BX','C03CA','C03DA','C03DB') 
                and c1.vocabulary_id='ATC' 
                and a.ancestor_concept_id=c1.concept_id and 
a.descendant_concept_id=c2.concept_id 
                and c2.concept_class_id in ('Ingredient') 
          ), 
          rec as (select * from omop.drug_era  
            where drug_concept_id in (select distinct concept_id from htnmed) 
            and (to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_start_date and drug_era_end_date)  
            and person_id=@PERSON_ID 
          ) 
        select case when count(1)>0 then 1 else 0 end as HTNTRT from rec; 
      </Statement> 
    </Extension> 
    <Extension name="SBP" extender="omop"> 
      <InputParameters> 
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        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with sbp as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
          FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
            where measurement_concept_id in 
(3028737,3004249,3018586,3035856,3018822,21490779,21492239,4161413)  
              and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD') and 
person_id=@PERSON_ID) meas 
          join (select distinct person_id, measurement_concept_id,  
            max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
            from @SCHEMA.measurement 
            where measurement_concept_id in 
(3028737,3004249,3018586,3035856,3018822,21490779,21492239,4161413)  
              and person_id=@PERSON_ID 
              and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD')) 
measmax 
          on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from sbp 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
    </Extension> 
    <Extension name="smoker" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with smoker as (SELECT DISTINCT person_id,observation_concept_id, 
observation_date 
                FROM omop.observation  
                where observation_concept_id IN 
(4218741,4246415,4276526,4052947,4052029,4052030,4218917,4298794,427099
96,4043053,4144273,4144273,4043056)  
                  and person_id=@PERSON_ID and observation_date 
&lt;=to_date('@INDEXT_DATE','YYYY-MM-DD') 
              ), 
              last_smoke as (select max(observation_date)over(partition by 
person_id) as latest 
                from smoker 
              ) 
        select case when count(1)>0 then 1 else 0 end as SMOKER 
        from last_smoke where to_date('@INDEX_DATE','YYYY-MM-DD')-latest 
&lt;=90; 
      </Statement> 
    </Extension> 
    <Extension name="diabetic" extender="omop"> 
      <InputParameters> 
 137 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with medrec as (select * from omop.drug_era  
                where drug_concept_id in 
(1529331,1530014,44816332,43013884,19035533,43526465,19033498,1594973,447
85829,45774435,45774751,1583722,19001409,19059796,1597756,1560171,1909782
1,1559684,19001441,1000979,19122121,35604829,35605670,35602717,1516976,40
056629,1502905,1588986,1550023,1531601,1567198,1544838,40051349,40051350,
46221581,42899447,19090244,19090229,19090247,19090249,1513876,19090180,19
013926,19091621,19090187,19013951,1590165,1586346,1513849,1562586,1909020
4,1513843,40239216,40170911,44506754,1503297,1510202,1502826,19033909,152
5215,1517998,1596977,1516766,1547504,40166035,1580747,1502809,1502855,190
42191,1515249,19090226,19090221,1586369,19122137) 
                and (to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_start_date and drug_era_end_date 
                  OR to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_end_date and drug_era_end_date+30)  
                and person_id=@PERSON_ID 
            ), 
            hasdiabmed as (select case when count(1)>0 then 1 else 0 end as 
DIABETIC 
                from medrec 
            ) 
            , 
            lab AS (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
              FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from omop.measurement 
                where measurement_concept_id in (3037110)  
                  and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
and value_as_number>=126 and person_id=@PERSON_ID) meas 
              join (select distinct person_id, measurement_concept_id,  
                max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
                from omop.measurement 
                where measurement_concept_id in (3037110)  and 
person_id=@PERSON_ID 
                  and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-
DD')) measmax 
              on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE 
            ), 
            hasdiablab as (select case when count(1)>0 then 1 else 0 end as 
DIABETIC 
                from lab 
                where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=60 
            ), 
            diabdx as (select max(condition_era_end_date) as latest 
                from (SELECT DISTINCT * 
                  FROM omop.condition_era  
                  where condition_concept_id IN 
(201820,45757674,45757474,4096666,4008576,201254,4152858,201531,4099214,4
43412,201826,4196141,201530,4151282,4198296,4200875,4099651,4193704)  
                  and person_id=@PERSON_ID and condition_era_end_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD'))as dx 
            ), 
            hasdx as (select case when count(1)>0 then 1 else 0 end as DIABETIC 
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                from diabdx 
            ) 
          select case when sum(diabetic) > 0 then 1 else 0 end as DIABETIC from     
            (select diabetic from hasdiabmed 
            union all 
            select diabetic from hasdiablab 
            union all 
            select diabetic from hasdx) u 
          ; 
      </Statement> 
    </Extension> 
  </MiningBuildTask> 
  <DataDictionary numberOfFields="8"> 
    <DataField name="hazard" displayName="Cumulative Hazard" 
optype="continuous" dataType="double"/> 
    <DataField name="age" displayName="Age" optype="continuous" 
dataType="double"> 
      <Interval closure="closedClosed" leftMargin="30" rightMargin="74"/> 
    </DataField> 
    <DataField name="TCL" displayName="Total Cholesterol" optype="continuous" 
dataType="double"/> 
    <DataField name="HDL" displayName="HDL" optype="continuous" 
dataType="double"/> 
    <DataField name="HTNTRT" displayName="Antihypertensive medication use 
(y/n)" optype="categorical" dataType="boolean"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="SBP" displayName="Systolic Blood Pressure" 
optype="continuous" dataType="double"/> 
    <DataField name="smoker" displayName="Smoker(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="diabetic" displayName="Diabetic(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
  </DataDictionary> 
  <TransformationDictionary> 
    <DerivedField name="logAge" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="age"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logTCL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="TCL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logHDL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="HDL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="SBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_NOTTRT" dataType="double" optype="continuous"> 
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      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <Constant dataType="integer">0</Constant> 
        <FieldRef field="logSBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_TRT" dataType="double" optype="continuous"> 
      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <FieldRef field="logSBP"/> 
        <Constant dataType="integer">0</Constant> 
      </Apply> 
    </DerivedField> 
  </TransformationDictionary> 
  <RegressionModel modelName="framingham10ycvdmen" functionName="regression" 
algorithmName="Cox proportional-hazards regression" isScorable="true"> 
    <MiningSchema> 
      <MiningField name="hazard"  usageType="predicted"/> 
      <MiningField name="logAge"  usageType="active"/> 
      <MiningField name="logTCL"  usageType="active"/> 
      <MiningField name="logHDL"  usageType="active"/> 
      <MiningField name="logSBP_TRT"  usageType="active"/> 
      <MiningField name="logSBP_NOTTRT"  usageType="active"/> 
      <MiningField name="smoker"  usageType="active"/> 
      <MiningField name="diabetic"  usageType="active"/> 
    </MiningSchema> 
    <Output> 
      <OutputField name="hazard" optype="continuous" dataType="double" 
feature="predictedValue" isFinalResult="false"/> 
      <OutputField name="hazard_ratio" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="false"> 
        <Apply function="exp"> 
          <FieldRef field="hazard"/> 
        </Apply> 
      </OutputField> 
      <OutputField name="risk" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="true"> 
        <Apply fucntion="-"> 
          <Constant>1.0</Constant> 
          <Apply fucntion="pow"> 
            <Constant>0.88936</Constant> 
            <FieldRef field="hazard_ratio"/> 
          </Apply> 
        </Apply> 
      </OutputField> 
    </Output> 
    <RegressionTable  intercept="-23.9802"> 
      <NumericPredictor name="logAge" coefficient="3.06117"/> 
      <NumericPredictor name="logTCL" coefficient="1.12370"/> 
      <NumericPredictor name="logHDL" coefficient="-0.93263"/> 
      <NumericPredictor name="logSBP_TRT" coefficient="1.99881"/> 
      <NumericPredictor name="logSBP_NOTTRT" coefficient="1.93303"/> 
      <CategoricalPredictor name="smoker" value="1" coefficient="0.65451"/> 
      <CategoricalPredictor name="diabetic" value="1" coefficient="0.57367"/> 
    </RegressionTable> 
  </RegressionModel> 
</PMML>  
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Appendix 10. The O-PMML containing predictive model for estimating Framingham 10-
year risk of cardiovascular disease for women. 
<?xml version="1.0"?> 
<PMML version="4.3" xmlns="http://www.dmg.org/PMML-4_3" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.dmg.org/PMML-4_3 http://www.dmg.org/v4-3/pmml-
4-3.xsd"> 
  <Header copyright="Copyright (c) 2017 Hamed Abedtash 
{hamed.abedtash@gmail.com}" description="Framingham 10-year risk of 
cardiovascular disease for women"> 
    <Extension extender="omop"> 
      <OmopCdm version="5.1"/> 
      <author name="Hamed Abedtash"/> 
    </Extension> 
    <Application name="OMOP-PMML Writer" version="0.1"/> 
    <Timestamp>2017-04-30 16:52:26</Timestamp> 
  </Header> 
  <MiningBuildTask> 
    <Extension name="age" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        select distinct extract(year from date '@INDEX_DATE')-year_of_birth as 
AGE from @SCHEMA.person where person_id=@PERSON_ID; 
      </Statement> 
    </Extension> 
    <Extension name="TCL" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with tcl as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
            FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
              where measurement_concept_id in (3027114) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                 and person_id=@PERSON_ID) meas 
            join (select distinct person_id, measurement_concept_id,  
              max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
              from @SCHEMA.measurement 
              where measurement_concept_id in (3027114) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                 and person_id=@PERSON_ID) measmax 
            on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from tcl 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
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    </Extension> 
    <Extension name="HDL" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with hdl as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
            FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
              where measurement_concept_id in (3007070) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                and person_id=@PERSON_ID) meas 
            join (select distinct person_id, measurement_concept_id,  
              max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
              from @SCHEMA.measurement 
              where measurement_concept_id in (3007070) and measurement_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
                and person_id=@PERSON_ID) measmax 
            on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from hdl 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
    </Extension> 
    <Extension name="HTNTRT" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with htnmed as (select distinct c2.concept_id 
                from omop.concept c1,omop.concept_ancestor a,omop.concept c2 
                where c1.concept_code in ('C02A', 'C02B', 'C02C', 'C02D', 
'C02K','C09AA','C09CA','C07AA','C07AB','C07AG','C08CA','C08D','C03AA','
C03BA','C03BX','C03CA','C03DA','C03DB') 
                and c1.vocabulary_id='ATC' 
                and a.ancestor_concept_id=c1.concept_id and 
a.descendant_concept_id=c2.concept_id 
                and c2.concept_class_id in ('Ingredient') 
          ), 
          rec as (select * from omop.drug_era  
            where drug_concept_id in (select distinct concept_id from htnmed) 
            and (to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_start_date and drug_era_end_date)  
            and person_id=@PERSON_ID 
          ) 
        select case when count(1)>0 then 1 else 0 end as HTNTRT from rec; 
      </Statement> 
    </Extension> 
    <Extension name="SBP" extender="omop"> 
      <InputParameters> 
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        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with sbp as (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
          FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from @SCHEMA.measurement 
            where measurement_concept_id in 
(3028737,3004249,3018586,3035856,3018822,21490779,21492239,4161413)  
              and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD') and 
person_id=@PERSON_ID) meas 
          join (select distinct person_id, measurement_concept_id,  
            max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
            from @SCHEMA.measurement 
            where measurement_concept_id in 
(3028737,3004249,3018586,3035856,3018822,21490779,21492239,4161413)  
              and person_id=@PERSON_ID 
              and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD')) 
measmax 
          on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE) 
        select value_as_number from sbp 
        where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=30 
        order by meas_date desc limit 1; 
      </Statement> 
    </Extension> 
    <Extension name="smoker" extender="omop"> 
      <InputParameters> 
        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with smoker as (SELECT DISTINCT person_id,observation_concept_id, 
observation_date 
                FROM omop.observation  
                where observation_concept_id IN 
(4218741,4246415,4276526,4052947,4052029,4052030,4218917,4298794,427099
96,4043053,4144273,4144273,4043056)  
                  and person_id=@PERSON_ID and observation_date 
&lt;=to_date('@INDEXT_DATE','YYYY-MM-DD') 
              ), 
              last_smoke as (select max(observation_date)over(partition by 
person_id) as latest 
                from smoker 
              ) 
        select case when count(1)>0 then 1 else 0 end as SMOKER 
        from last_smoke where to_date('@INDEX_DATE','YYYY-MM-DD')-latest 
&lt;=90; 
      </Statement> 
    </Extension> 
    <Extension name="diabetic" extender="omop"> 
      <InputParameters> 
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        <InputParameter name="INDEX_DATE" displayName="Index date (YYYY-MM-DD)" 
optype="continous" dataType="date"/> 
        <InputParameter name="PERSON_ID" displayName="OMOP Person ID" 
optype="continuous" dataType="bigint"/> 
        <InputParameter name="SCHEMA" displayName="Database schema" 
dataType="string"/> 
      </InputParameters> 
      <Statement dialect="postgresql"> 
        with medrec as (select * from omop.drug_era  
                where drug_concept_id in 
(1529331,1530014,44816332,43013884,19035533,43526465,19033498,1594973,4
4785829,45774435,45774751,1583722,19001409,19059796,1597756,1560171,190
97821,1559684,19001441,1000979,19122121,35604829,35605670,35602717,1516
976,40056629,1502905,1588986,1550023,1531601,1567198,1544838,40051349,4
0051350,46221581,42899447,19090244,19090229,19090247,19090249,1513876,1
9090180,19013926,19091621,19090187,19013951,1590165,1586346,1513849,156
2586,19090204,1513843,40239216,40170911,44506754,1503297,1510202,150282
6,19033909,1525215,1517998,1596977,1516766,1547504,40166035,1580747,150
2809,1502855,19042191,1515249,19090226,19090221,1586369,19122137) 
                and (to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_start_date and drug_era_end_date 
                  OR to_date('@INDEX_DATE','YYYY-MM-DD') between 
drug_era_end_date and drug_era_end_date+30)  
                and person_id=@PERSON_ID 
            ), 
            hasdiabmed as (select case when count(1)>0 then 1 else 0 end as 
DIABETIC 
                from medrec 
            ) 
            , 
            lab AS (select distinct meas.person_id, 
meas.measurement_concept_id, meas.value_as_number, measmax.MEAS_DATE  
              FROM (select distinct person_id, measurement_concept_id, 
value_as_number, measurement_date from omop.measurement 
                where measurement_concept_id in (3037110)  
                  and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-DD') 
and value_as_number>=126 and person_id=@PERSON_ID) meas 
              join (select distinct person_id, measurement_concept_id,  
                max(measurement_date) over(partition by 
person_id,measurement_concept_id) as MEAS_DATE   
                from omop.measurement 
                where measurement_concept_id in (3037110)  and 
person_id=@PERSON_ID 
                  and measurement_date &lt;=to_date('@INDEX_DATE','YYYY-MM-
DD')) measmax 
              on meas.person_id=measmax.person_id and 
meas.measurement_date=measmax.MEAS_DATE 
            ), 
            hasdiablab as (select case when count(1)>0 then 1 else 0 end as 
DIABETIC 
                from lab 
                where to_date('@INDEX_DATE','YYYY-MM-DD')-MEAS_DATE &lt;=60 
            ), 
            diabdx as (select max(condition_era_end_date) as latest 
                from (SELECT DISTINCT * 
                  FROM omop.condition_era  
                  where condition_concept_id IN 
(201820,45757674,45757474,4096666,4008576,201254,4152858,201531,4099214
,443412,201826,4196141,201530,4151282,4198296,4200875,4099651,4193704)  
                  and person_id=@PERSON_ID and condition_era_end_date 
&lt;=to_date('@INDEX_DATE','YYYY-MM-DD'))as dx 
            ), 
            hasdx as (select case when count(1)>0 then 1 else 0 end as DIABETIC 
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                from diabdx 
            ) 
          select case when sum(diabetic) > 0 then 1 else 0 end as DIABETIC from     
            (select diabetic from hasdiabmed 
            union all 
            select diabetic from hasdiablab 
            union all 
            select diabetic from hasdx) u 
          ; 
      </Statement> 
    </Extension> 
  </MiningBuildTask> 
  <DataDictionary numberOfFields="8"> 
    <DataField name="hazard" displayName="Cumulative Hazard" 
optype="continuous" dataType="double"/> 
    <DataField name="age" displayName="Age" optype="continuous" 
dataType="double"> 
      <Interval closure="closedClosed" leftMargin="30" rightMargin="74"/> 
    </DataField> 
    <DataField name="TCL" displayName="Total Cholesterol" optype="continuous" 
dataType="double"/> 
    <DataField name="HDL" displayName="HDL" optype="continuous" 
dataType="double"/> 
    <DataField name="HTNTRT" displayName="Antihypertensive medication use 
(y/n)" optype="categorical" dataType="boolean"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="SBP" displayName="Systolic Blood Pressure" 
optype="continuous" dataType="double"/> 
    <DataField name="smoker" displayName="Smoker(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
    <DataField name="diabetic" displayName="Diabetic(y/n)" optype="categorical" 
dataType="integer"> 
      <Value value="1"/> 
      <Value value="0"/> 
    </DataField> 
  </DataDictionary> 
  <TransformationDictionary> 
    <DerivedField name="logAge" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="age"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logTCL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="TCL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logHDL" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="HDL"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP" dataType="double" optype="continuous"> 
      <Apply function="ln"> 
        <FieldRef field="SBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_NOTTRT" dataType="double" optype="continuous"> 
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      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <Constant dataType="integer">0</Constant> 
        <FieldRef field="logSBP"/> 
      </Apply> 
    </DerivedField> 
    <DerivedField name="logSBP_TRT" dataType="double" optype="continuous"> 
      <Apply function="if"> 
        <Apply function="equal" dataType="boolean"> 
          <FieldRef field="HTNTRT"/> 
          <Constant dataType="integer">1</Constant> 
        </Apply> 
        <FieldRef field="logSBP"/> 
        <Constant dataType="integer">0</Constant> 
      </Apply> 
    </DerivedField> 
  </TransformationDictionary> 
  <RegressionModel modelName="framingham10ycvdmen" functionName="regression" 
algorithmName="Cox proportional-hazards regression" isScorable="true"> 
    <MiningSchema> 
      <MiningField name="hazard"  usageType="predicted"/> 
      <MiningField name="logAge"  usageType="active"/> 
      <MiningField name="logTCL"  usageType="active"/> 
      <MiningField name="logHDL"  usageType="active"/> 
      <MiningField name="logSBP_TRT"  usageType="active"/> 
      <MiningField name="logSBP_NOTTRT"  usageType="active"/> 
      <MiningField name="smoker"  usageType="active"/> 
      <MiningField name="diabetic"  usageType="active"/> 
    </MiningSchema> 
    <Output> 
      <OutputField name="hazard" optype="continuous" dataType="double" 
feature="predictedValue" isFinalResult="false"/> 
      <OutputField name="hazard_ratio" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="false"> 
        <Apply function="exp"> 
          <FieldRef field="hazard"/> 
        </Apply> 
      </OutputField> 
      <OutputField name="risk" optype="continuous" dataType="double" 
feature="transformedValue" isFinalResult="true"> 
        <Apply fucntion="-"> 
          <Constant>1.0</Constant> 
          <Apply fucntion="pow"> 
            <Constant>0.95012</Constant> 
            <FieldRef field="hazard_ratio"/> 
          </Apply> 
        </Apply> 
      </OutputField> 
    </Output> 
    <RegressionTable  intercept="-26.1931"> 
      <NumericPredictor name="logAge" coefficient="2.32888"/> 
      <NumericPredictor name="logTCL" coefficient="1.20904"/> 
      <NumericPredictor name="logHDL" coefficient="-0.70833"/> 
      <NumericPredictor name="logSBP_TRT" coefficient="2.82263"/> 
      <NumericPredictor name="logSBP_NOTTRT" coefficient="2.76157"/> 
      <CategoricalPredictor name="smoker" value="1" coefficient="0.52873"/> 
      <CategoricalPredictor name="diabetic" value="1" coefficient="0.69154"/> 
    </RegressionTable> 
  </RegressionModel> 
</PMML> 
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Appendix 11. Estimated 10-year risk score of cardiovascular disease for 56 records of 8 unique patients. F: Female, M: Male, TCL: Total 
cholesterol level, HDL: High-density lipoprotein cholesterol level, SBP: Systolic blood pressure. 
Patient ID Gender Age TCL HDL 
Antihypertensive Use 
(1: Yes, 0: No) 
SBP 
Smoker 
(1: Yes, 0: No) 
Diabetic 
(1: Yes, 0: No) 
Risk 
Score 
Patient 1 F 31 161 42 1 133 0 0 2.07% 
Patient 1 F 31 161 42 1 133 0 0 2.07% 
Patient 2 M 44 219 47 0 162 0 0 10.10% 
Patient 3 F 30 184 31 0 106 0 0 1.11% 
Patient 3 F 30 184 31 0 108 0 0 1.17% 
Patient 4 F 52 200 35 0 140.5 0 0 8.51% 
Patient 5 M 67 143 36 1 134.9 0 0 25.69% 
Patient 5 M 67 143 36 1 119.6 0 0 20.81% 
Patient 5 M 67 143 36 1 134.9 0 0 25.69% 
Patient 5 M 67 143 36 1 119.6 0 0 20.81% 
Patient 5 M 67 143 36 1 134.9 0 0 25.69% 
Patient 5 M 67 143 36 1 119.1 0 0 20.66% 
Patient 6 F 49 170 47.5 1 149 0 0 7.86% 
Patient 6 F 49 170 47.5 1 149 0 0 7.86% 
Patient 6 F 50 170 47.5 0 149 0 0 6.12% 
Patient 6 F 50 170 42.7 0 149 0 0 6.59% 
Patient 6 F 51 170 42.7 0 149 0 0 6.89% 
Patient 7 M 64 87 25 1 149.5 0 1 36.37% 
Patient 7 M 64 87 25 1 148 0 1 35.79% 
Patient 7 M 64 87 25 1 148 0 1 35.79% 
Patient 7 M 64 87 25 1 148 0 1 35.79% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
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Patient ID Gender Age TCL HDL 
Antihypertensive Use 
(1: Yes, 0: No) 
SBP 
Smoker 
(1: Yes, 0: No) 
Diabetic 
(1: Yes, 0: No) 
Risk 
Score 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 1 130 0 0 5.32% 
Patient 8 F 49 140 35 0 130 0 0 3.98% 
Patient 8 F 49 140 35 0 130 0 0 3.98% 
Patient 8 F 49 140 35 0 124.5 0 0 3.54% 
Patient 8 F 49 140 35 0 124.5 0 0 3.54% 
Patient 8 F 49 140 35 0 124.5 0 0 3.54% 
Patient 8 F 50 140 35 0 124.5 0 0 3.71% 
Patient 8 F 50 140 35 0 124.5 0 0 3.71% 
Patient 8 F 50 140 35 0 124.5 0 0 3.71% 
Patient 8 F 50 149 40 0 124.5 0 0 3.64% 
Patient 8 F 50 149 40 0 124.5 0 0 3.64% 
Patient 8 F 50 149 40 0 124.5 0 0 3.64% 
Patient 8 F 50 149 40 0 119.3 0 0 3.24% 
Patient 8 F 50 149 40 0 119.3 0 0 3.24% 
Patient 8 F 50 149 40 0 119.3 0 0 3.24% 
Patient 8 F 50 149 40 0 119.3 0 0 3.24% 
Patient 8 F 51 149 40 0 119.3 0 0 3.39% 
Patient 8 F 51 149 40 0 119.3 0 0 3.39% 
Patient 8 F 51 149 40 0 119.3 0 0 3.39% 
Patient 8 F 51 149 40 1 119.3 0 0 4.51% 
Patient 8 F 51 149 40 1 119.3 0 0 4.51% 
Patient 8 F 51 149 40 1 119.3 0 0 4.51% 
Patient 8 F 51 149 40 1 119.3 0 0 4.51% 
  
1
4
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Patient ID Gender Age TCL HDL 
Antihypertensive Use 
(1: Yes, 0: No) 
SBP 
Smoker 
(1: Yes, 0: No) 
Diabetic 
(1: Yes, 0: No) 
Risk 
Score 
Patient 8 F 52 149 40 1 116.3 0 0 4.40% 
Patient 8 F 52 149 40 1 116.3 0 0 4.40% 
Patient 8 F 52 149 40 1 116.3 0 0 4.40% 
Patient 8 F 52 149 40 1 116.3 0 0 4.40% 
Patient 8 F 52 143 43 1 114 0 0 3.77% 
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